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ABSTRACT 
The mucosal disease, gonorrhea, caused by the Gram-negative pathogen 
Neisseria gonorrhoeae, is estimated to have at least 700,000 cases annually in 
the United States and 62 million cases worldwide. A strict human pathogen, N. 
gonorrhoeae infects several mucosal sites throughout the body making proper 
gene regulation crucial. The goal of these studies was to define the global 
transcriptional response of N. gonorrhoeae during infection by analyzing its 
transcriptome during in vitro growth, during incubation with human epithelial cells, 
and during in vivo mucosal infection of the human female genital tract. Using 
RNA sequencing , we identified several new small RNA transcripts expressed in 
vitro that have the potential to regulate target mRNAs. Our studies were aided 
by the development of a novel computer program, Rockhopper, designed 
specifically for analysis of prokaryotic transcriptomes. Secondary methods were 
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used to corroborate a strong correlation between Rockhopper analysis and N. 
gonorrhoeae transcriptional start sites, operon structures and gene expression 
levels. We also utilized Rockhopper to analyze the gonococcal transcriptome 
expressed during incubation with a human endocervical cell line. During such 
incubation , N. gonorrhoeae was demonstrated to regulate a large number of 
stress response and respiratory genes. Corresponding analysis of host cells 
during incubation with N. gonorrhoeae revealed increased expression of host 
pathways involved in innate immunity, adaptive immunity, cancer and apoptosis. 
Finally, analysis of gonococcal RNA from four vaginal lavage samples of 
female patients exposed to partners infected with N. gonorrhoeae was 
performed. This analysis demonstrated a similar profile of gonococcal stress 
response genes compared to incubation with epithelial cells. In addition , several 
novel sRNAs expressed by the gonococcus only during in vivo infection were 
also identified. Analysis of the same vaginal lavage samples demonstrated that 
a number of human genes involved in immune pathways and cancer are 
expressed during mucosal gonococcal infection. These studies are the first to 
analyze gene regulation inN. gonorrhoeae globally during infection and greatly 
expand our knowledge of how the host and pathogen respond to infection. 
Furthermore, they have the potential to aid in the development of novel 
antibacterial therapeutics or new vaccine targets for this disease. 
vii 
Title 
Copyright Page 
Reader's Approval Page 
Acknowledgements 
Abstract 
Table of Contents 
List of Tables 
List of Figures 
List of Abbreviations 
Introduction 
Methods 
Bacterial culture conditions 
TABLE OF CONTENTS 
Methodology used specifically to identify novel sRNAs 
RNA isolation 
Ribosomal RNA depletion 
Preparation of eDNA libraries and RNA sequencing 
Analysis of N. gonorrhoeae RNA sequencing data 
Analysis of human RNA sequencing data 
Northern blot analysis of small RNAs 
Primer extension analysis 
viii 
ii 
ii 
iv 
vi 
viii 
xi 
xiii 
XV 
1 
48 
48 
49 
51 
51 
51 
53 
59 
59 
60 
13-galactosidase assays 
Quantitative qRT-PCR 
RT-PCR of operons 
Human cell lines 
Human cell line growth conditions 
In vitro incubation of human cells with N. gonorrhoeae 
Clinical samples 
Medium, Buffers, and Reagents 
Results 
Chapter 1. Regulatory small RNAs of Neisseria 
Identification of novel sRNAs in N. gonorrhoeae 
Confirmation of novel sRNAs 
Regulation of sRNAs of the gonococcus 
Genomic location of novel sRNAs 
Secondary structure of novel sRNAs 
Role of Hfq in NrrF regulatory mechanisms 
Chapter 2. Tools to analyze the complete transcriptome 
of N. gonorrhoeae. 
Challenges in analysis of RNA-seq data 
Alignment and normalization of input data 
Determining transcriptional start sites 
Gene expression levels 
ix 
63 
63 
67 
67 
68 
68 
69 
73 
77 
77 
77 
79 
91 
92 
97 
102 
107 
107 
111 
115 
119 
Operon prediction 121 
Chapter 3. Global RNA analysis of N. gonorrhoeae and host 129 
during infection. 
Transcriptome response of N. gonorrhoeae to incubation with End E6/E7 129 
cells. 
Transcriptome response of End E6/E7 cells to incubation with 
N. gonorrhoeae 
Analysis of N. gonorrhoeae and the human host in vivo 
Patient population 
Gonococcal transcriptional response during mucosal Infection 
of the female genital tract 
Host transcriptional response to gonococcal infection 
of the female genital tract 
Chapter 4. Discussion and Conclusions 
List of journal abbreviations 
References 
Curriculum Vitae 
X 
136 
145 
148 
154 
167 
177 
207 
212 
244 
LIST OF TABLES 
Table Title Page 
1 Probes used in this study 61 
2 Primers used in these studies 64 
3 Expression of putative N. gonorrhoeae small RNA 80 
regulators 
4 Size of putative N. gonorrhoeae small RNA regulators 82 
5 Previously known non-coding sRNAs that were also found 90 
in this study. 
6 Putative targets of smRNA8 93 
7 Gonococcal sRNAs regulated via incubation of N. 137 
gonorrhoeae with End E6/E7 cells 
8 Host genes whose expression was decreased after 143 
incubation with N. gonorrhoeae 
9 Unannotated transcripts of End E6/E7 cells regulated 146 
during incubation with N. gonorrhoeae. 
10 Clinical history of female patients 150 
11 Symptomatic response of female patients 153 
12 Preliminary analysis of patient RNA-sequencing 155 
13 To 25 gonococcal genes expressed during clinical 156 
infection of the female genital tract 
xi 
14 N. gonorrhoeae genes showing the largest decrease in 161 
expression when comparing Patient 4 to average of . 
Patients 1, 2, and 3. 
15 N. gonorrhoeae genes showing the greatest increase in 163 
expression when Comparing Patient 4 to average of 
Patients 1, 2, and 3. 
16 Non-annotated N. gonorrhoeae transcripts expressed 168 
during clinical infection. 
17 Top 25 human genes expressed during clinical infection 171 
with N. gonorrhoeae. 
xii 
LIST OF FIGURES 
Figure Title Page 
1 N. gonorrhoeae interactions with host cells 6 
2 Schematic of bacterial regulatory sRNAs 27 
3 Regulatory mechanisms of sRNAs 29 
4 Schematic describing global RNA sequencing 42 
5 Experimental design for identifying novel N. gonorrhoeae 78 
sRNAs 
6 Confirmation of sRNAs as determined by Rockhopper 84 
analysis 
7 Northern blot analysis of novel sRNAs 87 
8 Primer extension analysis of identified sRNAs 96 
9 Genomic location of sRNAs in N. gonorrhoeae genome 98 
FA1090 
10 mFold analysis of smRNA 15 100 
11 Effect of the hfq- mutation on regulation of the succinate 103 
dehydrogenase genes 
12 Effect of the hfq- mutant on the iron regulation of the sdhC 105 
promoter 
13 Aspects of the global transcriptome of prokaryotes 108 
14 Comparison of Rockhopper to other alignment programs 113 
xiii 
15 Primer extension corroboration of Rockhopper predictions 117 
16 qRT-PCR corroboration of Rockhopper predictions 120 
17 RT-PCR corroboration of Rockhopper predictions 123 
18 IGV visualization of Rockhopper results 126 
19 Categorization of gonococcal genes upregulated during 131 
incubation with End E6/E7 cells 
20 Categorization of gonococcal genes downregulated during 134 
incubation with End E6/E7 cells 
21 Keyword categorization (DAVID) of host genes 138 
upregulated during infection 
22 KEGG pathway categorization (DAVID) of host genes 140 
upregulated during infection 
23 Immunity and apoptosis related host genes regulated via 142 
incubation with N. gonorrhoeae 
24 Top 100 N. gonorrhoeae genes expressed during mucosal 166 
infection of the female genital tract. 
25 KEGG pathway categorization (DAVID) of host genes 173 
expressed during in vivo N. gonorrhoeae infection 
xiv 
ATP 
CDC 
COM 
DAVID 
DGI 
End E6/E7 
FDA 
IG 
IGV 
KEGG 
KSFM 
lncRNA 
LOS 
NCSTD 
NOD 
PCR 
PID 
PMN 
PNK 
RPKM 
ABBREVIATIONS 
Adenosine triphosphate 
Centers for Disease Control 
Chemically defined media 
Database for Annotation, Visualization and Integrated Discovery 
Disseminated Gonococcal infection 
Transformed endocervical epithelial cells 
Food and Drug Administration 
lntergenic 
Integrated Genome Viewer 
Kyoto Encyclopedia of Genes and Genomes 
Keratinocyte Serum Free Media 
Long non-coding RNA 
Lipooligosaccharide 
National Center for Sexually Transmitted Diseases 
Nuclear oligomerization domain 
Polymerase chain reaction 
Pelvic inflammatory disease 
Polymorphonuclear neutrophil 
Polynucleotide kinase 
Reads Per kilobase per million reads 
XV 
RIT 
RNA-seq 
RT-PCR 
SDS 
sRNA 
sse 
STI 
TBE 
TE 
THUEC 
TLR 
TSS 
UTR 
WHO 
Rho independent terminator 
Global RNA sequencing 
Reverse transcriptase-polymerase chain reaction 
Sodium dodecyl sulfate 
small RNA 
Saline sodium citrate 
Sexually transmitted infection 
Tris/borate/EDTA 
Tris/EDTA 
Transformed human urethral epithelial cells 
Toll-like receptor 
Transcriptional start site 
Untranslated region 
World Health Organization 
xvi 
INTRODUCTION 
Epidemiology of Pathogenic Neisseria Species 
The sexually transmitted infection (STI) gonorrhea, caused by the Gram-
negative bacteria Neisseria gonorrhoeae, represents the second most common 
reportable disease in the U.S. with 310,000 confirmed cases in 2010 and as 
many as 700,000 estimated cases (CDC) . A worldwide disease, N. gonorrhoeae 
also infects an estimated 62 million people globally (WHO). As a mucosal 
bacterial pathogen N. gonorrhoeae most commonly colonizes the male and 
female genital tracts, although oropharyngeal, anal , and conjunctival infections 
have also been reported [1, 2]. Infection generally produces a pro-inflammatory 
response of the host culminating in symptoms including purulent discharge and 
painful urination. Without medical intervention the infection continues and can 
lead to other complications such as pelvic inflammatory disease (PID) and 
disseminated gonococcal infection (DGI) [3 , 4]. PID is a microbial infection of the 
upper genital tract that affects approximately 750,000 women annually in the 
U.S. [5]. Women who have PID have a 20% chance of developing infertility due 
to tubal scarring and a 9% chance of having an ectopic pregnancy [6, 7]. 
Infection by N. gonorrhoeae can also lead to DGI, the spread of the organisms to 
other sites of the body causing skin lesions, polyarthralgias and arthritic 
symptoms [8] . Indeed, among STis, N. gonorrhoeae is the most common cause 
of bacterial arthritis and in the 1970s-80s was the most common cause of 
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bacterial arthritis among all bacteria [9]. In the United States in the 1970s 
approximately 3% of gonorrhea cases progressed to DGI, though this number 
has fallen as cases of gonorrhea have decreased [1 0]. With the development of 
antibiotic therapy in the 1940s patients suffering from gonorrhea enjoyed a 
relatively easy course of treatment. However, as with any pathogen, the 
emergence of antibiotic resistant strains is a constant medical issue. Strains 
isolated in Canada, Europe, Japan, China and South Africa are beginning to 
show resistance to azithromycin as well as the cephalosporin antibiotics cefixime 
and ceftriaxone, the last single dose antibiotic treatments approved by the FDA 
[11-15]. To address this, the CDC has recently updated the recommended 
treatment for gonorrhea to comprise an injectable dose of ceftriaxone combined 
with an oral dose of azithromycin or doxycycline. This is in contrast to previous 
recommendations of only a single oral dose of cefixime. While doses with two or 
more antibiotics is a possible temporary solution, the added costs and logistical 
aspects associated with a dual drug treatment means that new avenues of 
antibiotic therapy are necessary. 
Besides infection with N. gonorrhoeae, many patients reporting to STI 
clinics with gonococcal urethritis may be suffering from co-infections with one or 
more organisms. For example, in both the U.S. and China, approximately 40% 
of patients with gonorrhea are suffering from a co-infection with Chlamydia 
trachomatis. In addition, it is known that host immune responses differ during co-
infection compared to those patients suffering from infection of N. gonorrhoeae 
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alone making the study of co-infections as important as the study of N. 
gonorrhoeae infections alone [16]. 
The only other pathogenic Neisseria species is N. meningitidis, another 
mucosal pathogen that can reside in the nasopharynx of 10-30% of the 
population asymptomatically [17-19]. In the United States, meningococcal 
infection rates have waxed and waned over the past decades, with 1,194 cases 
in 2006 [20, 21]. N. meningitidis can become infectious through breaching of the 
epithelial barrier of the nasopharynx where it can then move into the 
bloodstream, giving rise to one of two disease states. N. meningitidis can either 
cross the blood-brain barrier and present as meningococcal meningitis or remain 
in the bloodstream and lead to meningococcal septicemia (CDC). Symptoms 
include fever, malaise, chills and a characteristic purpuric rash that does not 
blanch under pressure. The fatality rate of meningocococal infection is up to 
40% with 20% of patients suffering hearing loss, neurological damage or loss of 
limbs (CDC). Unlike N. gonorrhoeae, there is less concern over antibiotic 
resistant strains of N. meningitidis, likely due to the lower prevalence of the 
disease. 
Development of Neisseria! Vaccines 
Due to increased antibiotic resistance there has recently been a renewed 
interest in the development of a gonococcal vaccine. Vaccination against N. 
meningitidis has been available and in use in the United States since 1982 [22] in 
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the form of a polysaccharide vaccine directed against the meningococcal 
capsule. Improvements on this vaccine came approximately two decades later 
with the development of conjugate polysaccharide vaccines [23] . All of these 
vaccines use the meningococcal capsule as an immunogenic ligand. However, 
the capsule of serotype B of N. meningitidis (MenB) is similar to host ligands and 
thus vaccines against this capsule are poorly immunogenic [24, 25]. It is a 
testament to the immunogenic importance of the capsule that there has been 
considerable difficulty in developing a vaccine to MenB. Despite these 
challenges there has been progress in developing a MenB vaccine recognizing 
other targets besides the capsule. A new vaccine (4CMenB) has been 
developed against 4 non-capsule targets: the factor H-binding protein, Neisseria! 
heparin binding antigen , Neisseria! adhesin A, and outer membrane vesicles. 
This vaccine has been tested in both Europe and Canada with positive results 
[26, 27]. In contrast, the lack of a vaccine against N. gonorrhoeae is likely the 
result of a variety of factors. Firstly, the development of a vaccine against N. 
meningitidis was encouraged by the high mortality associated with the disease, 
unlike gonorrhea, which is almost never fatal and until recently was easily cured 
with antibiotics. Secondly, the social stigmas attached with developing a vaccine 
against an STI likely hampered such efforts. Thirdly, possible vaccine targets of 
N. gonorrhoeae such as pilin or outer membrane proteins including Rmp or Opa 
are subject to a large amount of variation both in expression and antigenic 
variability, making their use as vaccine targets problematic when considering 
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cross-reactivity between gonococcal strains [28-30]. Lastly, N. gonorrhoeae 
lacks a capsule so potential vaccine targets that are present on N. meningitidis 
are absent on N. gonorrhoeae. With antibiotic resistant strains of N. 
gonorrhoeae on the rise, the need for a pan-gonococcal vaccine is paramount. 
Fortunately, there has been some promising research in this direction and 
researchers at the University of Massachusetts currently have a candidate 
undergoing testing at the National Institutes of Health and are preparing for 
human trials. Despite this, work on gonococcal vaccines still lags behind 
corresponding meningococcal vaccines. 
Gonococcal Pathogenesis and Initial Interactions between N. gonorrhoeae 
and the Human Host 
As a strictly human pathogen, N. gonorrhoeae is uniquely adapted to its 
human host and expresses a large number of proteins and pathways to initiate 
infection, survive within multiple cells types, obtain nutrients and resist both the 
natural immune response of the host as well as exogenous antibiotic treatment. 
Infection begins in the mucosal tract of one of several body sites, the most 
common being the male and female genital tracts. Here, N. gonorrhoeae first 
comes into contact with epithelial cells (Figure 1). Initial attachment to epithelial 
cells is mediated by pilin on the surface of N. gonorrhoeae that binds to host 
CD46, which is expressed on all epithelial cells [31] and seems to be restricted to 
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Figure 1. N. gonorrhoeae interactions with host cells. N. gonorrhoeae (GC) 
expresses many types of adhesin proteins that can interact with specific 
receptors on host cells. Initial interactions are carried out through pilin proteins 
expressed by N. gonorrhoeae and host CD46. More intimate contact is mediated 
by gonococcal Opa proteins and host CEACAM or HSPGs. In addition to acting 
as translocases, N. gonorrhoeae porin proteins can bind to Gp96 receptors on 
host cells. N. gonorrhoeae also expresses a homologue of the OmpA 
Escherichia coli adhesin. In E. coli, this adhesin also binds to Gp96 but the 
receptor for gonococcal interaction has not been definitively shown. Gonococcal 
LOS has also been shown to mediate invasion of host cells and specific host 
receptors differ between men and women with LOS binds to glycoproteins in the 
male genital tract and complement receptor 3 in the female genital tract. Finally, 
the L 12 riboprotein has been shown to mediate invasion through binding to the 
lutropin receptor on host cells. 
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these cell types [32]. Pilin may also have other targets as CD46 does not seem 
to be strictly necessary for gonococcal host cell binding [33]. The PiiC subunit of 
pilin was shown to be crucial for attachment as a pi/C mutant strain of N. 
gonorrhoeae was unable to attach to host cells and pre-treatment with the PiiC 
subunit alone prevented subsequent binding by whole cell N. gonorrhoeae [34, 
35]. Once attached, pilin act on host cells by upregulating phophoinositide-3-
kinase pathways (involved in endocytosis) [36] as well as releasing intracellular 
stores of Ca2+, which can promote intracellular survival of bacteria [37]. Pi lin are 
dynamic molecular structures and can retract along their length, bringing the 
gonococcus into intimate contact with the host cell [38]. Further binding between 
N. gonorrhoeae and host cells is carried out through interactions between 
gonococcal Opa proteins and either Carcinoembryonic antigen-related cell 
adhesion molecules (CEACAMs) or heparin sulfate proteoglycans (HSPGs) 
expressed on the surface of host cells [39]. Aside from these main adhesins N. 
gonorrhoeae express several others including porins, OmpA, lipooligosaccharide 
(LOS) and the L 12 riboprotein. Porins, specifically PorB1A have been shown to 
bind to both the Gp96 glycoprotein as well as the scavenger receptor expressed 
by endothelial cells receptor on host cells [40]. OmpA was recently shown in N. 
gonorrhoeae to mediate adherence to human cervical and endometrial cells as 
well as play a role in successful infection in the mouse. This protein is a 
homologue of an adhesin in E. coli that also uses Gp96 for binding but currently 
the specific host target of gonococcal OmpA is unknown [41]. LOS, aside from 
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being an important virulence factor has also been implicated in adherence to 
epithelial cells [42]. LOS binds to different host proteins depending on whether 
infection takes place in the male or female genital tract. In the male genital tract, 
LOS binds to glycoprotein receptors while in the female genital tract complement 
receptor 3 (CR3) acts as the binding molecule for LOS. Finally, aside from acting 
in translation pathways, the gonococcal L 12 ribosomal protein has been shown 
to be an important adhesin that interacts with the host lutropin receptor [43, 44]. 
This last observation suggests the possibility that other genes that are thought to 
be involved in metabolic or housekeeping functions could also have dual 
functions in physical interactions with host cells. 
Gonococcal Mechanisms of Host Resistance 
During infection, N. gonorrhoeae is subjected to environmental stresses 
that require a counteracting bacterial response necessary for survival. Such 
stresses include lack of critical nutrients, epithelial-produced antimicrobial factors 
and elements of the innate immune system. N. gonorrhoeae is also a facultative 
intracellular pathogen and can survive inside both epithelial cells as well as 
professional immune cells such as polymorphonuclear neutrophils (PMNs) [45-
49]. While growth within epithelial cells likely offers a measure of protection 
against further immune detection by the host, the gonococcus must still contend 
with other antimicrobial defenses such as bile salts, antimicrobial peptides and 
bactericidal free fatty acids [50, 51]. Survival of N. gonorrhoeae in the presence 
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of these molecules is mediated by gene products from two distinct genetic loci 
that act as efflux pumps to remove these toxic compounds from the bacterial cell 
wall. 
The first to be discovered, the multiple transferable resistance (mtr) CDE 
locus, was shown to confer resistance to several host-derived hydrophobic 
compounds such as protegrin-1 , progesterone, LL-27 and Triton X-1 00 as well as 
hydrophobic antibiotics including erythromycin and rifampicin [51-55]. This locus 
is under the control of two classical DNA binding proteins. The Mtr repressor 
(MtrR) protein acts to down regulate expression of the mtrC transcript and 
presumably others in the operon as well [56]. In contrast, expression of mtrCDE 
is enhanced by Mtr activator (MtrA), a protein that leads to the induction of mtrC 
in the presence of hydrophobic compounds such as Triton X-1 00 [57]. Several 
studies have shown that mutations of the MtrR protein lead to enhanced fitness 
of N. gonorrhoeae in a mouse model of infection suggesting that this system may 
also be crucial for survival of the organism in the human host [55, 58]. 
The observation that gonococcal strains exist that are hypersensitive to 
hydrophobic compounds while resistant to the effects of free fatty acids (another 
bactericidal host compound) suggests that the mtrCDE efflux pump is not the 
only such system used by the gonococcus to remove toxic compounds [59]. 
Resistance of N. gonorrhoeae to free fatty acids is mediated by an independent 
efflux system, the fatty acid resistance (far) AB pump [59]. There also appears to 
be significant cross talk between the two systems as expression of the farAB 
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pump is under the control of MtrR while the MtrE component of the mtrCDE 
pump appears to function in concert with FarAB [60]. Subsequent studies 
showed that MtrR actually represses the expression of an additional repressor, 
farR. This repressor, when translated, then goes on to repress transcription of 
farAB. Thus, MtrR acts as an indirect activator of farAB expression [61]. Both 
MtrR and FarR can also expand their regulon to other genes. Microarray studies 
of an mtrR mutant strain of N. gonorrhoeae identified 69 genes that were 
regulated by MtrR including several clinically relevant proteins such as heat 
shock response systems, proteases, and the RpoH alternative sigma factor [62]. 
One gene, ginA, a glutamine synthetase protein, was also shown to be regulated 
by FarR. The transcription of ginA is enhanced by FarRand repressed by MtrR 
[63]. 
Free fatty acids and bactericidal hydrophobic compounds are only a 
fraction of the stresses placed on N. gonorrhoeae during in vivo infection. The 
bacteria must also contend with potentially toxic levels of hydrogen peroxide and 
free radicals. During infection of the human genital tract, and particularly in the 
male genital tract, there is a potent influx of PMNs to the site of infection [64]. 
Once at the site of infection , PMNs act through several mechanisms to kill 
bacteria including an oxidative burst that produces free radicals such as 02- that 
can then be converted to potentially bactericidal H202 [65-67]. However, such 
molecules are largely ineffective in eradicating N. gonorrhoeae and it is thought 
that the gonococcus has developed a series of mechanisms designed to either 
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detoxify or quench reactive oxygen species (ROS) or repair the damage that they 
cause [68-70]. 
Evidence for this includes the observation that while purified Neisseria! 
porin acts on PMNs to initiate an NADPH oxidase-mediated response, in the 
presence of viable N. gonorrhoeae, these responses are greatly diminished 
compared to porin alone [71]. This suggests that N. gonorrhoeae may encode 
mechanisms to downregulate such an oxidative burst. To resist the effects of 
oxidative bursts that do take place, N. gonorrhoeae encodes very high levels of 
both catalase and peroxidase [72]. In fact, catalase presence has been used in 
clinical tests to differentiate N. gonorrhoeae from other bacterial species [73]. 
Catalase acts as an enzyme in converting HzOz to non-toxic water and oxygen 
and its expression inN. gonorrhoeae can be induced upon contact with either 
H20 2 or human PMNs [74]. Strains of N. gonorrhoeae lacking catalase are much 
more sensitive to oxidative stress and DNA isolated from this organisms shows 
significant damage [75]. N. gonorrhoeae also expresses cytochrome C 
peroxidase and mutant strains lacking this enzyme are more susceptible to H20 2 
though not to the same degree as catalase mutants [49]. In contrast to several 
other bacteria including N. meningitidis, N. gonorrhoeae does not produce high 
levels of superoxide dismutase [76]. N. gonorrhoeae can also act to quench high 
levels of H202 through acquisition of manganese [77] . To prevent buildup of 
excessive DNA damage in the face of oxidative stress, N. gonorrhoeae 
expresses several DNA repair recombinases including RecN , RecBCD, and 
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ReeF [78]. While these enzymes act on DNA, reparation of proteins damaged by 
oxidative stress is mediated by the gonococcal methionine sulfoxide reductase 
(msr) AB genes [79] . Aside from extracellular mechanisms of bacterial 
degradation, PMNs, as professional immune cells, can also phagocytize N. 
gonorrhoeae and degrade them intracellularly [80, 81]. Unlike invasion of 
epithelial cells, which represents an advantage for the bacteria, N. gonorrhoeae 
phagocytized by PMNs are subject to extreme stresses. The gonococcus has 
developed several mechanisms to avoid phagocytosis including binding to 
complement inhibitory factors such as complement factor H that directly interacts 
either with gonococcal LOS or the PorB protein and coats the gonococcus [82, 
83]. 
Innate Immune detection of N. gonorrhoeae in the genital tract. 
There exists a large number of innate immunity proteins that act to detect 
N. gonorrhoeae during infection, the most common of which are Toll-like 
receptors (TLRs). TLRs recognize different categories of microbial products 
termed pathogen-associated molecular patterns (PAMPs) [84]. Of the 10 human 
TLRs identified so far, the most well studied include TLR2, which recognizes 
microbiallipopeptides, peptidoglycans and porins [85-91], TLR4, which 
recognizes bacterial lipopolysaccharide (LPS) (or in the case of Neisseria 
species the immunologically similar LOS) [92, 93], TLR5, which recognizes 
bacterial flagellin [94] and TLR9, which recognizes bacterial CpG DNA [95, 96]. 
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Any or all of these TLRs can act to detect immunogenic characteristics of N. 
gonorrhoeae and different TLRs are expressed by different tissue types in the 
male and female genital tract. Expression of TLRs in the male genital tract is low 
and TLR 1 through TLR9 expression is absent in the epididymis, vas deferens, 
seminal vesicles and testes [97]. Expression of TLR3 and TLR8 is detected in 
the prostate and high expression of TLR9 is detected in the penile urethra. In 
addition, studies in primary human urethral cells have shown activation of TLR4 
dependent signaling pathways [98] as well as signaling via TLR2, TLR3, TLR4 
and TLR9 in primary epithelial cells from the prostate, epididymal-vas deferens 
and seminal vesicle [99] despite the apparent lack of TLR expression . 
In contrast, TLR expression in the female genital tract is more widespread. 
Epithelial cells of the vagina express TLR1, TLR2, TLR3, TLR5, TLR6 and TLR9 
[100, 101]. There is controversy as to whether TLR4 is expressed in the vaginal 
epithelium, and in studies that have shown expression, levels appear to be low 
[1 02]. Both the endocervical and the ectocervical epithelia present the same TLR 
expression profile as determined by PCR analysis [101, 102]. While TLR1 
through TLR6 proteins are detected in the endocervix, expression of TLR4 in 
both endocervical and ectocervical epithelia is controversial [1 00, 1 03]. TLR1 
through TLR6 and TLR9 are also expressed in cells of the cervical and 
endometrial epithelia [100, 103, 104]. TLR7, TLR8 and TLR9 mRNA is 
expressed in the fallopian tubes, cervix, ectocervix and endometrium, and ligand-
specific cell activation can be detected. In contrast, TLR10 is only detected at the 
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mRNA level in the fallopian tubes [1 05]. The expression of various TLRs in the 
genital tract of males and females plays a direct role in how the host responds to 
a bacterial infection such as N. gonorrhoeae. In contrast to TLRs, the expression 
of the nucleotide-binding oligomerization domain (Nod) like receptors Nod1 and 
Nod2 in the female genital tract is less well studied. Nod1 and Nod2 mRNA is 
detected in the fallopian tubes, cervix, ectocervix and endometrium and cells 
derived from these tissues respond to Nod-specific ligands in vitro, suggesting 
that Nod1 and Nod2 proteins are expressed and functional [105]. 
Host Inflammatory Response to Infection 
Cell activation via intracellular and surface-expressed TLRs and Nods in 
response to gonococcal ligands results in production of pro-inflammatory 
cytokines and chemokines for recruitment of immune cells (i.e. macrophages, 
dendritic cells , natural killer cells and PMNs) to the site of infection. These cells 
contribute to clearance of STI through phagocytosis and, in some cases, 
degradation of invading pathogens. In gonorrhea and other STis, PMNs are 
primarily responsible for the characteristic purulent discharge often associated 
with the disease. Attempts to clear the pathogen are further amplified by 
induction of adaptive immune responses and production of inflammatory 
mediators by professional immune cells. In the case of N. gonorrhoeae, LOS 
stimulates cells via TLR4 and can also bind to the triggering receptor expressed 
on myeloid cell 2 (TREM-2) , another innate signaling protein, expressed on 
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human genital tract epithelial cells [1 06, 1 07]. The Neisseriallipoprotein Lip and 
porins also stimulate cells through TLR2 [1 08, 1 09]. Studies of infection in vitro 
show that both male and female cells increase production of pro-inflammatory 
cytokines following stimulation with gonococci. Specifically, transformed urethral 
epithelial cells secrete interleukin (IL)-6 and IL-8 after challenge with liveN. 
gonorrhoeae or purified gonococcal LOS [98]. Transformed endocervical 
epithelial cells also secrete IL-1 a, IL-1 ~ , IL-6, IL-8 and intracellular adhesion 
molecule 1 (ICAM1) upon gonococcal challenge [110] . Increased secretion of 
tumor necrosis factor-a (TNF-a) , IL-1~ , IL-6 and IL-8 has been reported in urine 
samples obtained from male volunteers infected with N. gonorrhoeae after the 
onset of symptoms. While an increase in plasma pro-inflammatory cytokines 
was also detected, there was no increase in transcript levels of these cytokines in 
peripheral blood mononuclear cells, suggesting that cytokines were produced at 
the site of infection before traveling to distal sites [111]. In vivo infection of the 
female genital tract is still being investigated with one study reporting no increase 
in pro-inflammatory cytokines during in vivo infection of female patients reporting 
to STD clinics [16]. However, due to the inherent dangers of gonococcal 
infection of the female genital tract, studies of mucosal gonococcal infection and 
inflammatory responses in females are inherently difficult. 
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Adaptive immune response to N. gonorrhoeae 
The role of adaptive immunity in gonococcal disease has been a field of 
controversy for several decades. Unlike meningococcal disease where adaptive 
immune responses are readily apparent, there is much less data showing such a 
response to uncomplicated mucosal gonococcal infection. As described above, 
N. gonorrhoeae is able to escape several aspects of acquired immunity through 
antigenically varying potential immunogenic targets such as pi lin or by controlling 
expression of other targets such as Opa proteins. In addition, N. gonorrhoeae 
can suppress CD4 T-cell proliferation [112]. Other mechanisms involving 
down regulation of complement response to N. gonorrhoeae are also likely to 
reduce overall immune detection through both the innate and adaptive immune 
system. Despite this, a handful of studies have shown that at least a limited 
adaptive immune response can take place during uncomplicated infection with N. 
gonorrhoeae. Studies in the past few decades showed that while patients can be 
readily re-infected with different strains of N. gonorrhoeae they do show some 
resistance to re-infection with gonococcal strains of the same porin serotype 
[113-115]. However, these responses are likely only toward the infecting strain 
of N. gonorrhoeae and do not confer pan-gonococcal protection. Adaptive 
immune response is somewhat more robust in patients with complicated 
gonococcal infections including PID and DGI. Patients who developed PID 
during infection were less likely to be re-infected with a strain of the identical 
serotype and preexistence of antibodies against the Opa proteins of N. 
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gonorrhoeae conferred some protection against the development of PID [116, 
117]. Patients with DGI have also been shown to develop antibodies against 
several gonococcal targets including porin and Rmp [118-121]. 
Complicating matters further is the observation that a robust antibody 
response during infection can actually offer protection not to the host but rather to 
N. gonorrhoeae itself. Studies carried out in vitro show that human lgA can coat 
individual gonococcal bacterium and offer a protective shield, protecting the 
bacteria from other more functionally active antibodies such as lgG [122]. This 
observation explains the serum resistance of gonococcal strains isolated from 
patients with DGI. If normal sera are incubated with such strains, they are 
sensitive to killing, however priming normal sera with sera from DGI patients 
actually diminished killing rather than increasing it, a result of DGI patients' sera 
containing large amounts of lgA that act to coat N. gonorrhoeae and protect it 
from being killed [123, 124]. Several elegant studies eventually concluded that 
this protection was the result of preventing the complement cascade from 
proceeding to a point of inserting the terminal complement membrane [125]. 
N. gonorrhoeae and Apoptosis 
As a facultative intracellular human pathogen N. gonorrhoeae readily 
invades host cells. Within host cells the bacteria is protected from antibiotic 
stress as well as several aspects of the innate immune system and has access to 
a wide variety of nutrients required for growth. Indeed, N. gonorrhoeae has been 
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shown to be able to survive and replicate within epithelial cells [46, 47, 126]. To 
maintain these growth conditions, N. gonorrhoeae acts to downregulate pro-
apoptotic mechanisms of host cells. Microarray analysis of both male and female 
epithelial cells has shown that infection of cells with N. gonorrhoeae acts to both 
protect such cells from apoptosis induced by staurosporine and to increase the 
expression of anti-apoptotic host genes such as birc3 and bf/-2 [46, 127, 128]. 
Other studies have identified specific bacterial factors that lead to such anti-
apoptotic mechanisms including gonococcal PorB. Incubation of urethral cells 
with PorB both activates nuclear factor-K B (NF-KB) and increases the expression 
of host anti-apoptotic factors [129]. The role of N. gonorrhoeae in preventing 
apoptosis is not restricted to epithelial cells and the pathogen has also been 
shown to be able to survive and replicate within professional immune cells such 
as PMNs [45, 48]. As in epithelial cells , N. gonorrhoeae also acts to prevent 
apoptosis in PMNs [130, 131 ]. Here anti-apoptotic mechanisms must be even 
more prevalent due to the extremely short life span of PMNs compared to 
epithelial cells. 
Gender Specific Differences in Infection 
One of the most perplexing aspects of gonococcal disease is the apparent 
difference in symptomatic response between men and women. While men are 
nearly always symptomatic, women are actually asymptomatic 50-80% of the 
time [3]. This disparity in symptomatic response could be due to a number of 
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host or pathogen issues and possibly a combination of one or more. Differences 
in growth mechanisms employed by N. gonorrhoeae, in host expression of 
particular adhesins and in the composition of commensal microbiota may all play 
a role in the strong symptomatic response of men versus women. Several 
studies have demonstrated the ability of N. gonorrhoeae to form protective 
biofilms in vitro as well as during in vivo infection in women [132, 133]. In other 
infectious diseases, biofilms have been shown to protect bacterial cells from 
antimicrobial agents and from host immune responses [134-136] and also likely 
facilitate horizontal gene transfer between bacteria, allowing resistance to 
antibiotics to develop more quickly. Thus, N. gonorrhoeae biofilm formation may 
result in sequestration of the organism from a robust immune response in 
females. In contrast, biofilm formation has not yet been identified in the male 
genital tract during gonorrhea. It is possible that the formation of purulent 
exudates in male gonococcal urethritis may disrupt the formation of biofilms 
resulting in increased exposure of N. gonorrhoeae and a corresponding increase 
in innate immune responses of the male host. 
As described above, gonococcal LOS can act as an adhesin for entry into 
host cells, another area where differences in the male and female genital tract 
may lead to differences in symptomatic responses. In the male genital tract, 
gonococcal LOS binds to host integrins followed by binding of the complex to 
glycoprotein receptors expressed on the male urethral cell surface, an event 
which leads to the induction of pro-inflammatory cascades [98, 137]. In contrast, 
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invasion of female epithelial cells is mediated between CR3 on the surface of 
these cells and gonococcal LOS [138]. Unlike with integrin-mediated pathways, 
endocytosis via complement-mediated receptors occurs without a robust pro-
inflammatory response in immune cells [139]. In the male genital tract however, 
CR3 is not expressed [64, 138, 140] and these mechanisms of cellular invasion 
are not possible. For this reason, N. gonorrhoeae may be able to invade female 
epithelial cells using gender specific mechanisms that circumvent the pro-
inflammatory immune response. Once sequestered within such epithelial cells N. 
gonorrhoeae is protected from detection by the innate immune system and thus a 
less robust inflammatory response is mounted. 
In addition to the differences described above, the male and female 
genital tracts harbor different populations of commensal bacteria. In the urethral 
tract of healthy males, the main bacterial genera are Lactobacillus, Sneathia, 
Veillonella, Corynebacterium, Prevotella, and Streptococcus, as detected by 
DNA analysis [141, 142]. The female genital tract microflora, as determined by 
CFU counts, is also composed mainly of Lactobacilli as well as Gardnerella 
species (not found in the male genital tract) [143]. In addition to differences in 
bacterial species, there are also differences in the total amount of probiotic 
bacteria among male and female genital tracts. Lactobacilli have been detected 
in the female genital tract at concentrations of 1x109 CFU/ml [143]. It is thought 
that such bacteria may provide a protective shield against microbial infection via 
lowering the pH of the vagina to <4.5. Studies of N. gonorrhoeae co-incubated 
21 
with Lactobacilli with and without human cells have shown that Lactobacilli 
reduce gonococcal growth via lowering the pH of the media [144, 145]. 
However, in contrast to the female genital tract, a CFU count of live bacteria from 
the male urethra failed to detect Lactobacilli while instead reporting 
Streptococcus, Corynebacterium, and Stapholococcus as the most highly 
represented species (approximately 0.3-1 x1 06 CFU/ml) [146]. Therefore, any 
protective effect provided by Lactobacilli against gonococcal infection in the 
female genital tract may be absent or greatly reduced in males. 
Gene Regulation in Neisseria 
Because Neisseria species can encounter various environments during 
infection, proper gene regulation is crucial. To establish tight control over the 
expression of various genes, Neisseria species employ a number of different 
gene regulatory mechanisms. Neisseria utilize various classical transcription 
factors which bind to specific DNA sequences within promoters and either 
repress or enhance transcription of downstream genes. Other transcriptional 
regulatory mechanisms include the addition or removal of cytosine residues to 
alter the subsequent binding of RNA polymerase. Post-transcriptional 
mechanisms of regulation comprise mainly frame shift mutations involving 
insertion of DNA sequences into coding regions resulting in non-functional 
proteins. These mechanisms are discussed in greater detail below. 
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In addition to regulating adhesins and other gene products necessary for 
successful infection, Neisseria species must scavenge iron from the host to 
maintain intracellular iron homeostasis. Free iron in the host is scarce and both 
N. meningitidis and N. gonorrhoeae express a repertoire of proteins whose 
function is to bind to and extract iron from host iron-containing proteins. These 
include ferric-binding protein (Fbp), transferrin binding protein (Tbp) and 
lactoferrin binding protein (Lpb). Studies have shown that these proteins are 
expressed by N. gonorrhoeae and N. meningitidis during natural mucosal 
infection [113, 147, 148]. However, high levels of iron can be bactericidal and 
these iron-scavenging genes are tightly regulated. Regulation of these proteins, 
and many others, is carried out in a large part by the ferric uptake regulator (Fur) 
protein. Fur is often thought of as a classical DNA binding transcription factor, a 
15 kDa homodimer that, upon complexing with free iron, binds to specific DNA 
sequences known as Fur boxes. Fur-mediated repression of transcription is a 
highly characterized model that has been well known for decades. Under iron-
replete conditions, inactive Fur monomers bind to Fe2+ and dimerization of Fur 
takes place followed by the binding of Fur to promoter regions. This binding 
inhibits the subsequent recruitment of RNA polymerase, thereby blocking 
transcription of target genes. Conversely, when iron is limiting, Fur is present as 
an inactive monomer that cannot bind DNA allowing RNA polymerase access to 
promoter regions and, subsequently, gene transcription ensues [149, 150]. 
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In addition to Fur, Neisseria encodes several other DNA binding 
transcription factors but interestingly, there are relatively few such regulators 
(-35) compared to other bacterial species such as E. coli (-200). Alternative 
sigma factors, proteins that bind to the RNA polymerase complex and are 
specific for certain sets of genes, include RpoH, RpoD, and Ecf. RpoH increases 
transcription of genes involved in stress response and adherence to epithelial 
cells [151 , 152]. Other DNA-binding transcription factors include those involved 
in response to changing oxygen levels during infection. As a facultative 
anaerobe, N. gonorrhoeae can be cultured from the female genital tract along 
with obligate anaerobes and antibodies against proteins that facilitate 
anaerobiosis have been detected in the sera of women with gonorrhea [153, 
154]. When oxygen is not present, N. gonorrhoeae can utilize nitrite or nitric 
oxide as a terminal electron acceptor via the activity of a truncated denitrification 
pathway, composed of a nitrite reductase (AniA) and a nitric oxide reductase 
(NorB). The expression of genes related to nitrogen respiration is a complex 
combination of pathways involving several proteins that require sensitive 
transcriptional control. These proteins sense specific molecules and bind to DNA 
to regulate genes under their control similar to Fur activity after complexing with 
free iron . For example, the fumurate nitrate reduction (FNR) protein drives 
expression of the aniA gene in the absence of oxygen, while further control is 
mediated by the ability of NsrR to repress aniA gene expression in the absence 
of nitric oxide [155]. Additional DNA-binding proteins including Fur, an ArsR-Iike 
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protein and NsrR are involved in promoting and repressing the transcription of 
norB, depending on the presence of iron or nitric oxide [156]. 
As the number of classical DNA-binding proteins in Neisseria is relatively 
low compared to other bacteria, it is not surprising that several protein-
independent mechanisms of regulation also exist in Neisseria. These include 
phase variation regulating expression Opa and Ope proteins [157]. Within the 
coding region of opa genes are pentameric repeats which can form H-DNA 
structures, regions of triple-stranded DNA Such regions can promote slip 
stranded mispairing events that can insert addition nucleotides in the coding 
region of opa genes [158]. These insertions can result in frame shift mutations 
and non-functional Opa proteins. In the case of the ope gene, other promoter 
mutations have a direct effect on transcription. Addition or subtraction of 
cytosine residues between the -35/-10 elements of promoters can alter binding 
and function of RNA polymerase and thus gene expression. Cytosine repeats 
between 11 and 15 nucleotides show a gradient in transcription while repeats 
greater than 15 or less than 11 nucleotides results in a complete loss of 
transcription [159]. 
Small Regulatory RNAs 
Aside from classical DNA binding proteins and DNA insertions and 
deletions in promoters, one mechanism of gene control that is well known in 
other bacteria but is only beginning to be described in N. gonorrhoeae is 
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mediated via small RNAs (sRNAs). Bacterial sRNA molecules are analogous to 
eukaryotic microRNAs and act as post-transcriptional regulators affecting the 
translation of mRNA targets or regulating proteins directly [160, 161]. Despite 
significant variability, sRNAs share several characteristics that can aid in their 
identification (Figure 2). Firstly, sRNAs, as the nomenclature implies, are 
generally small, usually between 50-250 nucleotides in length. Nearly all sRNAs 
are expressed from intergenic (IG) regions or are expressed as antisense 
transcripts opposite a known open reading frame. As the majority of the bacterial 
genome is dedicated to coding strands of DNA, this restricts genomic locations of 
sRNAs to a small fraction of the genome. Several sRNAs also end transcription 
using a Rho independent terminator (RIT), a -40 basepair inverted repeat which 
forms an RNA hairpin loop and stalls transcription. These characteristics have 
been used extensively to perform global searches for sRNAs through in silica 
analysis of bacterial genomes [162-164]. 
Known sRNAs can be roughly divided into 5 categories (Figure 3) : those 
that negatively regulate translation of target mRNAs, those that negatively 
regulate stability of target mRNAs, those that positively regulate expression of 
targets mRNAs, those that interact with proteins directly and those that alter DNA 
structure to promote transcription. In the first, and most well studied category, 
sRNAs may bind to target mRNAs and form an RNA: RNA duplex at the ribosome 
binding site (RBS). This prevents binding of the ribosome complex and the 
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Figure 2. Schematic of bacterial regulatory sRNAs. Small RNAs are short 
(50-250) nucleotide RNA transcripts that are expressed either from IG regions or 
opposite known reading frames (antisense transcription). Many sRNAs use an 
RNA secondary structure termed a RIT to end transcription. Once expressed, 
most sRNAs go on to interact with and alter transcription of target mRNAs while 
a smaller subset act directly on proteins. The former is brought about through 
homologous base pairing between the sRNAand its target mRNA and can lead 
to either increased or decreased translation of the mRNA. Some sRNAs require 
protein cofactors to for stability and function. The most common such cofactor is 
Hfq, a homohexameric ring-shaped protein that binds to many kinds of RNA to 
facilitate mRNA:sRNA interactions. 
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Figure 3. Mechanisms of sRNA-mediated regulation. Generally, bacterial 
sRNAs can be divided into 5 categories based on how they interact with and 
affect the.ir targets. (A) Binding of a sRNA leads to blockage of the RBS on the 
target mRNA leading to decreased translation . (B) Binding of a sRNA leads to 
degradation of both the sRNA and target mRNA leading to decreased translation. 
(C) Binding of a sRNA to a target mRNA changes RNA structure, revealing a 
previously occluded RBS and leading to increased translation. (D) Binding of a 
sRNA to a target protein occupies a nucleic acid binding site on the protein. This 
prevents binding of the protein to other nucleic acid targets with a similar 
sequence. (E) Transcription of a sRNA alters DNA secondary structure leading 
to increased transcription of downstream target genes. 
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translation of the target mRNA is decreased. The E. coli sRNA OxyS, which 
binds to the fhiA transcript that codes for a gene involved in formate metabolism, 
uses this mechanism. Binding between fhiA and OxyS leads to blockage of the 
30S ribosome subunit. A similar mechanism is at play when the Spot42 sRNA 
binds to and prevents translation of the galactokinase transcript in E. coli [165, 
166]. A second class of sRNAs acts to bind to mRNAs and destabilize their 
target transcripts through increased recruitment of RNase E, which then acts to 
degrade both the target and sRNA. This mechanism is used by the sRNA SodB 
of E. coli [167]. Many sRNAs employ both RBS blocking and degradation 
mechanisms to decrease translation of their target mRNAs. 
While sRNAs have traditionally been thought of as negative regulators 
there are a large number that can act positively on their targets either by 
increasing stability of the target mRNA or by opening up a previously occluded 
RBS site through binding to target mRNAs and altering RNA secondary structure. 
The collagenase transcript of Clostridium perfringens is stabilized by its 
corresponding sRNA, VR-RNA and the streptokinase transcript of Group A 
Streptococcus is stabilized by its regulator RNA, FasX [168, 169]. Another class 
of sRNAs does not interact with target mRNAs but rather acts on proteins 
directly. The CsrB and CsrC sRNAs of E. coli act to bind to and sequester CsrA, 
an RNA-binding protein that binds to 5' UTR regions of mRNAs to affect their 
translation and stability. By mimicking 5' UTRs, the CsrB/C sRNAs act to titrate 
out active CsrA from the system and allow translation of CsrA target genes [170]. 
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A similar mechanism is used by the 6S sRNA, of which homologues have been 
found in several bacteria. This sRNA mimics a binding site for the alternative 
sigma factor a70 thereby reducing expression of genes that require this sigma 
factor for transcription [171]. Finally, a new class of sRNAs is emerging whose 
transcription serves to alter the secondary structure of DNA facilitating 
subsequent gene expression. A sRNA utilizing this mechanism has been 
discovered inN. gonorrhoeae and is discussed in detail below. 
Protein Cofactors of sRNAs 
To date, several of the sRNAs identified in bacteria require a protein 
cofactor for stability and function, the most common of which is the host factor of 
the RNA bacteriophage Q~ (Hfq). Hfq was first identified as a host factor needed 
for replication of the Q~ bacteriophage and has since been found to be a major 
cofactor of bacterial sRNAs [172]. It is part of a larger family of RNA binding 
proteins with representatives across all domains of life. In eukaryotes these 
proteins are the Sm proteins and are intimately involved in post-transcriptional 
regulation . Hfq is a basic protein that forms a homohexameric ring-shaped 
quaternary structure. Both faces of a complete Hfq molecule are able to bind to 
an RNA transcript. The proximal face of Hfq is, by definition, the side containing 
the amino-terminal alpha helix and the distal face is the opposite side [173]. 
Studies of S. aureus Hfq and RNA show that an AUUUUUG sequence binds to 
the proximal face of Hfq through interactions of the side chains of amino acids 
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and the backbone of RNA with base pairs exposed to the solvent. Each 
protomer of Hfq binds to a single nucleotide [174]. In contrast, the distal face of 
Hfq can bind RNA with one protomer binding to three nucleotides and prefers a 
sequence of either ARN or AAYAAYAA [175, 176]. Searching for RNA 
sequences rich in AU stretches is one way to try to predict where sRNAs bind to 
Hfq or which mRNAs or sRNAs may require Hfq for proper regulation. 
The positive effect that Hfq has on sRNA-mediated regulation is likely 
through two mechanisms. First, Hfq increases the stability of sRNAs in vivo. In 
an E. coli hfq knockout strain, the half-life of the Hfq-dependent Spot42 sRNA 
was significantly reduced [166]. A similar mechanism is at play with the Yersinia 
pestis sRNA RyhB1, which shows a much shorter half-life in the absence of Hfq 
compared to a wild-type strain [177]. However, Hfq does not affect the stability of 
all sRNAs. Interestingly, in Y. pestis, another sRNA, RyhB2 is not dependent on 
Hfq for stability, showing that different sRNAs even within the same species can 
have differing Hfq dependencies [177]. Hfq also aids in sRNA-mediated 
regulation by facilitating interactions between sRNAs and mRNAs, acting as a 
true chaperone. Elegant FRET studies by Arluison et al. show that Hfq can 
disrupt the secondary structure of RNA and act as a catalyst in forming 
sRNA:mRNA duplexes [178]. It is thought that Hfq acts by binding to an mRNA 
and a sRNA and disrupting the secondary structure of one or both. This 
disruption then reveals previously occluded binding sites in each RNA strand and 
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leads to the formation of homologous base pairing between sRNAs and mRNAs. 
Once bound , downstream regulatory effects of sRNAs can take place. 
While Hfq is by far the most common of the bacterial sRNA cofactors, it is 
not required for all sRNA circuits. Other sRNA protein cofactors include Rom 
and FinO. Rom has been shown to bind to the sRNA RNAI encoded by the 
plasmid Co1E1 and stabilize the sRNA's interaction with its target in E. coli [179]. 
Also in E. coli, FinO binds to the sRNA FinP and stabilizes its interaction with the 
traJ mRNA [180]. A homologue of FinO has also been found in N. gonorrhoeae 
strain FA1090, NG01332. Finally, in Bacillus subtilis, a sRNA FsrA has been 
described which regulates sdhC and other genes independently of Hfq. Instead, 
three small basic proteins, Fbp A B and C fulfill the role of Hfq in this organism 
[181]. There also appears to be significant variability of the requirement of these 
proteins based on which target mRNA is under regulation . For example, 
repression of leuCD requires FbpA and C while regulation of /utABC specifically 
requires FbpB [181, 182]. Complicating matters further is the observation that 
regulation of other targets, including sdhCDAB, citB and gltAB does not require 
any Fbp protein [181] . It is possible that binding between FsrA and these targets 
is sufficient to mediate regulation or that another as yet undiscovered chaperone 
protein exists in B. subtilis that fills this role. Regardless of the protein cofactor 
used , sRNAs show reduced ability to function in the absence of their protein 
cofactors and in some cases, sRNA stability is reduced as well [180, 183]. 
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Small RNAs Regulated by Iron 
sRNAs generally act as post-transcriptional regulators and as such are 
regulated themselves via a variety of stimuli. They can be regulated through 
transcriptomic changes as bacteria shift to different growth phases as is the case 
with the 6s sRNA of E. coli [171]. E. coli and B. subtilis also express sRNAs 
which respond to different sources of sugar and carbon including the sRNAs 
SgrS and SR1 [184, 185]. Finally, several sRNAs respond to intracellular iron 
levels and pathogenic mechanisms as described below. 
During bacterial growth, proper homeostasis of intracellular iron levels is 
mediated, in part, by regulatory sRNAs. The first, and perhaps most well studied, 
iron-regulated sRNA is the E. coli sRNA RyhB. The expression of RyhB is 
mediated in an iron-responsive manner via the Fur protein. Under iron-replete 
conditions, Fur binds to the promoter region of RyhB and represses transcription, 
an effect that is reversed under iron-deplete conditions. Once RyhB is 
transcribed, it affects several E. coli target genes including iron storage proteins 
such as Bfr, as well as SodS and enzymes of the tricarboxylic acid (TCA) cycle 
such as SdhC/A [186]. Autoregulation of Fur also takes place through RyhB 
binding to the coding region for a small open reading frame that is co-transcribed 
with Fur. This binding leads to instability of this polycistronic message and thus 
reduced levels of functional Fur protein [187]. Function of RyhB requires the 
RNA degrading enzymes RNaselll and RNase E as well as the sRNA cofactor 
Hfq [186, 187]. Homologues of RyhB have been discovered in a large number of 
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pathogenic bacteria including Shigella species, Vibrio cholera , Salmonella 
enterica, andY. pestis [177, 188-192]. In many cases the targets and sequence 
of RyhB in these other species are very similar to that of E. coli though some 
small variations can occur [177, 188, 189, 193]. The function of RyhB in several 
of these species is related to virulence mechanisms of these organisms. 
In several other bacterial species there are functional analogs of RyhB 
that may have a somewhat different regulon and nucleic acid sequence 
compared to E. coli RyhB. The sRNA FsrA of the commensal gut bacteria 
Bacillus subtilis is regulated by Fur and controls the stability of several genes 
involved in metabolism including sdhABC, citB, gltAB, leuCD, dctP and lutABC 
[181 , 182]. Iron regulation via sRNAs is not limited to bacteria that interact with 
humans. The non-pathogenic soil bacterium Azotobacter vinelandii must also 
regulate intracellular iron levels. To do this, A. vinelandii expresses a sRNA 
termed azotobacter RNA responsive to Fe (ArrF). Like RyhB, ArrF is negatively 
regulated by iron via the Fur protein . ArrF also negatively regulates the sodB 
transcript but does not seem to affect levels of the sdh transcripts [194]. ArrF 
also acts to expand its regulon beyond that of RyhB by regulating genes involved 
in the poly-~-hydroxybutyrate (PHB) biosynthetic pathway. A proteome analysis 
of an arrF knockout strain of A. vinelandii showed that genes involved in PHB 
synthesis were some of the most highly upregulated [195]. 
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Small RNAs Involved in Bacterial Pathogenesis 
A large number of sRNAs have been discovered that have roles in 
pathogenic mechanisms of bacteria. In Pseudomonas aeruginosa the action of a 
translational repressor protein RsmA is regulated by two sRNAs, RsmY and 
RsmZ. These sRNAs act as decoy targets for the DNA binding sequence of 
RsmA [196] acting to sequester the protein. RsmY has also been shown to bind 
to Hfq and RsmA, an interaction that may suggest that Hfq is required for this 
sRNA to function [197]. Sequestration of RsmA allows the expression of 
pathogenic genes such as sidephores, type VI secretion proteins, biofilm proteins 
and other extracellular enzymes [198-200]. This genetic profile is consistent with 
chronic infection by P. aeruginosa. A similar mechanism is at play between the 
sRNAs CrcZ and the Crc protein as CrcZ acts as a decoy target for Crc and 
allows transcription of genes that are repressed by Crc [201]. The regulation of 
Crc function likely has a profound effect on pathogenesis as Crc has been shown 
to regulate porins [202] and a ere knockout mutant was especially sensitive to 
antibiotics and impaired in twitching motility, type Ill secretion and biofilm 
formation [202, 203]. 
In V. cholera, quorum sensing is a crucial element of pathogenesis and is 
regulated by four redundant sRNAs termed quorum regulated RNA (Qrr)1-4 
[204]. Qrr1-4 are expressed during times of low cell density and bind to (among 
other targets) the hapR transcript [205, 206]. Orr's repress translation and 
downregulate stability of the hapR transcript by binding to regions adjacent to the 
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ribosome-binding site. As V. cholera grows in vivo , cell density increases and 
the Qrr sRNAs are no longer transcribed. This allows for the successful 
translation of the hapR transcripts and functional HapR protein then goes on to 
regulate several transcripts involved in elements of V. cholera virulence and 
biofilm formation [207 -209]. These interactions require the sRNA cofactor Hfq 
and strains lacking Qrr sRNAs are severely impaired in mouse models of 
infection [205, 207, 209]. Additional sRNAs encoded by Vibrio species include 
the TarA and TarB sRNAs that negatively regulate the ptsG and tcpF transcripts 
respectively [204, 210]. Interactions between TarA and ptsG require the Hfq 
cofactor, yet interestingly, the same is not true for TarB, again showing that 
similar sRNAs in the same organism can have varying dependencies on Hfq 
[204, 211]. While there are conflicting reports of the effect of TarA on virulence, 
strains of V. cholera lacking TarB show an increase in virulence compared to 
wild-type strains in mouse models of infection [204, 211, 212]. 
Small RNAs of the Gonococcus 
While sRNAs have been well known for decades and a multitude of 
examples have been described in E. coli and other organisms, regulatory 
mechanisms using sRNAs in Neisseria species are only beginning to be 
analyzed. Our laboratory identified the first sRNA in Neisseria, Neisseria! RNA 
responsive to Fe (NrrF} , which is regulated by iron availability via the Fur protein 
[163]. Once transcribed, NrrF goes on to negatively regulate translation of the 
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sdhCIA mRNA transcripts. NrrF likely uses an mRNA-degrading mechanism as 
we have seen a reduction in the amount of the sdhCIA transcript [163]. The 
sdhC/A transcripts code for succinate dehydrogenase enzymes that require iron 
as a cofactor. Therefore, only translating these proteins under iron-rich 
conditions (when NrrF levels are low) ensures that N. gonorrhoeae and N. 
meningitidis will not expend energy generating a protein that cannot function due 
to lack of a cofactor. Targets of NrrF are not restricted to sdhCIA as our 
laboratory and others have shown that the pete transcript is also regulated via 
NrrF (unpublished data). Interestingly, though in Neisseria the expression of 
sodB is regulated via iron and Fur, this regulation does not require the NrrF 
sRNA nor has another sRNA been found in Neisseria that does regulate sodB. 
Another sRNA that has been described inN. gonorrhoeae acts to increase 
antigenic variability of pilin structures of the gonococcus [213]. Altering the 
nucleotide sequence of this sRNA has no effect on antigenic variability nor does 
mutation of the endogenous copy followed by expression of the sRNA from 
another portion of the genome. If the sequence of this sRNA was a critical 
aspect of its mechanism of action, as has been seen for all previously known 
sRNAs, then these alterations would have affected pilin variability. The fact that 
they did not suggests novel sRNA regulatory mechanisms. In accordance with 
this, alterations in the strength of the sRNA promoter did affect pi lin antigenic 
variability with stronger promoters leading to greater variability. This suggests 
that sRNA transcription itself is what alters pilin antigenic variability. Subsequent 
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studies showed that such transcription allows for an alteration in the secondary 
structure of adjacent DNA allowing for increased expression of genes involved in 
pilin antigenic variability [213]. 
In addition to these sRNAs, pathogenic Neisseria species likely express 
many other such transcripts . Deep sequencing experiments have found sRNAs 
that respond to changing oxygen conditions inN. gonorrhoeae and sRNAs that 
are regulated by oxygen and alternative sigma factors inN. meningitidis [214-
216]. In addition, a microarray study of an hfq knockout strain of N. gonorrhoeae 
MS11 identified 369 genes that were differentially regulated when comparing 
wild-type MS11 to the hfqknockout strain [217]. As Hfq is a known cofactor of 
sRNAs in other organisms, this may suggest that several genes in N. 
gonorrhoeae are regulated via sRNAs that have yet to be discovered. 
Global RNA Sequencing 
There has been an increasing use of global transcriptome expression 
methodologies over the past decade. Perhaps the most well known is the 
microarray, a method for detecting expression levels of all known genes using 
fluorescently labeled RNA hybridized to a pre-made chip containing homologous 
sequences of all genes under analysis. Microarray analysis has revolutionized 
how we analyze gene expression levels and has opened up new fields of 
bioinformatics and global analysis. Recently, a new methodology for studying 
global gene expression levels has emerged: global RNA sequencing (RNA-seq) 
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(Figure 4). This method differs from a microarray analysis in several 
fundamental ways and shows significant advantages over previous methods. 
RNA-seq involves isolating all RNA from a group of cells under certain conditions 
and using one of several methods to sequence the RNA to determine which 
genes are being expressed and at what levels. RNA-seq is a significant 
improvement on transcriptome analysis methods and holds several advantages 
over a traditional microarray. Firstly, a microarray analysis must hypothesize the 
existence of each gene that is to be detected, allowing generation of the probes 
for these genes. If a gene is not hypothesized to exist then no probe is 
generated and this gene will not be detected using microarray methods. RNA-
seq suffers from no such bias and will detect all RNA expressed under given 
conditions, including transcripts that have not yet been hypothesized to exist. 
This advantage is especially critical when examining bacterial transcriptomes as 
bacterial genomes are not nearly as well annotated as certain eukaryotic 
genomes making prediction of genes, as well as microarray chip development, 
difficult. This aspect of RNA sequencing is especially important for the work 
described here as RNA sequencing allows for the identification of novel sRNA 
transcripts of N. gonorrhoeae. Such identification of previously unknown genes 
is what makes RNA-seq the ideal methodology for these studies. Secondly, 
RNA-seq also allows for more in-depth of information compared to a microarray. 
A microarray analysis will only reveal the expression level of each gene under 
analysis. However, RNA sequencing reveals the nucleotide content of the entire 
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1. Total RNA 
is isolated 
3. RNA is 
fragmented 
5. eDNA is generated by 
reverse transcription . 
7. Reads are 
aligned to genome 
of interest 
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2. Ribosomal 
RNA is removed 
4. RNA adapters 
are sequentially 
added to the 3' and 
5' ends 
6. eDNA is 
sequenced by 
synthesis 
Figure 4. Schematic describing global RNA sequencing. RNA sequencing 
(also called Next-Gen Sequencing, RNA-seq, or deep sequencing) starts with 
RNA isolation . An optional step of removing ribosomal RNA (rRNA) can follow. 
Since rRNA can account for 85-95% of total RNA in a sample and since rRNA is 
not regulated to the same degree that other RNA species are, its removal can 
help increase detection of other RNA transcripts such as mRNA and sRNAs. 
Various methods are used for library generation and sequencing and one method 
is shown here. Following rRNA removal the RNA is fragmented so that there is 
no bias toward RNA transcripts of different lengths. RNA adapters are then 
added sequentially to the 3' and 5' ends of the fragmented RNA. Sequential 
addition of adapters allows for strand-specific sequencing, the identification of 
which DNA strand codes for the RNA transcript being detected. A reverse 
transcription reaction then generates eDNA using the RNA as a template. This 
eDNA is then sequenced by sequentially adding single nucleotides to the 
reaction. DNA polymerase then covalently binds the nucleotide to the nascent 
DNA strand if it base pairs with the eDNA strand under analysis. A fluorescent 
reaction is then detected by the machine revealing the identification of the base 
pair on the eDNA strand. This process is repeated for the entire length of the 
eDNA (termed a "read"), read length is usually between 36-101 base pairs. 
Finally, the eDNA reads are computationally aligned to the genome of interest 
using one of many available programs. 
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transcript. This resolution at the single nucleotide level allows one to detect the 
existence of single nucleotide polymorphisms (SNPs) as well as non-coding 
aspects of transcription such as the content of 5' or 3' untranslated regions 
(UTRs) and transcriptional start and stop sites. Besides more depth of 
information, RNA-seq contains other technical advantages over microarray 
including reduced cost and less input RNA. 
For experiments involving more than one organism (such as in vitro 
incubations of host and pathogen cells or clinical samples) RNA-seq is a much 
more efficient method of data analysis . Once sequenced , information regarding 
RNA transcripts is completely digital. This digital RNA-seq data can then be 
quickly applied to a genome of choice using computer programs. The studies 
described here utilize vaginal lavage samples containing both human and 
bacterial RNA. These clinical lavage samples can thus be sequenced once and 
individual reads assigned to the human genome as well as various bacterial 
genomes to gain insight into each transcriptome. A similar experiment using 
microarray technology would require several different chips and a corresponding 
increase in cost and input RNA. RNA-seq has already been used to determine 
the transcriptomes of several bacterial species including Neisseria under a 
variety of stimuli in vitro [156, 218-220]. These experiments have revealed a 
wealth of knowledge regarding bacterial gene regulation as well as several 
previously unknown transcripts such as sRNAs. Clinical aspects of RNA-seq 
have primarily focused on transcriptomic analysis of cancer cells and tumors 
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extracted from patients. These studies have aided in revealing novel therapeutic 
options as well as mechanisms of cancer biology [221, 222]. Expanding RNA-
seq to clinical specimens of infectious disease has been lacking, possibly due to 
the inherent difficulties involved in isolating RNA from clinical specimens as well 
as identifying the source of individual RNA transcripts. However, RNA-seq has 
been applied to studies of parasitic disease such as Leishmania braziliensis. 
Analysis of both human and Leishmania transcriptomes from primary cutaneous 
lesions have aided in identifying differences in immune responses between 
various stages of the disease [223]. 
Currently, there has been no RNA-seq analysis of bacterial or viral clinical 
specimens. The future aspects of RNA-seq medicine are focused on decreasing 
the cost and time investment of the methodology. Methods currently being 
developed aim to carry out a complete transcriptomic analysis of a clinical 
sample in less than 6 hours for a cost of approximately $1000. This level of 
analysis may one day allow a patient to visit a doctor with an unknown infection 
or other disease. Sample collection from the infected site followed by analysis 
will reveal the patient's genome and how well he/she may respond to particular 
treatments (a process termed "individualized medicine") as well as the presence 
of infecting organisms. Transcriptomic analysis will also reveal which genes are 
being expressed by these pathogens. The expression of antibiotic resistance 
genes may also help to guide therapies and treatments. 
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Summary 
N. gonorrhoeae is a common STI in the United States and abroad and is 
showing an alarming rise in antibiotic resistance, necessitating the development 
of novel antimicrobials and pan-gonococcal vaccines. During infection, the 
bacterium initially attaches to both epithelial cells and professional immune cells 
such as PMNs initiating a strong pro-inflammatory, but gender-specific, 
response. Males infected with N. gonorrhoeae show an upregulation of pro-
inflammatory cytokines and a corresponding influx of PMNs while females are 
often asymptomatic or show less severe symptoms. As a pathogen, proper gene 
regulatory mechanisms are crucial for N. gonorrhoeae. One mechanism of 
regulation that has been well-studied in other organisms but is only beginning to 
be understood in Neisseria involves bacterial sRNAs. These are short RNA 
transcripts that are regulated by a variety of conditions including stimuli related to 
bacterial infection. Once expressed, they go on to regulate mRNA targets either 
positively or negatively. Only a small handful of sRNAs have been discovered to 
date in N. gonorrhoeae. However, with the advent of global RNA sequencing, 
there are now new avenues of research open that can not only identify novel 
sRNAs but can also analyze the total transcriptome of both N. gonorrhoeae and 
the human host during both in vitro and in vivo infection. 
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HYPOTHESIS AND SPECIFIC AIMS 
N. gonorrhoeae expresses sRNAs that respond to iron and other environmental 
stimuli relevant to infection. In addition, such sRNAs are expressed and 
regulated during incubation with epithelial cells and during clinical infection. To 
test this hypothesis we propose the following Aims. (1) To determine the 
sRNAome of N. gonorrhoeae when cultured in vitro under differing iron and 
infection conditions. (2) To determine the global transcriptome of N. 
gonorrhoeae when cultured under in vitro conditions. (3) To determine the global 
transcriptome, including sRNAs, of N. gonorrhoeae during both in vitro incubation 
with epithelial cells as well as during natural mucosal infection. 
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METHODS 
Bacterial culture conditions 
Neisseria gonorrhoeae F62 was the gonococcal strain used in this study 
[224]. We chose to use this strain as it has been used in our laboratory 
successfully in the past and is particularly amenable to transformation. N. 
gonorrhoeae was plated onto a complex medium of gonococcal base (GCB) agar 
plates and grown for 16-18 hrs. at 3JO C in 5% C02. For growth of the 
gonococcus in tissue culture media, N. gonorrhoeae was resuspended at a final 
concentration of 5.0 x1 07 CFU/ml in pre-warmed Keratinocyte Serum Free 
Media (KSFM) (Invitrogen) with 0.4 mM CaCI2. Cultures were then incubated for 
2 hrs. at 3JO C in 5% C02. RNA was extracted from N. gonorrhoeae cultures 
using TRizol (Invitrogen) according to the manufacturer's instructions. For growth 
of the gonococcus under iron-replete and deplete conditions N. gonorrhoeae was 
resuspended in Chemically Defined Media (COM) [225] at an 0.0.600 of 0.1 and 
grown until mid-log phase (O.D.soo of approximately 0.25). To constitute iron-
replete conditions ferric nitrate was then added to the culture at a final 
concentration of 100 !JM. To constitute iron-deplete conditions, desferal, an iron 
chelater, was added to the culture at a final concentration of 100 !JM. RNA was 
isolated 90 min. later as described below. 
N. meningitidis MC58 was the meningococcal strain used in this study. An 
hfq knockout mutant was generated by transforming wild-type MC58 with pSLhfq-
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KO, a derivative of pSLfur-C1 [226] constructed with primers hfqflank listed in 
Table 2. Complementation of the hfq knockout mutant was by transformation 
with pSLhfq-C1, a derivative of pSLfur-C1 [226] constructed with hfqcomp 
primers (Table 2). Strain MC58/sdhCProm was generated by transforming a 
derivative of the pLES94 plasmid (Silver eta/. , 1995) into wild-type MC58. The 
plasmid contains the sdhC promoter region from -277 to +14 with respect to the 
translational start site. Strains hfq-/sdhCProm and hfqComp/sdhCProm were 
constructed in the same manner except using hfq knockout mutant strains and 
complemented hfq knockout mutant strains in place of the wild-type strain 
respectively. All DNA manipulations were carried out as described previously 
[226] or via the manufacturer's instructions and correct insertion of the /acZ 
transcriptional fusion was verified by PCR. 
Methodology used specifically to identify novel sRNAs 
Our goal was to identify and characterize novel sRNA transcripts in the 
gonococcus and experiments were designed to maximize sRNA identification. 
To begin, we chose two different culture conditions designed to induce 
expression of the greatest number of sRNAs inN. gonorrhoeae. In one 
condition , N. gonorrhoeae was grown under either iron replete or iron deplete 
conditions with agitation in COM in a closed container at 37° C (referred to as 
Condition A) and RNA was isolated at various time points. Iron was chosen due 
to its pivotal role in bacterial survival and because it was the condition used to 
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identify the first sRNA in the Neisseria, NrrF [163]. Due to the initial prohibitive 
cost of RNA-seq experiments, we combined RNA isolated from N. gonorrhoeae 
grown separately under iron replete or deplete conditions into one RNA-seq 
experiment. In addition, for Condition A, the RNA sample was first 
electrophoresed through a 15% TBE-Urea gel to enrich for RNA transcripts 50-
250 nucleotides in length . In order to explore diversity of sRNA expression, we 
also investigated a different growth condition for N. gonorrhoeae designed to 
induce the expression of sRNAs that might not be transcribed under Condition A. 
This condition was a static incubation in the cell culture media KSFM in an open 
container exposed to 5% C02 at 3r C (referred to as Condition B). KSFM is a 
proprietary medium that is used to culture human epithelial cells, particularly 
fibroblasts and cervical cells , and represents a fundamentally different growth 
condition compared to Condition A. The amount of iron in KSFM is 
approximately 7 mM, therefore it represents neither a completely iron-replete nor 
-deplete condition. In addition, this is a static growth condition with exposure to 
C02 unlike Condition A. Our previous experiments show that N. gonorrhoeae is 
metabolically active and able to replicate under Condition B but its growth is 
significantly slowed (data not shown). Condition B was chosen due to its 
differences from Condition A and because viability of N. gonorrhoeae under this 
condition had been observed by our group previously. As our results show, the 
disparate growth conditions allowed us to explore a broader range of sRNA 
expression. 
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RNA isolation 
For all experiments RNA was isolated using TRizol (Invitrogen) according 
to the manufacturer's instructions. Glycogen was not used as an optional 
additive and RNA pellets were washed twice with 70% ethanol as opposed to 
once. For all RNA-seq or RT-PCR experiments RNA was treated with TURBO 
DNase (Ambion) according to the manufacturer's instructions. All water and 
aqueous solutions used with RNA were made with Diethylpyrocarbonate 
(DEPC)-treated water. A 0.5% solution of DEPC/water was mixed and allowed 
to incubate at 37° C overnight before being autoclaved for 30 min. to inactivate 
DEPC. 
Ribosomal RNA depletion 
A maximum of 2.5 ug of RNA was subjected to rRNA depletion. 
Prokaryotic rRNA was depleted using the MicrobeEXPRESS Kit (Ambion) and 
eukaryotic rRNA was depleted using the Ribo Minus Kit (Invitrogen). All 
protocols were carried out in duplicate to ensure sufficient depletion of rRNA. At 
no time was EDTA used. 
Preparation of eDNA libraries and RNA sequencing 
Representative samples of RNA were prepared for sequencing using 
either lllumina's Small RNA Sample Preparation Kit (Condition A) or BioChain's 
High Yield Directional mRNA Sample Prep Kit (All other experiments) according 
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to the manufacturer's instructions. For Condition A RNA was not fragmented and 
instead was electrophoresed through a 15% TBE-Urea gel and RNA between 50-
250 nucleotides in size was cut out of the gel. RNA was then extracted using TE 
by agitation overnight and RNA was prepared for sequencing. Briefly, for both 
kits the preparation of eDNA libraries is as follows. RNA was fragmented by 
metal ion scission for 3-5 minutes at 94° C (or electrophoresed for Condition A). 
RNA was then treated with polynucleotide kinase (PNK) and purified using 
TRizol. Specific RNA adapters approximately 60 nucleotides in length were then 
ligated sequentially to the 5' and 3' termini of the RNA fragments. This was 
followed by 15-18 cycles of a PCR reaction using primers analogous to the 
adaptors. For Condition A RNA was electrophoresed through a 2% agarose gel 
to remove primer dimers and adaptor dimers followed by analysis using an 
Agilent Technologies 2100 Bioanalyzer to confirm eDNA library size and quantity. 
For the all other conditions eDNA libraries were electrophoresed through an 8% 
TBE gel for 60 min. at 140 V. eDNA fragments between 200-500 basepair were 
then extracted from the gel using TE buffer with agitation. Libraries were then 
analyzed on an Agilent Technologies 2100 Bioanalyzer to confirm eDNA library 
size and quantity. Libraries were sequenced using 36-77 single-end base pair 
reads on an lllumina GAIIX machine or using 101 base pair paired-end reads on 
an lllumina High-Seq machine. 
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Analysis of N. gonorrhoeae RNA sequencing 
Aligning reads to genome 
While many gonococcal isolates have been collected worldwide there are 
currently 17 strains that have been characterized, assembled into a dendogram 
and either have been fully sequenced or are being sequenced. The studies 
described here primarily concern three different strains of N. gonorrhoeae, two of 
which, FA 1090 and TCDC-NG081 07, have been fully sequenced and 
assembled. Strain FA 1090 is a serum-resistant strain that was originally isolated 
from the cervix of a patient suffering from DGI. Strain TCDC-NG08107 was 
isolated in Taiwan from a 17-year old male patient in May 2008. This strain is 
resistant to cefixime and had a reduced susceptibility to ceftriaxone [227]. Many 
of our in vitro experiments also utilize N. gonorrhoeae strain F62. This strain has 
been partially sequenced but has not yet been fully assembled. This strain was 
originally isolated from a case of uncomplicated gonococcal infection in the 
United States in 1960 and shows resistance to serum. The final strain of N. 
gonorrhoeae that has been fully sequenced is NCCP11945. This strain was 
isolated from a smear of a Korean patient in 2008 and shows resistance to 
penicillin , tetracycline and ciprofloxacin [228]. 
For analysis of F62 grown in vitro, reads were aligned to theN. gonorrhoeae 
FA 1090 genome. We have used the FA 1090 genome for design of primers and 
probes that were then used with F62 RNA and DNA and have encountered no 
problems. Indeed, several studies have shown the high degree of similarity 
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between the F62 and FA 1 090 genomes [229, 230] indicating that alignment of 
F62 reads to the FA 1090 genome pose no major impediment to downstream 
analysis. For vaginal lavage samples from mucosal infection, RNA was aligned 
to each of the three fully sequenced strains of N. gonorrhoeae (FA1090, TCDC-
NG081 07, and NCCP11945) and designations from the strain with the highest 
percentage of alignment were used in subsequent figures and discussion. Using 
an approach similar to that of Bowtie2 a Burrows-Wheeler index based on the 
full-text minute space was created for each N. gonorrhoeae genome. Using the 
index, an alignment to the genome was attempted for each read . If a read did 
not align exactly, then seed regions of the read were aligned to the genome. 
These seed alignments were extended with a dynamic program that employed a 
quality aware scoring function based on the error probability of each sequencing 
read nucleotide to ensure the highest quality alignment of the read to the 
genome. Seed regions were constrained to be no less than one third the length 
of the read and inexact alignments of a read to the genome were allowed to 
contain up to a threshold number of mismatches, insertions, and deletions, where 
the threshold was set to 15% of the length of the read. 
Following alignment of the sequencing reads to the genome, reads from 
each experiment were normalized by upper quartile normalization [231] and 
transcripts were assembled, first, by identifying a set of transcript seeds 
consisting of annotated genes and high confidence novel transcripts and, then, 
by extending the seeds using a Bayesian approach to identify more precise 
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transcript boundaries. Transcript abundance levels were quantified using the 
Reads Per Kilobase per Million mapped reads (RPKM) measure except that 
instead of normalization by total read counts in each experiment, upper quartile 
normalization was used to increase robustness of the transcript abundance 
estimates. This approach eliminated potential skewing of the normalization 
process due to large numbers of gonococcal genes that may have very low or no 
expression. Other studies have found that upper quartile normalization has the 
best concordance with qRT-PCR data [231]. 
Identifying transcript boundaries 
To generate a transcriptome map based on reads from an RNA-seq 
experiment, a multi-step approach was used. First, a set of transcript seeds were 
identified corresponding to annotated genes and to novel transcript seeds. Novel 
transcript seeds are genomic regions at least w nucleotides in length (w is 10 by 
default) such that every nucleotide in the region has at least Treads mapping to 
the nucleotide, where the threshold Tis a function of the average number of 
reads per nucleotide throughout the genome. Novel transcript seeds are 
maximal, i.e., the number of reads mapping to the nucleotide immediately 
upstream and to the nucleotide immediately downstream of a novel transcript 
seed is less than T. Note that transcript seeds correspond to genomic regions 
rather than RNA transcripts. 
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Each transcript seed was then extended, upstream and do~nstream, 
using a Bayesian approach. Lets refer to a transcript seed and r be a genomic 
region consisting of one or more nucleotides adjacent to s. Our goal was to 
determine whether or not r corresponds to part of the same transcript as s, i.e., 
whether s should be extended to include r. Using Bayes' theorem, we have 
p(C I x,) = p(C)p(x, I C) 
p(x,) 
where Xr is the number of reads mapping to rand C is a dependent class variable 
with two outcomes, C={cr .... s, CrJs} with Cr .... s corresponding tor and s being co-
transcribed and CrJs corresponding tor and s not being co-transcribed. The 
probability p(xr I Cr .... s) was determined by fitting a normal distribution to the 
number of reads mapping to s. The probability p(xr I CrJs) was determined from a 
background geometric distribution based on the number of reads mapping 
antisense throughout the genome to annotated protein coding genes. Using the 
maximum a posteriori (MAP) estimate, the seed s was extended to include r, or 
not, based on 
argmax p(C = c)p(xr I C =c) 
cE{ cr-s ,crls} 
which is equivalent to the maximum likelihood estimate since uniform prior 
probabilities are assumed. Finally, after each transcript seed was extended, 
adjacent or overlapping transcript seeds are merged if the distributions of reads 
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across two adjacent or overlapping transcript seeds are significantly similar. The 
transcriptome map reported by Rockhopper corresponds to the set of merged, 
extended transcript seeds. 
Differential gene expression 
Rockhopper computed a p-value for the differential expression of each 
gene using the approach of Anders and Huber [232]. For a given gene, let R1 
and R2 refer to the sum of normalized reads aligning to the gene across all 
replicates in condition 1 and condition 2, respectively. Let the probability of the 
event R1 = x and R2 = y be denoted as p(x, y). Then the p-value for a pair of 
observed read summations, R1 and R2, is the sum of probabilities less than or 
equal to p(R1, R2) and can be expressed as 
To compute p(x, y) , assuming independence of conditions 1 and 2, we 
calculated the product of the probabilities that R1 = x and R2 = y by approximating 
the random variables R1 and R2 with negative binomial distributions whose 
variance parameters are estimated as described above. From the resulting p-
values , differentially expressed genes are determined by computing q-values 
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based on Benjamini-Hochberg correction with a false discovery rate (FOR) less 
than 1%. 
Operon prediction 
To estimate the likelihood that consecutive genes on the same strand are 
part of the same operon, a na·ive Bayes classifier was used based on prior 
operon probabilities and on two features, IG distance and correlation of gene 
expression across RNA-seq experiments. The prior probability that two 
consecutive genes on the same strand are co-transcribed was estimated as 1 -
(#of directons I# of pairs of genes on the same strand), where a directon is a set 
of consecutive genes on the same strand [233]. As examples, we estimated the 
prior probability of co-transcription for two consecutive genes on the same strand 
as 74% for N. gonorrhoeae. Given the distance between two consecutive genes, 
the probability that they correspond to the same operon was based on the 
distribution of distances between consecutive genes on the same strand, 
smoothed via an Epanechnikov kernel, and the probability that they did not 
correspond to the same operon is based on the distribution of distances between 
consecutive genes on the opposite strand, smoothed via an Epanechnikov 
kernel. The probability that two consecutive genes are similarly expressed was 
based on their correlation of expression across the RNA-seq experiments. 
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Analysis of Human RNA sequencing data 
Analysis of the human RNA-seq data was carried out using three different 
programs to handle various aspects of eukaryotic transcriptomics. These 
programs have been previously developed and published and therefore only a 
short description of their function is given here. Initial alignment of human 
transcripts to the hg19 human genome (NCBI Ascension Number: 
GCA_000001405.1) was carried out using Bowtie, a program developed to align 
short RNA-seq reads to large genomes [234]. Following initial alignment splice 
junctions were identified and mapped using TopHat [235]. This program corrects 
for the differences in sequenced RNA transcripts and eukaryotic genomes due to 
the presence of introns in DNA. Finally, transcript assembly and expression 
levels of individual genes was carried out using Cufflinks [236]. Gene expression 
levels were calculated using RPKM. 
Northern blot analysis of small RNAs 
For Northern blot analysis, 20-30j.Jg of bacterial RNA along with a ssRNA 
ladder were first denatured with glyoxal dye at 50° C for 30 min. Denatured RNA 
was subjected to electrophoresis through a native 1.5% agarose gel at 90V for 
60 min. Following confirmation that RNA was intact via viewing with UV light, 
RNA was transferred to positively charged nitrocellulose membranes for 2.5-3 
hrs. using passive transfer with 20X SSC. After transfer, RNA was crosslinked to 
membranes with UV light and pre-incubated with OligoHyb Buffer (Ambion) for 
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45-60 min. at 3r C with rotation. Simultaneously, -50 nucleotide oligo probes 
were labeled with [y-32P] ATP as described above (Table 1). After pre-
incubation, each probe was diluted with 1 ml of OligoHyb and placed in tubes 
containing each pre-incubated membrane. Membranes were incubated with 
probes at 3r C with rotation overnight. Following probe hybridization, 
membranes were washed twice at RT with 2X sse containing 0.1% SDS. 
Membranes were exposed to x-ray film overnight at -80° C and developed. Size 
of sRNAs was determined by plotting the base 1 0 logarithm of the size of each 
ladder marker against distance traveled in the gel on semi-log paper. Ladders 
used in these experiments contained markers for 50, 100, 200, 300, 400, 500, 
750, and 1000 nucleotide lengths. sRNAs were then sized using the resulting 
standard curve. 
Primer extension analysis 
For primer extension analysis, 1 Oj..Jg of bacterial RNA was incubated with 
an [y-32P] ATP radiolabeled oligonucleotide probe at varying temperatures 
corresponding to the probe's melting temperature. Probes (Table 1) were 
labeled using T4 PNK for 60 min. at 3r C followed by 2 min. at 90° C to 
inactivate the PNK. Following probe hybridization to bacterial RNA the probes 
were extended using reverse transcriptase for 1 hr. at 41 o C. Single stranded 
DNA (ssDNA) products were then electrophoresed through an 8% TBE-Urea gel 
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Table 1. Probes used in this study 
Probes used for primer sxtension 
Gene orsRNA Probe sequence 
NG00732 CGATTTCGGCATCTA I I I I I 
NG00926 TTGACCGGTACGATCTTGCAAAG 
NG01577 CATTAGATTTGTACAGCAGATAC 
NG01628 GATTGTGCAACTTTATACCAACC 
NG01676 GTATCTGTTCTACTTTCAATTTT 
NG01680 TTGCCGGACATCGGGCGTTTACC 
NG01762 TTACGCCCAGTTGTTCAGCAAT 
NG01812 ATCGGCCATTGCCGCAACAGGAA 
NG01858 GTGCCAACGTTTACGTGCGGTTT 
NG02134 CAAATGGTTCATTCTCTTTTACG 
smRNA16 CAGATATATTCGGACTGCACCTC 
smRNA17 GAATGTGTGCCAAGTCTACA 
smRNA20 AGGAGAAATAGAGGAGAAACTATT 
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smRNA 
smRNA6 
smRNA? 
smRNAS 
smRNA10 
smRNA11 
smRNA15 
smRNA16 
smRNA17 
smRNA20 
smRNA30 
Probes used for Northern blot analysis 
Probe sequence 
ATGCCTGGTAAATTGCCAATC 
TTCTACGGTGTTGCATATTGACCCTTTC 
CAAACAGGCTGTGCTTATTCCCT 
GTTGAACAGGTATTGTATTCGCAGCCC 
TTGTAAACGTTTTGCCTTGCATGA 
TGAAATGCCGTCCGAAGATAAAAATATT 
AATTCAGTGTTTTACGGGAATCT 
GAGACCCCGGTATGCCCGCATCTGCTT 
CTGACCCGGTGTTCCGATTTG 
CCATGCGGGGAGACCCGCAAC 
GGCAACTTGCTTTCATTACTTGA 
CCGCGTATCAACTACGGGAGCCTCTG 
CCGAATATATCTGCCTGCTGTT 
TCCTCTTTATTCAGCCTTTATAATA 
GTCTACAAAGGAGAAGTAGAGG 
AGAAAAATCAAGCTGCATCAAGCAAC 
ACTATTAACTGACTACTCGAACCAGCTAAC 
ACCTTTTCACCCTTGCCTGTGC 
TGCCAAAGCAGCCATCGGCGGTTTTGCT 
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along with a radiolabeled ssONA ladder. Gels were exposed to x-ray film 
overnight at -80° C and developed. Size of primer extension products was 
determined by plotting the base 1 0 logarithm of the size of each ladder marker 
against distance traveled in the gel on semi-log paper. 
~-galactosidase assays. 
N. meningitidis strains harboring the sdhC promoter fusion were grown 
to00600 of 0.5-0.6. under iron-replete or -deplete conditions. Cells were then 
collected by centrifugation and 13-galactosidase assays were carried out as 
described previously. The 0.0. was determined at 420 nm and again at 550 nm 
to correct for light scattering. Miller units were then calculated using the following 
equation: Miller Units= 1000 x (0042o- (1.75 x OOsso))/ (V x T x 006oo) where V 
is the volume in ml and Tis the time in min . 
Quantitative qRT -PCR 
Quantitative RT-PCR was carried out using the One-Step QuantiTect 
SYBR green RT-PCR kit (Qiagen) on an ABI Prism 7700 sequence detection 
system (Applied Biosystems, Foster City, CA). A total of 125 ng of RNA was 
used in each reaction mixture along with 2 ng of each primer (Table 2). The 
relative mRNA levels were evaluated using the comparative cycle threshold 
(llllCT) method. The relative expression level of each gene was normalized to 
the endogenous NG00616 gene and is represented as the ratio to that gene. 
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Table 2: Primers used in this study 
RT-PCR for confirming sdhC Hfq-independent regulation 
Primer 
16SF 
16SR 
NMB0948F 
NMB0948R 
Primer sequence 
CATACCGTGGTAAGCGGACT 
TGGTCGGTACAGAGGGTAGC 
GGGGTCGGGCTGTITA TI AT 
GGTGCAGATAAGCCCACAAT 
Generating Hfq knockout and complemented strains 
Primer 
hfq-5'flankF 
hfq-5'flankR 
hfq-3'flankF 
hfq-3'flankR 
hfqcompF 
hfqcompR 
Primer sequence 
GGAACTAGTAGCCACAATCCCGTAAACAG 
GACTCGAGGCACGAAGCATGACGTGT 
GGACGGCCGATTTTIAACTCCGTTATIATGATIGTG 
GGAGTCGACTGGACATGAACGAAACCGT 
ACAGGATCCAAAGATATGACACGTCATGCTIC 
ACACGGCCGCAACCCGTTACCATCGTATTG 
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RT -PCR for Corroborating Rockhopper Expression Level Prediction 
Primer Primer Sequence 
NG00616F GACACTCGCCCTACGCAATC 
NG00616R AAGGTTTCGCCGTCTTGGAT 
NG00745F CAACCGCCTGATCGAAGAAA 
NG00745R GCCACTTTTGCCGATTCAAA 
NG01734F CACCCCGAAATCGTTTGAAG 
NG01734R CAGCTCGTTGCCTTCCTGAT 
NG01450F GACAATCTGAATCCGCAGGAA 
NG01450R TCCTTCGCCCAAAGGTAAAAA 
NG01426F ATTGCGGGTTTTTGTCAACG 
NG01426R CGGATCGACCAAAAAGACCA 
NG01948F ATGGAACGGGGAGAATTGGT 
NG01948R GCAGCAAAAGCTCCGCATAC 
NG00183F CGTTTTGATATTCGGCACC 
NG00183R TCTTTGCCGTCTGTGCCTTC 
NG00058F TATCCTGACCCGCCTTGAAA 
NG00058R TCGTAACGCTCGTCCACTTC 
NG00777F TCGAAGCGATTGCTCAAGAA 
NG00777F ACGGTGTCGGCCTTGTTTCAG 
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RT -PCR for Corroborating Rockhopper Operon 
Prediction 
Primer Primer Sequence 
NG00568-0569F CCTGTCCAACCACTTTCTCG 
NG00568-0569R TAACCTTCACGCCCGTTG 
NG00664-0665F TGGGATTGGGTATGGAAATC 
NG00664-0665R TCTGCCAGTAGGTTTTGCG 
NG00883-0884F CGCTTTCACCGTGTAATCTGT 
NG00883-0884R ACCTGTTGGATTTCGTGAATAG 
NG01282-1283F TCTTTATCCGATTTACAAIIIIICC 
NG01282-1283R TTATAAGGCAACGGAGCAAA 
ppnk-NG00391 F CCTCCTCCCCATCATCAAC 
ppnk-NG00391 R GACTAATTGCTCGCCCCAGT 
NG00635-0636F GTCAAAACCCCGTTTACCT 
NG00635-0636R ATTTCAAACTTCCTTTATCACGA 
NG00936-0937F ACGCTTTTCCTGTCTGTTGG 
NG00936-0937R CCGGTACGGGTATCGATTT 
NG01873-1874F AAAATGCGGAACATTTGTTATC 
NG01873-1874R GGAATCGTTCCCTTTGAGC 
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RT -PCR of operons 
For operon prediction, primers (Table 2) were designed to hybridize to the 
beginning of the upstream gene and the end of the downstream gene so that the 
entire two-gene operon was amplified by RT -PCR, not merely a part of it. RT-
PCR was carried out using 125 ng of bacterial RNA and 2 ng of primers. 
Products were then run out on a 1.0% agarose gel with a dsDNA ladder. 
Human cell lines 
Cell lines used in these experiments derived from endocervical epithelial 
cells isolated from a premenopausal woman who had undergone a hysterectomy 
for endometriosis and immortalized by Fichorova et al in 1997 [237]. Cells were 
immortalized through transduction with the retroviral vector LXSN-16E6E7 
inserting the E6 and E7 proteins of human papillomavirus into the genome of the 
cells generating End E6/E7 cells. Immortalization of these cells was confirmed 
through continuous passage in media for more than a year. The transformed cell 
line maintains characteristics of its tissue of origin and can be distinguished from 
similar cell types through the expression of specific cytokeratins [237]. Similar to 
primary endocervical cells these cells do not express TLR4 but do express TLR 1, 
TLR2, TLR3, TLR5, and TLR6 [1 01 ]. This was confirmed by release of IL-8 in 
response to Chlamydia! MOMP protein but not to purified LPS [88, 101]. 
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Human cell line growth conditions 
A single vial of approximately 1x106 End E6/E7 cells were seeded into a 
T25 flask and maintained in 1 x KSFM at 3JO C in 5% C02. Media was changed 
every 3-4 days and cells were allowed to grow to 70-90% confluence. Cells were 
then trypsinized for 10 minutes with 1 ml of trypsin for every 25 cm2 of flask 
area. Trypsin was inactivated with DMEM supplemented with 5% FBS (7 ml 
added to a 25 cm2 or 75 cm2 flask and 15 added to a 162 cm2 flask). Cells were 
then centrifuged at 1500 rpm for 5 min. and washed once with 10 ml of PBS. 
Cells were centrifuged as before and split 1:3 into new flasks with fresh media. 
In vitro incubation of human cells with N. gonorrhoeae 
Epithelial cells End/E6E7 were seeded in six-well tissue culture plates 
(5x1 05 cells/well) and allowed to grow to confluence (1 06 cells/well) in antibiotic-
free KSFM, a process taking 24-48 hours. Concurrently, N. gonorrhoeae F62 
was plated on GCB plates containing Kellogg's supplement (See Media, Buffers 
and Reagents) and grown aerobically at 3JO C in 5% C02 for 17 hours. N. 
gonorrhoeae was then resuspended in KSFM at an O.D.6oo of 1 and viable cells 
were determined by counting CFUs of various dilutions on GCB plates. This was 
done to ensure that subsequent MOis determined by spectrophotometric 
analysis of resuspended bacteria were correct. Approximately 17 hours before 
incubation with human cells N. gonorrhoeae were plated on GCB and grown 
overnight. Bacterial cells were removed from plates and resuspended in KSFM. 
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Media was then removed from wells containing End/E6E7 and KSFM containing 
N. gonorrhoeae was then added to each well at an MOl of 100. An equal 
number of wells of End/E6E7 were also incubated with fresh KSFM to constitute 
negative controls. Correspondingly, an equal number of wells of N. gonorrhoeae 
were also incubated with KSFM alone to constitute a negative control. A sample 
of the original N. gonorrhoeae inoculum was also plated and GFU counted to 
determine exact MOl. Plates were then incubated at 3JC C in 5% C02 and two 
hours later media was removed from End/E6E7 incubated with N. gonorrhoeae 
or media alone and wells were washed 3x with 2.5 ml of PBS to remove all N. 
gonorrhoeae cells which were not adherent to or within host cells. TRizol was 
then added to each well and plates were agitated gently for 10 min. TRizol from 
each well was then transferred to a 2 ml tube and RNA was isolated as 
described below. For N. gonorrhoeae incubated alone in media the contents of 
each well were transferred to a 2 ml tube and were centrifuged for 3 min. at 
3,000 rpm. The resulting bacterial pellet was resuspended in 1 ml of TRizol and 
RNA extracted as described below. 
Clinical Samples 
Human samples were obtained from the Clinical Core of the U19AI084048 
grant which is located at the National Center For Sexually Transmitted Diseases 
(NCSTD) in Nanjing, China. The Clinical Core is located at the Institute of 
Dermatology of Chinese Academy of Medical Sciences in Nanjing and is under 
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the direction of Dr. Baoxi Wang. The Institute is outfitted with extensive clinical, 
research and teaching facilities and undertakes the tasks of control, surveillance, 
health education, research, training , and scientific exchange in respect to STis. 
In the year between April 2011 and April 2012, the NCSTD clinic recorded a total 
of 321 gonorrhea cases; 278 were males and 43 were females. The high 
number of patients has allowed us to obtain sufficient samples for an ongoing 
study in the Genco laboratory. This has allowed us to reach statistical 
significance in a shorter time period, which is particularly important in regards to 
the quickly evolving antimicrobial resistance of the pathogen N. gonorrhoeae. 
The patients who present with a gonorrhea infection at the NCSTD clinic also 
tend to be of an older age demographic than the US. While 50-70% of 
gonorrhea patients in the US are under the age of 25 (2010 CDC Surveillance 
Report) , only 10-20% of gonorrhea patients at the NCSTD center are under 25 
years . 
We chose to use this facility for two reasons. First, through the existing 
U 19 grant the clinical infrastructure to recruit subjects and collect data and 
samples was currently in place and running efficiently. Second, from the 278 
recorded clinic cases, the study was able to recruit 18 matched pairs, that is, 
male and female partners infected with the identical strains of N. gonorrhoeae. 
This high number of matched pairs would be difficult to find in the US and is 
mainly due to both the high volume of patients and the older age demographic of 
the NCSTD, making it more likely that patients are married couples with one 
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member remaining monogamous. Matched pairs will allow us to analyze 
differences in the male and female transcriptome of the host and pathogen with 
minimal contributions resulting from different strains of N. gonorrhoeae infecting 
males and females. The experiments and results described here comprise the 
pilot portion of a larger study that will expand patient numbers, analyze 
uninfected samples and make comparisons between genders. 
At the NCSTD male patients report with symptoms indicative of 
gonorrhea. If these male patients test positive for gonorrhea by PCR and plating 
of the organism then their female partners are contacted. Female partners are 
monogamous with the male partner (the male is their only sexual contact). 
Eligible female partners lived in the local Nanjing area and were willing to come 
into the clinic. Women were excluded if they have taken azithromycin at any time 
in the prior 14-day period before exposure or had used any other antibiotic in the 
prior 4 day period before exposure, if they are pregnant, if their sex-partner 
always uses condoms successfully, if they are HIV positive or if they are < 18 
years of age. Once at the clinic, enrolled women underwent an extensive 
medical and sexual history evaluation as well as information regarding social and 
demographic information. Following this interview, each subject underwent a 
complete clinical examination including sample collection. Samples were tested 
for the presence of N. gonorrhoeae both by plating of the organism as well as by 
PCR to test for the presence of gonococcal DNA. In total, we have collected and 
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analyzed 4 such samples. Samples were then stored in RNAiater (Qiagen) or 
RL T Buffer (Qiagen) and shipped to the United States on dry ice. 
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Medium, Buffers and Reagents 
All reagents were obtained from Sigma Chemical Corp. (St. Louis, MO) unless 
stated otherwise. 
Chemically Defined Medium (COM) 
Amino acids 
L-cysteine (0.15 mM, catalog# C 4424), Dissolved in 50 ml of 1.0 N HCI, L-
hypoxanthine (0.37 mM, catalog# T 8941 ), Uracil (0.45 mM, catalog# U 0750), 
Dissolved in 100 ml of 1.0 N NaOH. 
L-alanine (1.1 mM, catalog# A 5824), L-arginine-HCI (0.71 mM, catalog# A 
5131), L-asparagine.H20 (0.17 mM, catalog# A 8381), L-aspartic acid (3.8 mM, 
catalog# A 6558), L-cysteine HCI (0.35 mM, catalog# C 1276), L-glutamic acid 
(8.8 mM, catalog# G 1626), L-glutamine (0.34 mM, catalog# G 3126), 
Glutathione reduced (0.15 mM, catalog# G 1404), Glycine (0.33 mM, catalog# 
G 7403), DL-histidine HCI-H20 (0.12 mM, catalog# H 7875), DL-isoleucine (0.23 
mM , catalog# J 5393), DL-Ieucine (.69 mM, catalog# L 7875), DL-Iysine HCI 
(0.27 mM, catalog# L 6001 ), DL-methionine (0.1 mM, catalog# M 9500) DL-
phenylalanine (0.15 mM, catalog# P1876), L-proline (0.43 mM, catalog# P 
8449), DL-serine (0.48 mM, catalog# S 4375), DL-threonine (0.42 mM, catalog# 
T 8375), and L-valine (0.51 mM, catalog# V 0500). Dissolved in 2000 ml double 
distilled water (ddH20). 
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Amino acids in acid an·d base (from above) were added and made up to a 
volume of 2700 ml with ddH20. 
Vitamins/Biotin 
Thiamine HCI (0.0059 mM, catalog# T 4625). co-carboxylase (0.001 mM, 
catalog# C 8754), biotin (0.012 mM, catalog# B 4501), D-pantothenic acid 
(0.004 mM catalog # P 2250. Dissolved in 300 ml of 95% ethanol and made up 
to a volume of 600 ml with ddH20. 
Phosphate buffer 
KH2P04 (4 mM , catalog# P 0662), K2HP04 (4 mM, catalog# P 8281) . Dissolved 
in 200 ml of ddH20 and made up to a volume of 400 ml with ddH20. 
HEPES buffer 
HEPES (20 mM, catalog# H 3375). Dissolved in 200 ml ddH20 and made up to 
a volume of 400 ml with ddH20. 
Salt solution 
NaCI (58.45 g, catalog# S 3014), K2S04 (10 g, catalog# P 9458), MgCb-6H20 
(2.18 g, catalog# M 2670), NH4CI (2.2 g, catalog# A 9434), EDTA (30 mg, 
catalog# E 5134) . Dissolved in 150 ml of ddH20 and made up to a volume of 
250 ml with ddH20. 
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Glucose 
(20% stock in ddH20, catalog# 016-500) 
Calcium Chloride 
(0.25 mM, catalog# C 3881) 
2XCDM 
Amino acids (360 ml), vitamins/biotin (20 ml), HEPES buffer (80 ml), phosphate 
buffer (8 ml), salt solution (50 ml), glucose (50.4 ml) were mixed and diluted to 
800 ml with ddH20, The pH was adjusted to 7.2 with 10N NaOH and 20 ml 0.25 
mM calcium chloride added. The total volume was diluted to 1 L with ddH20 and 
filter sterilized with a 0.2 1-1m filter. 
Gonococcal Medium Base (GCB) 
(Difco Laboratories, catalog # 228950) 
Kellogg's supplement 
Glucose (40 g, catalog# 49158), glutamine (0.5 g, catalog# G 3126) Fe(N03)3 
(50 mg, catalog# F 3002), co-carboxylase (2 mg, catalog# C 8754). Dissolved 
in 50 ml of ddH20 and made up to a volume of 100 ml with ddH20. Filter 
sterilized with 0.2 1-1m filter. 
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Iron chelator 
Desferal (Desferoxamine mesylate) (catalog# D 9533) 
Iron supplement 
Ferric nitrate (Fe(N03)3) (catalog# F 3003) 
20X SSC buffer 
NaCI (3M, catalog# S 5150), Sodium citrate (0.3 M, catalog# S 1804). 
Adjusted the pH to 7.0 with 1 M NaCI. 
1X Kerotinocyte-SFM (Invitrogen, Product# 17005-075) 
Kerotinocyte-Serum Free Media supplemented with 0.4 mM CaCI2, Epidermal 
Growth Factor (EGF) 1-53 and Bovine Pituitary Extract (BPE) 
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RESULTS 
Chapter 1. Regulatory small RNAs of Neisseria 
Identification of novel sRNAs in N. gonorrhoeae 
The first step in finding novel sRNAs inN. gonorrhoeae was to isolate RNA from 
the gonococcus grown under various conditions (Condition A and Condition B) 
and carry out RNA-sequencing to identify transcripts which might represent 
sRNAs. Condition A represented iron-replete and -deplete conditions and 
Condition B represented static incubation in KSFM. RNA was isolated and 
sequenced and following RNA sequencing, subsequent analysis focused on the 
identification of possible transcripts that corresponded to sRNAs. Analysis of the 
sequencing data was carried out using Rockhopper, a new program designed to 
analyze prokaryotic RNA-seq data [238]. Transcripts showing significant 
expression were identified within IG regions or antisense to protein coding genes. 
These parameters generated a list of 280 transcripts that were expressed under 
Condition A and 81 transcripts that were expressed under Condition B. 
Considering that the total number of putative sRNAs (365) was expansive, we 
selectively focused on a set of candidate sRNAs that were defined through step-
wise application of restricting characteristics. The workflow of our identification of 
sRNAs is depicted in Figure 5. To begin, only the 33 putative sRNAs that were 
found to be expressed under both conditions tested were chosen for continued 
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COM 
+Iron 
Condition A 
COM 
-Iron 
Human 
Cell Culture Media (KSFM) 
Condition B 
Rockhopper (New program to Analyze Prokaryotic RNA-seq Data) 
280 Putative sRNAs 81 Putative sRNAs 
33 Common sRNAs 
Figure 5. Experimental design for identifying novel gonococcal sRNAs. 
Two different growth conditions were chosen to maximize sRNA expression and 
discovery (described in the Methods section). Due to the initially high cost of 
RNA- seq experiments, RNA isolated separately from N. gonorrhoeae grown 
under iron replete and deplete conditions was combined into a single lane for 
sequencing. 
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study. Since sRNAs are generally between 50-250 nucleotides in length and thus 
any RNA transcripts that were 30 nucleotides or shorter in length in both growth 
conditions analyzed were removed from further analysis. At the conclusion of 
this analysis, we narrowed down our initial set of transcripts to a list of 32 high-
quality sRNA candidates that were at least 30 nucleotides in length under at least 
one condition tested and detected via RNA-seq under all conditions tested. The 
expression level of each of these sRNAs as well as what DNA strand they are 
expressed from and the presence or absence of an RIT are displayed in Table 3. 
The size of each sRNA as determined by both RNA-seq and Northern blot is 
displayed in Table 4. 
Confirmation of Novel sRNAs 
From the 32 sRNAs listed in Table 3, a subset of ten was chosen 
randomly for expression confirmation via Northern blot analysis. RNA-seq reads 
mapping to each of these ten sRNAs is shown in Figure 6. Northern blot analysis 
was carried out using RNA isolated under the same conditions as those used for 
the RNA-seq experiments. All of the ten sRNAs analyzed by Northern blot 
showed evidence of expression under at least one condition and all were less 
than 500 nucleotides in size, suggesting that they are not likely to be UTRs of 
flanking protein coding genes (Figure 7). In addition, a comparison was 
performed between the sizes of sRNAs as predicted by Northern blot analysis 
versus by RNA-seq analysis. The average ratio of sRNA sizes predicted by 
RNA-sequencing compared to sRNA sizes confirmed by Northern blot analysis 
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Table 3. Expression of putative gonococcal small RNA regulators 
ExpressionA ExpressionA in 
Name Strand Contains a RIT8 
in Condition A Condition B 
smRNA1 889 1946 No 
smRNA2 696 2764 No 
smRNA3 2051 5842 No 
smRNA4 576 4254 No 
smRNA5 1072 2125 + No 
smRNA6 584 4857 Yes 
smRNA7 21216 63483 + No 
smRNA8 16150 29851 + Yes 
smRNA9 726 8772 Yes 
smRNA10 3497 98119 + No 
smRNA11 3707 165916 No 
smRNA12 607 4208 + No 
smRNA13 760 3422 No 
smRNA14 2164 8435 + No 
smRNA15 709 3330 + No 
smRNA16 547 1515 Yes 
smRNA17 608 28062 + Yes 
smRNA18 1284 8287 + No 
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smRNA19 454 22076 + Yes 
smRNA20 499 38788 + Yes 
smRNA21 2087 8017 No 
smRNA22 415 1997 No 
smRNA23 1642 2427 No 
smRNA24 610 4145 + No 
smRNA25 1048 2172 No 
smRNA26 578 1781 Yes 
smRNA27 663 2263 + No 
smRNA28 1116 4365 + No 
smRNA29 919 2075 No 
smRNA30 13282 55472 + Yes 
smRNA31 2040 5788 No 
smRNA32 756 2645 + No 
AExpression levels are in RPKM 
8 RITs were determined with RNAMotif or TransTermHP 
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Table 4. Size of putative gonococcal small RNA regulators 
Transcript Transcript size 
Name Transcription Transcription size determined by 
startA stopA determined Northern blot 
by RNA-seq anal~sis 
smRNA1 36118 36078 40 N/D 
smRNA2 69334 69308 50 N/D 
smRNA3 69610 69524 86 N/D 
smRNA4 69759 69716 43 N/D 
smRNA5 260467 260508 41 N/D 
smRNA6 327414 327376 38 180 
smRNA7 471835 471927 92 89 
smRNA8 637363 637413 50 160 
smRNA9 640902 640863 39 N/D 
smRNA10 862950 863308 358 339 
smRNA11 870852 870754 98 99 
smRNA12 925189 925224 35 N/D 
smRNA13 1000314 1000251 63 N/D 
smRNA14 1035409 1035495 86 N/D 
smRNA15 1051802 1051835 33 91 
smRNA16 1100132 1100089 43 N/D 
smRNA17 1172605 1172662 57 165 
smRNA18 1231720 1231806 86 N/D 
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smRNA19 1248743 1248825 82 124 
smRNA20 1248943 1249028 85 72 
smRNA21 1428227 1428187 40 N/0 
smRNA22 1443403 1443238 165 N/0 
smRNA23 1481763 1481748 15 N/0 
smRNA24 1531527 1531562 35 N/0 
smRNA25 1617149 1617072 77 N/0 
smRNA26 1762955 1762916 39 N/0 
smRNA27 1779949 1779989 40 N/0 
smRNA28 1830813 1830868 55 N/0 
smRNA29 1848653 1848613 40 N/0 
smRNA30 1924431 1924792 361 304 
smRNA31 2036967 2036881 86 N/0 
smRNA32 2111953 2112001 48 N/0 
AGenomic locations are according to theN. gonorrhoeae FA1090 genome 
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smRNA6 
Con. A (plus strand) 
Con . B (plus strand) 
, Con. A (minus strand) 
i 
I Con. B (minus strand) 
Sequence 
Genes 
smRNA 7 
Con A (plus strand) 
Con . B (plus strand) 
Con . A (minus strand) 
Con. B (minus strand) 
327,100 bp 327,200 bp 
471,700 bp 471 ,800 bp 
327,400 bp 
I 
471 ,900 bp 
327,500 bp 
472,000 bp 
Sequence 
Genes 
... , UIIHIIU fl llll!lllllll'.llllliilillll llllllllllllliffi'iffiiiiiiiiiiUIUI·i lllllillldTillllll UlliiiiRl!I! !I II IJI!I I 111111 
smRNA8 
Con . A (plus strand) 
Con. B (plus strand) 
Con . A (mirius strand) 
Con. B (minus strand) : 
637,200 bp 637,300 bp 637,400 bp 
I 
Sequence 
Genes 
... 11:111 11111111'1 I IIMillllllltl•lll llllf:I IIGHIIIIIH IIIII IIIU IIIIIIIIIIU IHIII!IIJUIIIIIllllll liiUII III II II 
• 
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smRNA 15 1,o5poo bp 1 1,051 ,700 bp 1,051 ,800 bp I I I I 
Con. A (plus strand) 
-Con. B (plus strand) 
Con . A (minus strand) 
Con. B (minus strand) 
Sequence 
Genes 
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smRNA 17 
Con. A (plus strand) 
Con. B (plus strand) 
Con . A (minus strand) 
Con . B (minus strand) 
Sequence 
Genes 
smRNA 19,20 
Con. A (plus strand) 
Con . B (plus strand) 
Con . A (minus strand) 
Con . B (minus strand) 
1 '172,500 bp 
I 
1.172,600 bp 1,172,700 bp 
1 ,248,800 bp 
I 
I ! 
1,248,900 bp 1 ,249,000 bp 
I 
Sequence 
Genes 
_,.I ll II Ill ' HIIIIWllllllllllll>lll!lall!llllllllllllll lllll!l! i !Ifill' ill llllillltll!! IIIIIUllllitlllllll llll 
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Figure 6. Confirmation of sRNAs as determined by Rockhopper analysis. 
Growth conditions and strand specificity are shown on the left side of each panel 
and genomic location on the top of each panel. The shape of each pixelated 
column indicates expression level and coordinates of each sRNA. The 0-1000 
indicates that expression levels from 0-1000 are shown. Located in close genetic 
proximity, smRNA 19 and 20 are shown in one image. 
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Figure 7. Northern blot analysis of novel sRNAs. A 20 ~g sample of RNA 
was analyzed via Northern Blot analysis to confirm expression and size of 
putative sRNAs. All putative sRNAs that were examined were confirmed. 
Expression of sRNA was also tested under three conditions related to those used 
for RNA-seq. Growth in KSFM for 2 hr. (indicated by a 'K'), growth for 90 min. 
under iron replete conditions (indicated by a"+") , and growth for 90 min. under 
iron deplete conditions (indicated by a"-"). Experiments were performed three 
times and a representative film is shown. 
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was 0.73. Generally, sRNA sizes predicted by RNA-seq analysis were smaller 
than sRNA sizes as determined by Northern blot analysis. In order to determine 
if any of the ten sRNAs were likely to be orthologs of sRNAs identified in other 
organisms, we queried the Rfam database [239] and found that three (smRNA 
1 0, 11, and 30) were likely to be members of sRNA families that have been 
previously characterized in Neisseria (Table 5). A transfer messenger RNA 
(tmRNA), smRNA 10, is a short RNA transcript that has been implicated in the 
processing of truncated polypeptides. The tmRNA acts to remove polypeptides 
that have been synthesized using a truncated mRNA as a template [240]. 
Previous analysis of the gonococcal orthologue of tmRNA revealed a 363-
nucleotide RNA transcript [241]. This is in agreement with our finding of a RNA 
transcript of 339 nucleotides at the same coordinates. The smRNA 11 
corresponds to 4.58 RNA, part of an RNA-protein complex that targets proteins 
for transport to the cytoplasmic membrane. Previous investigation of 4.5s RNA 
in N. gonorrhoeae suggested a size of 114 nucleotides [242]. This is in proximity 
to our experimentally determined size of 99 nucleotides. Finally, our analysis 
detected the RNA portion of RnaseP, Ml RNA (designated as smRNA 30). This 
transcript has not been studied previously in N. gonorrhoeae but it has a 
predicted size of approximately 350 nucleotides in the RnaseP Database [243]. 
This is in accordance with our Northern blot analysis that shows this RNA 
transcript to be 304 nucleotides in length. The identification and proper sizing of 
several known sRNAs helps to validate the results of our RNA-seq and Northern 
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Table 5. Previously known non-coding sRNAs that were also found in this 
study 
Length by 
Northern blot Length in 
Number Name analysis literature Ref. 
smRNA10 tmRNA 339 363 [223] 
smRNA11 4.5s RNA 99 114 [226] 
Predicted RNaseP 
smRNA30 RNaseP 305 -350 Database 
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blot analyses. Beyond the ten sRNAs evaluated by Northern blot analysis, we 
investigated if any other putative sRNAs identified by our RNA-seq experiments 
corresponded to previously characterized sRNAs. Both NrrF and the TPP 
riboswitch were identified by our RNA-seq analysis in one of the conditions under 
study but not all [163, 244, 245]. 
Regulation of sRNAs of the Gonococcus 
The conditions used for N. gonorrhoeae culture in these experiments were 
chosen to maximize RNA identification by examining different bacterial 
environments. However, as several sRNAs were subjected to different 
conditions, a preliminary analysis of the regulation of these sRNAs was possible 
through analysis of Northern blot experiments. Many of the sRNAs tested 
showed higher expression under Condition B compared to the Condition A with 
smRNA 6, 8, 15, and 17 being particularly highly expressed under Condition B 
(Table 3 and Figure 7). Some of the sRNAs tested via Northern blot analysis also 
appeared to show regulation during growth under iron-replete or -deplete 
conditions. Both smRNA 8 and smRNA 19 appeared to be more highly 
expressed under iron-replete conditions as compared to growth under iron-
deplete conditions. As smRNA 8 appears to be a highly expressed iron-
regulated RNA, we performed a search for possible targets using TargetRNA 2, a 
new computational system for predicting mRNA targets of sRNA action 
(http://tempest.wellesley.edu/-btjaden!TargetRNA2/index.html). We then cross-
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referenced this list of putative targets against a list of iron-regulated genes in the 
gonococcus as determined by microarray analysis [246]. Table 6 shows which 
genes of N. gonorrhoeae were iron-regulated and computationally predicted to 
bind to smRNA 8. 
In addition, several of the sRNAs under analysis exhibited multiple 
products when examined via Northern blot analysis. These may represent non-
specific products that were detected by the oligonucleotide probe used in each 
Northern blot analysis but it is more likely that they represent programmed 
cleavage of a specific mRNA which generates multiple products. The latter 
hypothesis is supported by the observation that the multiple bands on each blot 
were regulated similarly to that of the sRNA under analysis. If the multiple bands 
resulted from non-specific binding of the probe, we would not expect the 
coincident regulation signals under different conditions. These results suggest 
that some of these RNA transcripts may serve as both regulatory RNAs and 
mRNAs. The longer RNA transcript may act as a coding template while the 
shorter transcript serves as a regulatory small RNA. 
Genomic Location of Novel sRNAs 
Following confirmation of the size and expression of each sRNA, the exact 
genomic location of each was confirmed via a combination of primer extension 
analysis and Northern blot analysis. Northern blot analysis was used to 
determine the size of the sRNA and primer extension was used to determine the 
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Table 6. Putative Targets of smRNAB 
Putative Targets of smRNAB 
Target Target Iron 
Designation Name RegulationA Hybridization Energy8 
NG02088 -15.19 
NG02083 -8.34 
NG02019 + -11.57 
NG01981 -15.51 
NG01770 priG -8.64 
NG01707 -15.65 
NG01520 sua5 -15.02 
NG00948 -8.6 
NG00578 uvrC -12.61 
NG00526 + -11 .86 
NG00285 + -19.81 
NG00260 + -9.22 
NG00115 -14.48 
A'lron regulation' refers to how the gene was regulated, a (+) indicates higher 
expression under iron-replete conditions and a (-) indicates higher expression 
under iron-deplete conditions. 
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8 Energy of hybridization is the Gibbs free energy (in kcal) predicted between the 
mRNA and smRNA8, with lower free energies indicating more stable interactions. 
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transcriptional start site. To this end, RNA was isolated under iron-replete 
conditions and three of the sRNAs that were not previously characterized were 
subjected to primer extension. Primer extension analysis revealed the 
transcriptional start sites of each of the sRNAs examined (Figure 8). As their 
transcriptional start sites are already predicted or known, tmRNA, 4.5s RNA and 
RnaseP were not examined. For smRNA 19 and smRNA 20, the predicted 
transcriptional start site as determined by RNA-seq corresponded exactly with 
that determined by primer extension . For smRNA 17, the transcriptional start site 
predicted by RNA-seq was approximately 30 basepair upstream of that 
determined by primer extension. It is possible that this discrepancy is due to a 
very small number of reads aligning upstream of the transcriptional start site of 
smRNA 17. This is confirmed in the Rockhopper view of smRNA 17 (Figure 6). 
This may arise from the misalignment of a small percentage of reads to the 
gonococcal genome or the possibility of multiple transcriptional start sites for 
smRNA 17. The transcriptional start site determined by RNA-seq may be 
transcribed at far lower levels than the stronger promoter sequence determined 
by primer extension. 
Overall , however, the adequate correlation between RNA-seq and primer 
extension increased our confidence in the transcriptional start sites determined 
by RNA-seq analysis. Other experiments performed by our group have also 
confirmed the ability of Rockhopper to predict transcriptional start sites from 
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smRNA17 smRNA19 smRNA20 
Figure 8. Primer extension of identified sRNAs. Between 8-10 !Jg of RNA 
isolated from an iron-replete growth condition were incubated with a radiolabeled 
DNA oligonucleotide that was homologous to the RNA sequence under analysis. 
Reverse transcription was allowed to take place and products were analyzed on 
an 8% TBE-Urea polyacrylamide gel. Radiolabeled size markers are shown and 
sizes of individual markers indicated. Samples were also examined without 
input RNA as a negative control as shown with a (-) sign. Experiments were 
preformed three times and a representative film is shown. 
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RNA-seq data [238]. Therefore, we used the transcriptional start sites predicted 
by our RNA-seq program in conjunction with Northern blot analysis to determine 
the genomic locations of the other four sRNAs that had not been previously 
characterized. The determination of both sRNA transcriptional start site and size 
allowed exact genomic coordinates of each sRNA, thus providing an exact sRNA 
sequence (Figure 9) . Since most sRNAs act as post-transcriptional regulators of 
mRNAs through base pairing , characterization of the location of a sRNA and, 
thus, its sequence, will aid in defining the mRNA targets of its regulation. 
Secondary Structure of Novel sRNAs 
For each sRNA whose sequence we were able to precisely determine, we 
used mFold [247] to determine the lowest free energy secondary structure of the 
sRNA. A representative of smRNA 15 is shown below (Figure 1 0) . While the 
lowest free energy structure may not correspond to the structural conformation 
adopted by the sRNA under all conditions , it can serve as a general starting point 
for structural analysis and target identification. Several of the sRNAs in question 
contained large single stranded regions that were rich in adenosine and uridine. 
In other bacteria, such unstructured AU rich regions have been shown to be 
putative binding sites for the common sRNA protein cofactor Hfq [175]. The 
presence of these sites suggests that these sRNAs may bind to Hfq as a 
required cofactor. 
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Figure 9. Genomic location of sRNAs inN. gonorrhoeae FA1090 genome. 
Using transcriptional start sites and Northern blot analysis data (total size of a 
sRNA), the exact genomic coordinates of transcription can be determined. Each 
novel sRNA that was confirmed by Northern blot analysis is shown with start and 
stop sites of transcription. Directionality of the sRNA and the flanking genes are 
indicated by the arrow (pointing right is transcription from the positive strand and 
left is transcription from the negative strand). A subset of sRNAs are antisense 
to known protein coding genes. 
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Figure 10. mFold analysis of smRNA 15. Genomic locations of sRNAs also 
reveal sequences of sRNAs under analysis. These sequences were then 
analyzed by mFold to determine the lowest free energy structure of the sRNAs, 
an example of which is smRNA 15. Note the areas of single-stranded AU rich 
regions that may represent putative Hfq-binding sites. 
101 
Role of Hfq in NrrF regulatory mechanisms 
As described above, the examination of sRNA-mediated regulation in 
Neisseria species is only just beginning and the role of sRNA cofactors such as 
Hfq is even less well understood. We previously reported that expression of the 
sdhC gene was increased under iron-replete conditions and was repressed 
under iron-deplete conditions in a NrrF-dependent manner in N. meningitidis 
[163]. Therefore, to begin to determine the role of Hfq in Neisseria species, we 
next examined the expression of the sdhC gene by quantitative RT-PCR inN. 
meningitidis wild-type (MC58) , hfq knockout mutant and complemented hfq 
knockout mutant strains grown in COM under either iron-replete or iron-deplete 
conditions. As expected, inN. meningitidis wild-type cultures, we observed a 3.7 
fold increase in the expression of sdhC under iron-replete conditions compared 
to iron-deplete conditions (Figure 11 ). Similar results were obtained when we 
examined the expression of the sdhC transcript inN. meningitidis hfq knockout 
and complemented hfq knockout strains grown under iron-replete conditions 
compared to iron-deplete conditions. Thus, repression of the sdhC gene under 
iron-deplete growth conditions was not altered in the hfq knockout mutant 
suggesting that NrrF is able to function independently of Hfq. 
To further support the results obtained by quantitative RT-PCR analysis, 
we created N. meningitidis /acZ translational fusions in strains MC58, hfq 
knockout and complemented hfq knockout strains with the promoter of sdhC, the 
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Figure 11. Effect of the hfq· mutation on regulation of the succinate 
dehydrogenase genes. Expression of sdhC transcript under iron-replete (dark 
grey bars) conditions versus iron-deplete (light grey bars) conditions was 
evaluated by quantitative RT-PCR in MC58 wild-type strain (WT) , hfq knockout 
knockout strain (hfq-) and complemented hfq knockout strain (hfq-C). Transcript 
levels were normalized to the 16s rRNA transcript which is not regulated in 
response to iron and further normalized to the expression of sdhC in the wild-
type strain under iron-replete conditions. Results represent the average of two 
independent experiments and error bars represent standard deviations. A** 
indicates a p-value of <0.01 . 
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first gene of the succinate dehydrogenase operon . As the binding site of NrrF is 
predicted to be within the sdhC promoter these fusions will allow for a 
complementing analysis of the role of Hfq in NrrF-mediated regulation. We 
observed similar iron-dependent and Hfq-independent regulation of the 
sdhC:IacZ fusion strains (Figure 12). These results indicate that Hfq is 
dispensable for iron-mediated regulation of the sdhC gene. 
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Figure 12. Effect of the htq· mutant on the iron regulation of the sdhC 
promoter. MC58/sdhCProm (wild-type N. meningitidis with the lacZ/sdhC 
promoter fusion) , hfq-/sdhCProm (hfq knockout strain with the /acZ/sdhC 
promoter fusion) , and hfqComp/sdhCProm (complemented hfq knockout strain 
with the lacZ/sdhC promoter fusion) cultures were grown under iron-replete (dark 
grey bars) or iron-deplete (light grey bars) conditions for 30 min. Beta-
galactosidase assays were carried out as described in Methods. Assays were 
carried out in duplicate and results represent the average of three independent 
experiments. Error bars represent standard deviation. A** indicates a p-value of 
<0.01. 
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Summary 
These experiments are some of the first to carry out a global analysis of N. 
gonorrhoeae focusing on the identification and characterization of novel sRNA 
transcripts. Here we compare the transcriptomes of N. gonorrhoeae grown 
under two different conditions: agitation in high iron and COM and static growth in 
the human cell culture media KSFM. These conditions identified several hundred 
putative sRNA transcripts and a subset of 32 were chosen which possessed 
characteristics of other known sRNAs and were found to be expressed in both 
conditions. Of ten randomly chosen sRNAs from this list, all were confirmed to 
be expressed and of proper size using Northern blot analysis. Such analysis 
also preliminarily delineated how these sRNAs were regulated by iron and KSFM 
conditions. Primer extension analysis and the mFold program were then used to 
map transcriptional start sites and identify genomic locations and secondary 
structures of these sRNAs. Finally, the role of Hfq in the regulation of sRNAs in 
Neisseria more generally was examined by showing that the first sRNA identified 
in Neisseria, NrrF, is able to operate independently of Hfq inN. meningitidis. 
Collectively, these studies significantly expand the known sRNAome of N. 
gonorrhoeae and demonstrate the power of RNA-seq in identifying novel 
transcripts. 
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Chapter 2. Tools to analyze the complete transcriptome of N. gonorrhoeae 
Challenges in analysis of RNA-seq data 
Over the past several years, there has been an increasing use of global 
RNA-seq to examine transcriptomes of various organisms under a variety of 
conditions [214, 220]. By sequencing all RNA expressed by an organism, one 
can gain a staggering amount of data regarding how the organism responds to 
stimuli at the RNA level. RNA-seq has many advantages over a traditional 
microarray with little increase in cost or labor and will soon become the gold 
standard for examining transcriptomes, eclipsing microarray methodologies. 
When examining the global transcriptome of an organism it is important to keep 
in mind that gene expression levels are only part of the transcriptome. Other 
aspects include sRNAs such as those described in Chapter 1, operon structure, 
determination of transcriptional start sites (TSS), and detection of previously 
unknown coding transcripts (Figure 13). This last aspect is perhaps the greatest 
advantage that RNA-seq holds over microarray technology. However, one of the 
difficulties in working with RNA-seq is the sheer amount of data that are obtained 
from a single experiment as well as the lack of tools to analyze the data obtained 
from prokaryotes. A typical RNA-seq experiment generates approximately 30-
100 million reads (lengths of sequenced RNA) that are between 35-1 00 
nucleotides in length. The data must be uploaded into software programs that 
align each read to the genome of the organisms under analysis and determine 
107 
Operon Structure Gene Levels 
/' 
The Global Prokaryotic 
Transcriptome 
/ ' sRNAs (microRNAs) 
Length of UTR 
Novel (Unannotated) 
Transcripts 
108 
Figure 13. Aspects of the global transcriptome of prokaryotes. The 
transcriptome of an organism is not limited to merely the expression level of 
annotated genes. Which genes are expressed as part of operons as well as 
where transcription initiates and terminates upstream and downstream of a 
particular gene are also part of the transcriptome. Unannotated transcripts, RNA 
molecules that are not yet hypothesized to exist, may also be present. Finally, 
non-coding RNAs such as sRNAs also represent an important aspect of a 
transcriptome through their role in post-transcriptional regulation of other 
transcripts. 
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expression levels for each nucleotide in the genome. Such analysis requires a 
level of computer programming that is beyond the skill of most biological 
scientists. Analysis of the data therefore requires either collaborations with 
bioinformatics experts or long hours spent learning how to use analysis 
programs. Fortunately, once these initial hurdles are passed there are several 
mature programs available to analyze the RNA-seq data derived from studies of 
eukaryotic organisms. Perhaps the most popular is the Bowtie suite of programs 
consisting of Bowtie, TopHat and Cufflinks [234-236]. While these programs 
are somewhat difficult for those without computer programming skill, they are 
available to the public and can be used in conjunction with a collaborator. 
However, when examining prokaryotic organisms such as N. gonorrhoeae 
there are no such programs specifically designed to analyze the data. While the 
Bowtie suite of programs can be used, they do not address the inherent 
differences between prokaryotic and eukaryotic genome structure. As more and 
more microbiologists turn to RNA-seq for analysis of bacterial transcriptomes, 
there must be a corresponding increase in programs that are sufficiently easy to 
use for scientists who may not have strong backgrounds in bioinformatics or 
computer programming. For the experiments described here, a user-friendly tool 
that can analyze prokaryotic transcriptomes would be invaluable in our analysis 
of N. gonorrhoeae during incubation with host cells as well as during mucosal 
infection. To that end, we developed Rockhopper, an open source computer 
program that is designed both to specifically analyze prokaryotic organisms and 
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present a user-friendly interface for researchers. To test the ability of 
Rockhopper to analyze multiple elements of bacterial transcriptomes, we 
analyzed RNA isolated from N. gonorrhoeae F62 after a 2-hr incubation in 
KSFM, identical to Condition B described above. 
Alignment and Normalization of Input Data 
Specific details regarding how the Rockhopper program analyzes input 
data are provided in the Methods section. Briefly, input RNA sequenced reads 
were uploaded in .fastq format. Rockhopper then attempted an exact alignment 
of each read to the referenced genome of the organism being studied. In some 
cases an exact alignment was unsuccessful due to inherent errors in the 
sequencing process. Rockhopper then attempted to align a seed region of each 
read to the genome under analysis. This seed region is a portion of the read that 
is no shorter than one-third the length of the total read. Once this seed region is 
aligned then the region is extended by continuing to match sequenced 
nucleotides of the read to the reference genome. Rockhopper will allow a certain 
number of mismatches, insertions or deletions to occur to allow for minor errors 
in sequencing. By default this is set to no more than 15% of the total read length. 
If no seed region of a read aligns to the genome, then the read is discarded. As 
an example, if a read of length 75 base pairs is unsuccessful, then alignment of 
seed regions of length no shorter than 25 base pairs is attempted. Once a seed 
region is aligned successfully, then the 5' and 3' ends of the read are extended 
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and a number of errors is no more than 15% of the total read length are 
permitted before the read is discarded, in this case 11. This approach is similar 
to that used by Bowtie [234] and the ability of Rockhopper to align reads to 
prokaryotic genomes quickly and accurately is comparable to many of the 
leading programs used to analyze eukaryotic genomes (Figure 14). Once reads 
are aligned to the genome, normalization of the data must take place. In most 
RNA-seq experiments, normalization is carried out using the RPKM 
methodology. This determines how many reads align to a particular gene and 
then divides that number by the total length of the gene to account for the fact 
that a 1000 base pair gene with 10 reads aligning to it is actually expressed at 
lower levels compared to a 1 00 base pair gene with 1 0 reads aligning to it. 
However, care must be taken when determining total reads which align to the 
genome as often a few highly expressed genes account for most of the aligned 
reads and these genes may not show similar expression across different 
biological conditions [235]. Therefore, expression changes in one of these genes 
may be incorrectly interpreted as a general increase or decrease in the total 
number of sequenced reads in the experiment. This will result in an apparent 
reduction in expression of other genes when RPKM is carried out. Alternatively, 
it is possible to normalize expression to one or more housekeeping genes, a 
method often used when analyzing qRT-PCR data. However, this can be 
problematic as it is difficult to determine which genes are housekeeping genes a 
priori and even then there is no guarantee that such genes show stable 
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Figure 14. Comparison of Rockhopper to other alignment programs. The 
performance of five tools for aligning reads to a genome is shown. The five tools 
are Rockhopper (version 1.00), Bowtie (version 0.12.7), Bowtie2 (version 2.0.0-
beta5), SOAP2 (version 2.21 ), and BWA (version 0.6.2). Each tool is based on 
an FM-index, and each tool was executed on the same machine with default 
parameters using the same number of processors. The tools were evaluated by 
the percent of 2,134,636,656 reads that they successfully aligned to a reference 
genome (x-axis) and by the execution time they required per million reads per 
processor (y-axis). The reads come from 75 RNA-seq experiments conducted 
using five different bacteria, N. gonorrhoeae, E. coli, S. enterica, S. pyogenes 
and Xenorhabdus nematophila 
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expression over all analyzable conditions. Instead, Rockhopper uses a method 
of upper-quartile normalization where the top 25% of expressed genes are used 
to determine read count after excluding genes with zero expression. Studies 
examining multiple methods of RNA-seq normalization have shown that this 
method generates the best concordance with qRT-PCR data [231]. 
Determining Transcriptional Start Sites 
Annotated genetic maps of bacterial genomes often present the 
translational start and stop sites of a gene as the beginning and end of the 
transcript. However, many mRNAs have both 5' and 3' UTRs which are 
transcribed but not translated and thus extend upstream and downstream of the 
AUG and UAG start and stop codons respectively. Knowing where transcription 
starts is important for determining the role of DNA binding proteins as well as 
predicting whether RNA in 5' UTRs participates in post-transcriptional regulation . 
To that end, Rockhopper is designed to determine where transcription of a given 
gene initiates and terminates. This is carried out by beginning at the AUG start 
codon and determining the expression (based on read count) of the nucleotide 
immediately upstream of the start codon. If the expression of this nucleotide is 
similar to the rest of the mRNA transcript then Rockhopper extends the length of 
the 5' UTR by one nucleotide. This process is repeated until a nucleotide is 
reached upstream of the AUG that has an expression level which is more similar 
to background expression compared to expression of the mRNA under analysis. 
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The transcript is then defined as beginning one nucleotide downstream of the 
background nucleotide. The process is repeated to determine the 3' UTR. 
To test the ability of Rockhopper to determine TSSs, we carried out primer 
extension on 1 0 genes in the gonococcus whose 5' UTRs had not been 
examined previously and compared the results to Rockhopper's prediction 
(Figure 15). For 5 out of 10 genes Rockhopper was able to determine the TSS to 
within 7 nucleotides. For 2 of the 1 0 genes, Rockhopper overestimated the UTR 
length by 37 and 16 nucleotides and for 3 out of 10 genes, Rockhopper 
underestimated the UTR length by 15, 27, and 89 nucleotides. With the 
exception of one gene, Rockhopper underestimated the UTR length for those 
genes with lower expression levels (average: 225) and overestimated the UTR 
length for genes with higher expression (average: 551 ). Genes for which the 
UTRs were correctly predicted had an average expression of 376. When 
analyzing the global TSS repertoire of N. gonorrhoeae, we were able to 
determine the 5' UTR length for 572 protein-coding genes and the 3' UTR length 
for 581 protein-coding genes. A total of 335 genes had a calculated 5' UTR 
length of zero and the average 5' UTR length after excluding genes with UTR 
lengths of 0 was 38 nucleotides. A total of 400 genes had a calculated 3' UTR 
length of zero and the average 3' UTR length after excluding genes with UTR 
lengths of 0 was 32 nucleotides. 
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Figure 15. Primer extension corroboration of Rockhopper. (A) Results from 
primer extension for ten N. gonorrhoeae genes. Probes were designed to 
hybridize 1 00 nucleotides downstream of the transcription start site identified by 
analysis of the RNA-seq data. Gene designations correspond to N. gonorrhoeae 
strain FA1090. A representative ladder is shown for sizing. (B) For ten N. 
gonorrhoeae genes, the length of the 5' UTR as determined from RNA-seq data 
is depicted (light gray) and the length of the 5' UTR as determined from primer 
extension analysis is depicted (dark gray). Gene designations correspond toN. 
gonorrhoeae strain FA 1090. Primer extension experiments were performed in 
duplicate and a representative film is shown. 
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Gene Expression Levels 
One of the main aspects of RNA sequencing is to determine gene 
expression levels similar to a microarray or qRT-PCR test. Rockhopper also has 
the ability to determine such information. Fifteen million reads were normalized 
as described above and 9 genes from N. gonorrhoeae that showed various 
expressed levels under Condition B were chosen to test by qRT-PCR to 
corroborate Rockhopper. Gene expression levels as determined by Rockhopper 
had an R-squared correlation value of 0.55 compared to qRT-PCR data (Figure 
16). We then tested how well Rockhopper was able to determine gene 
expression levels using an increasingly smaller number of reads. The results 
show that identical gene expression levels are determined with as little as 2 
million reads. These observations are of interest when considering that some 
RNA-seq experiments do have limits on how many reads can be generated. 
Experiments with a large number of different organisms, for example isolates 
from clinical specimens, may have very few reads that align to any one organism. 
These results show that Rockhopper is able to draw identical conclusions from a 
very large or very small number of reads. The modest correlation between qRT-
PCR and Rockhopper is likely a result of the short read length used to sequence 
gonococcal RNA. These experiments used a read length of 36 base pairs. 
Experiments done by our group and others using Rockhopper with a longer read 
length (77-100 basepair) have shown a much stronger correlation between RNA-
seq and qRT-PCR [248]. 
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Figure 16. Corroboration of Rockhopper predictions by qRT-PCR. 
Correlation between expression abundances determined by Rockhopper based 
on RNA-seq data and confirmed expression abundances. Correlation was 
computed based on expression abundances determined by Rockhopper when 
different sized random subsets of RNA-seq reads were used. The solid curve 
represents, for nine N. gonorrhoeae genes, the correlation between expression 
levels as determined by Rockhopper based on a RNA-seq experiment and as 
determined via qRT-PCR. 
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Operon Prediction 
Finally, Rockhopper has the ability to predict operon structures in 
prokaryotes. Knowledge of operon structure can be instrumental in determining 
expression conditions of uncharacterized genes as several genes in an operon 
are likely expressed under similar conditions and subjected to similar post-
transcriptional regulatory mechanisms. Therefore, if a well-studied gene is found 
to be in an operon with one or more unknown genes, then hypotheses can be 
generated for the unknown genes based on what is experimentally verified for 
the well-studied gene of the operon. Predicting polycistronic messages in 
bacteria can be carried using a variety of methods but IG distance between two 
genes on the same strand has been shown to have the greatest predictive power 
[249, 250]. Rockhopper takes this predictive power and combines it with results 
from RNA-sequencing. 
To predict operons we use two features: IG distances between adjacent 
genes on the same strand and similar expression levels of the two genes. To 
test the ability of Rockhopper to predict operons, we chose six gene pairs that 
were predicted by Rockhopper to be operons and tested for polycistronic 
structure using RT-PCR. We also chose two gene pairs that were not predicted 
by Rockhopper to be operons for testing . All gene pairs contained at least one 
hypothetical gene so there was no a priori knowledge of operon structure. 
Primers for RT-PCR were designed so that the forward primer annealed to the 
extreme 5' end of the upstream gene in the operon and the reverse primer 
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annealed to the extreme 3' end of the downstream gene in the operon. Presence 
of a complete RT-PCR product was taken as evidence that the polycistronic 
template existed and the two genes were part of an operon. Absence of a 
complete RT-PCR product was taken as evidence that the polycistronic template 
did not exist and the two genes were not part of an operon. 
For the six gene pairs predicted to be operons we found evidence of 
polycistronic transcription for all gene pairs. For gene pairs not predicted to be 
operons, one showed evidence of polycistronic transcription and one did not. 
Thus, Rockhopper has high sensitivity (6/6) and modest specificity (1/2) when 
predicting operon structure (Figure 17). When analyzing the complete 
transcriptome of N. gonorrhoeae incubated in KSFM, we predicted 363 distinct 
operons comprising more than one gene and found that 911 gonococcal genes 
were part of operons. These included several known operon structures in the 
gonococcus including ribosomal proteins as well as phage-associated operons 
(unpublished data). We also compared Rockhopper's ability to predict operons 
to the Database of prOkaryotic OpeRons (DOOR) database and found strong 
correlation between the two methods [251]. It is possible that some genes are 
expressed as operons under some conditions but not others, a more extensive 
study of N. gonorrhoeae operon structure under several conditions may shed 
light on this phenomenon. For visualization, Rockhopper exports data to the IGV 
program from the Broad Institute [252] (Figure 18). 
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Figure 17. RT-PCR corroboration of Rockhopper predictions. RT-PCR was 
performed on total RNA by using primer pairs (denoted by arrows) designed to 
span the entire region containing gene pairs. Below each lane, the gene pair is 
listed along with the size of the region containing the gene pair. Experiments 
were performed in duplicate and a representative gel is shown. (A) RT 
amplification products are evident for six gene pairs predicted to be co-
transcribed by Rockhopper based on RNA-seq data. For some gene pairs, there 
are multiple products perhaps arising from non-specific binding and extension of 
primers used . The presence of an amplification product indicates that the gene 
pairs are transcribed as one polycistronic mRNA as predicted by Rockhopper. 
(B) RT amplification products are evident for one of two gene pairs predicted not 
to be co-transcribed by Rockhopper based on RNA-seq data. In this case, the 
absence of an amplification product indicates that the gene pairs are not 
transcribed as one polycistronic mRNA as predicted by Rockhopper (indicated by 
an X). 
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Figure 18. IGV visualization of Rockhopper results. Rockhopper exports 
analyzed results to the IGV program from the Broad Institute. Genomic 
coordinates are shown along the top of the window. Experimental conditions are 
shown in the left window along with differentially expressed genes, UTRs, novel 
sRNAs and whether two or more genes are part of an operon. The size and 
shape of pixelated columns corresponds to the expression of each nucleotide. 
Annotated genes are shown along the bottom panel. Bracketed numbers refer to 
the range of expression levels visible in each window. 
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Summary 
These experiments describe the development and testing of one of the 
first RNA-seq analysis programs designed specifically for prokaryotic 
transcriptomes. This program, termed Rockhopper, is able to analyze RNA-seq 
data as quickly and accurately as the leading RNA-seq analysis programs 
designed for eukaryotic transcriptomes such as Bowtie. Rockhopper presents a 
user-friendly interface and in addition to gene expression levels is able to 
determine transcriptional start and stop sites, operon structure and, in the case of 
more than one experiment, differentially expressed genes. In addition, 
Rockhopper is able to identify non-annotated and non-coding RNA transcripts, a 
particular advantage when analyzing less well-characterized bacterial genomes. 
We corroborated the ability of Rockhopper using several RNA-seq experiments 
carried out on N. gonorrhoeae FA 1090. Rockhopper is able to predict 
transcriptional start sites with good accuracy (as tested by primer extension) and 
gene expression levels with modest accuracy (as tested by RT-PCR). The 
differences in Rockhopper predictions and RT-PCR outcome likely results from 
the comparatively small read length used in these experiments as well as 
differences in normalization methods between RNA-seq and RT-PCR 
experiments. Rockhopper also shows very high sensitivity and modest specificity 
when predicting operon structure. Collectively, these experiments show that a 
complete and global analysis of bacterial transcriptomes can be carried out 
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quickly and easily and is well within the skill set of the majority of infectious 
disease researchers. 
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Chapter 3. Global RNA Analysis of N. gonorrhoeae and host during 
infection 
Transcriptome response of N. gonorrhoeae to incubation with End E6/E7 
cells 
After completing analysis of a particular subset of transcripts in N. 
gonorrhoeae (sRNAs) and developing tools to analyze the global transcriptome 
of N. gonorrhoeae (Rockhopper) , we set out to answer fundamental questions 
regarding global mechanisms of gonococcal/host interactions during in vitro 
incubation as well as during natural mucosal gonococcal infection in vivo. The 
outcome of infection by any pathogen, including N. gonorrhoeae, results from the 
combined contribution of both the host and pathogen, neither exists in a vacuum 
and the transcriptional response of each will be determined, in a large part, by 
the other. Therefore, the most accurate understanding of how each organism 
responds at the transcriptional level to infection will result from analysis of both 
organisms together under infecting conditions including incubation in vitro as well 
as during natural mucosal in vivo infection. 
To begin to understand on a global level how the host and pathogen 
respond to each other, we set out to determine gene expression levels of N. 
gonorrhoeae as well as female endocervical epithelial cells after a two hour in 
vitro incubation together. These cells are a stably transformed endocervical 
epithelial cell line [237]. They maintain characteristics of their tissues of origin 
and have been used previously by our laboratory and others to study interactions 
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between N. gonorrhoeae and the human host [46, 101, 110, 148]. We incubated 
N. gonorrhoeae with transformed female endocervical cells (End E6/E7) for two 
hours in the human cell culture media KSFM. Both N. gonorrhoeae and End 
E6/E7 cells were also incubated alone in KSFM as a negative control. At the end 
of the incubation period, End E6/E7 cells were washed with PBS to remove N. 
gonorrhoeae not associated with human cells and RNA was extracted from both 
cell types for analysis as described in the Methods. 
After a two hour incubation with End E6/E7 cells, there were 150 
gonococcal protein coding genes showing a greater than 1.5 fold change with a 
False Discovery Rate (FOR) of <0.1 when comparing RNA isolated from N. 
gonorrhoeae incubated with End E6/E7 cells to RNA isolated from N. 
gonorrhoeae incubated in media alone. There were 126 genes that showed 
increased expression when incubated with End E6/E7 cells compared to media 
alone and 24 that showed decreased expression. These genes were 
categorized based on their role in the gonococcus and the results are shown in 
Figure 19. Gonococcal genes involved in translation, metabolism and other 
housekeeping functions were highly represented among genes showing 
increased expression during incubation with End E6/E7 cells compared to media 
alone. This may represent the fundamentally different growth conditions 
available for the gonococcus when incubated with a host cell compared to media 
alone. The next two categories of genes showing higher expression during 
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Figure 19. Categorization of gonococcal genes showing increased 
expression during incubation with End E6/E7 cells. Categorization of the 124 
gonococcal genes showing at least 1.5-fold higher expression two hrs after 
incubation with End E6/E7 cells compared to media alone with an FOR <0.1. 
Gene category is depicted on the y-axis and number of genes in that category on 
the x-axis. There were also 56 hypothetical genes that showed increased 
expression and were omitted from this figure for ease of viewing. 
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incubation with End E6/E7 compared to media alone were those involved in 
efflux/resistance and stress response. Expression of these genes contributes to 
the ability of N. gonorrhoeae to survive in the host while subjected to the innate 
immune defenses of epithelial cells. Translocase genes, another category of 
regulated transcripts, include those which are involved in moving nutrients and 
amino acids into and out of bacterial cells and their regulation again likely 
represents the different growth conditions present for the gonococcus when 
incubated with End E6/E7 cells compared to media alone. Several of the 
gonococcal genes showing increased expression were found to be within one of 
the seven putative phages found within the gonococcal genome. Our laboratory,· 
and others, have begun examining in detail a subset of these phage associated 
proteins and found that one, NG01 013, is involved in gonococcal adherence and 
invasion of host cells [248]. It is possible that other phage-associated genes 
have roles in gonococcal pathogenesis that are as yet unknown. There were 
also a small number of global regulators that showed increased expression 
during incubation with End E6/E7 cells. As regulators and their targets are 
usually governed by similar stimuli, it is very possible that the targets of these 
regulators may be among the other gonococcal genes that were found to be 
regulated during incubation with End E6/E7 cells or media alone. A small 
number of genes involved in respiration also showed higher expression during 
incubation with End E6/E7 cells compared to media alone. N. gonorrhoeae is a 
facultative anaerobe and is exposed to anaerobic or microaerobic conditions 
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during infection of the female genital tract [153, 154]. Incubation of N. 
gonorrhoeae with End E6/E7 cells is likely to be a more oxygen-rich environment 
compared to growth during natural mucosal infection but it is possible that 
' 
oxygen levels within host cells are lower than that found in media, necessitating 
the expression of such respiration-related proteins. Finally, genes involved in 
iron metabolism show higher expression during incubation with End E6/E7 cells 
compared to media alone. It is thought that the availability of free iron within the 
female genital tract is quite low, mostly complexed in host proteins such as 
heme, lactoferrin and transferrin . Thus, host End E6/E7 cells may deplete or 
sequester free iron available in KSFM. In contrast, the level of free iron in media 
alone is approximately 7 mM so there may be little iron acquisition stress applied 
to N. gonorrhoeae when incubated in KSFM alone. 
While the majority of gonococcal genes showed increased expression 
during infection, there were 24 genes that were downregulated during incubation 
with End E6/E7 cells compared to growth in media alone. The categorization of 
these genes is shown is Figure 20. Metabolism or housekeeping genes are 
highly represented as being regulated via incubation with End E6/E7 cells. In 
addition, genes involved in respiration are much more highly represented among 
genes showing decreased expression during incubation with End E6/E7 cells, 
again reflecting the likely changes in oxygen levels within such cells compared to 
the media alone. Of note, there were no gonococcal genes involved in stress 
response or efflux/resistance showing higher expression in media alone 
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Figure 20. Categorization of gonococcal genes showing decreased 
expression during incubation with End E6/E7 cells. Categorization of the 24 
gonococcal genes downregulated 2hr after incubation with End E6/E7 cells at 
least 1.5 fold with an FOR <0.1. Gene category is shown on they-axis and 
number of genes in that category on the x-axis. 
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compared to incubation with End E6/E7 cells. This is likely a result of innate 
immune stresses placed on N. gonorrhoeae during incubation with End E6/E7 
cells which are absent in media alone. In the absence of these stresses such 
response genes are not as highly expressed. We also observed 11 tRNA 
transcripts showing decreased expression following incubation with End E6/E7 
cells compared to media alone. 
In addition to protein coding genes, we identified a total of 341 instances 
of transcription either within an IG region or opposite a known open reading 
frame when examining RNA isolated from either N. gonorrhoeae incubated with 
End E6/E7 cells or KSFM alone. There were 203 of these transcripts showing 
either increased or decreased expression based on whether N. gonorrhoeae was 
incubated with End E6/E7 cells or media alone. The vast majority (198) of these 
transcripts showed increased expression during incubation with End E6/E7 cells 
compared to only 5 that showed decreased expression. Sixteen of these RNA 
transcripts were expressed opposite known open reading frames including one 
opposite NG00054, a hypothetical protein whose expression was also increased 
during incubation with End E6/E7 cells compared to media alone. All but one of 
these transcripts was below 250 nucleotides in length, suggesting that they are 
independent transcripts and not part of the 5' or 3' UTRs on adjacent genes. The 
majority of sRNAs discovered to date are between 50-250 nucleotides in length, 
therefore the size range of these transcripts suggested that some could be 
regulatory sRNA molecules. We then compared these RNA transcripts to the 
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sRNAs previously identified and described in Chapter 1. Of the 32 high quality 
sRNAs shown in Table 4, ten showed regulation based on whether N. 
gonorrhoeae was incubated with End E6/E7 cells compared to media alone. 
These sRNAs and their expression levels are shown in Table 7. 
Transcriptome response of End E6/E7 cells to incubation with N. 
gonorrhoeae 
Isolation of total RNA from endocervical cells incubated with N. 
gonorrhoeae allowed us to examine the gonococcal transcriptome. However, as 
host cells were also present in this incubation, we were able to analyze the RNA 
expression profile of these End E6/E7 cells during incubation with N. 
gonorrhoeae. As a negative control , End E6/E7 cells were incubated in KSFM 
alone. Total RNA was aligned to the Hg19 genome and analyzed as described 
above for eukaryotic transcriptomes. We identified 661 host genes whose 
expression was increased at least 1.5-fold during incubation with N. gonorrhoeae 
with an FOR of <0.1. In contrast, we detected only 13 genes whose expression 
decreased at least 1.5-fold with an FOR of <0.1. Human genes showing an 
increase in expression were categorized according to the DAVID program [253] 
using keyword annotation and the results are shown in Figure 21. While keyword 
categorization can give very general information about the global transcriptional 
response of cells, the data are not particularly specific and are difficult to 
interpret. Categories tend to be very broad ("Nucleus" merely indicates that the 
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Table 7. Gonococcal sRNAs Regulated via Incubation of N. gonorrhoeae 
with End E6/E7 cells 
Name Transcription sta~ 
Transcription 
stop A 
Fold change 
Epitheliai/Media8 
smRNA1 36128 36072 6.42 
smRNA5 260455 260514 6.00 
smRNA16 1100137 1100076 3.17 
smRNA17 1172604 1172667 4.49 
smRNA22 1443423 1443230 4.22 
smRNA25 1617174 1617007 3.03 
smRNA26 1762962 1762909 3.19 
smRNA27 1779946 1779990 3.27 
smRNA29 1848669 1848607 6.11 
smRNA32 2111949 2112005 2.51 
A: Refers to the genomic coordinates according to theN. gonorrhoeae 
FA 1090 sequence. 
B: Expression levels were calculated using RPKM and upper quartile 
normalization. 
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Figure 21. Keyword categorization (DAVID) of host genes upregulated 
during infection. Six hundred sixty one genes showed at least 1.5-fold increase 
in expression with an FDR <0.1. Of these, we were able to categorize 571 (86%) 
according to keywords using the DAVID Bioinformatics Resources. The top 15 
pathways are shown here with the name of the pathway on the y-axis and the 
number of genes in that pathway on the x-axis. The total number of categorized 
genes is larger than 571 due to certain genes being placed into more than one 
category. 
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protein product of the gene is associated with the nucleus) and generation of 
hypotheses for future directions can be complicated. Therefore, to try to 
generate a more specific and useful map of the transcriptional response of these 
cells during incubation with N. gonorrhoeae we categorized the genes according 
to pathways as determined by the Kyoto Encyclopedia of Genes and Genomes 
(KEGG). Again, DAVID was used for this categorization and the results are 
shown in Figure 22. Signaling pathways involved in innate and adaptive 
immunity were highly represented among genes showing increased expression 
during incubation with N. gonorrhoeae compared to media alone including 
cytokine signaling, MAPK signaling as well as TLR and NOD protein signaling 
pathways and other genes known to be involved in general bacterial infection. 
While infection with N. gonorrhoeae is not thought to stimulate a complete 
adaptive immune response, we did find that a subset of genes involved in T and 
8 cell signaling showed increased expression upon incubation with N. 
gonorrhoeae. It is possible that other mechanisms present during natural 
gonococcal infection are able to suppress these signals and downplay the 
adaptive immune response or that such responses are dampened at the post-
translational level. In addition, housekeeping genes were also upregulated 
including those involved in pyrimidine metabolism, cell-cell adhesion and axon 
guidance. This may be a result of changes on host cells mediated by invasion of 
such cells by N. gonorrhoeae as they alter cytoskeleton structures and 
transcytose through cells. 
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Figure 22. KEGG pathway categorization (DAVID) of host genes 
upregulated during infection. Six hundred sixty one genes showed increased 
expression with an FOR <0.1 2h after incubation of End E6/E7 cells with N. 
gonorrhoeae F62 compared to media alone. Of these, we were able to 
categorize 233 (35%) according to KEGG Pathways using the DAVID 
Bioinformatics Resources. The top 15 pathways are shown here with the name of 
the pathway on the y-axis and the number of genes in that pathway on the x-axis. 
All genes have category enrichment p-value of <0.05. 
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Of interest to note was the large number of cancer-related genes that 
showed increased expression following incubation with N. gonorrhoeae. The 
category "Pathways in Cancer" was one of the two most highly represented 
categories of genes showing increased expression during incubation with N. 
gonorrhoeae compared to media alone. In addition, pathways involved with p53 
signaling and lung cancer were also represented. Figure 22 depicts only the top 
15 categories of highly expressed genes for clarity but other gene categories that 
showed increased expression included those involved in colorectal , prostate, and 
pancreatic cancer as well as renal cell carcinomas. 
As infection by N. gonorrhoeae is thought to lead to an increase in pro-
inflammatory and anti-apoptotic response in the host we looked specifically at 
these genes in regard to incubation with N. gonorrhoeae. Figure 23 shows the 
expression level of several genes known to be involved in inflammatory and 
apoptotic mechanisms of the host during incubation with N. gonorrhoeae and 
these experiments confirm the increased expression of such genes as a function 
of incubation with N. gonorrhoeae. Studies in our laboratory and others have 
implicated N. gonorrhoeae in preventing apoptosis of infected epithelial cells [46, 
127]. Included in this list of highly expressed genes is birc3, a gene encoding the 
cellular inhibitor of apoptosis protein 2 (ciAP2) which is currently being studied in 
our laboratory as a mechanism of cell-cell communication between infected and 
uninfected epithelial cells. 
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Figure 23. Immunity- and apoptosis-related host genes showing increased 
expression during incubation with N. gonorrhoeae. Human genes showing 
an increase in expression following a 2hr incubation with N. gonorrhoeae 
compared to media alone. Gene names are shown on the x-axis with the fold 
change during incubation with N. gonorrhoeae compared to media alone shown 
on the y-axis. The regulation of all genes shown has a q value of <0.1. The 
genes c-FLIP, birc3 and ripK2 have also been shown to be upregulated in other 
studies in our laboratory. 
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Table 8. Host Genes whose expression was decreased after incubation 
with N. gonorrhoeae 
Fold Change: 
Gene Gene Description Infection with N. gonorrhoeae/Media 
Alone 
Uncharacterized cell migration 
C17orf80 protein 0.65 
DNA binding KRAB containing 
ZNF20 protein 0.56 
DNA binding KRAB containing 
ZNF45 protein 0.47 
DNA binding KRAB containing 
ZNF440 protein 0.47 
Splice variant of a 
TMEM79 transmembrane protein 0.36 
Thioredioxin interacting protein 
with probable role in 
TXNIP inflammation 0.35 
DNA binding KRAB containing 
ZNF420 protein 0.34 
AC097635.2 Pseudogene 0.31 
DNA binding KRAB containing 
protein with SCAN 
ZKSCAN4 oligomerization domain 0.24 
Antiapoptotic zinc finger DNA 
SNAI2 binding protein 0.24 
Sphingosine responsive cell 
S1PR5 differentiation factor 0.15 
AC093627 .1 0 Pseudogene 0.14 
Pregnancy associated 
PAPPA2 metalloproteinase 0.04 
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The expression of only a small number of host genes was shown to 
decrease as a result of incubation of End E6/E7 cells with N. gonorrhoeae. 
These genes are shown in Table 8. Several of these genes encode proteins 
containing DNA binding motifs suggesting that they may be regulatory proteins. 
As with the identification of regulatory proteins inN. gonorrhoeae it is likely that 
the targets of these putative regulators are among the host genes showing 
increased expression during incubation with N. gonorrhoeae compared to media 
alone. It is also possible that the targets of these genes are expressed at later 
time points in infection. 
As these experiments sequenced total RNA rather then merely protein 
coding genes, we were also able to detect the expression of several types of 
non-coding RNA in End E6/E7 cells that were also regulated following incubation 
of epithelial cells with N. gonorrhoeae. Our analysis of host cells detected the 
expression of 91 microRNAs out of a total of 655 annotated in Hg19. It should be 
pointed out that the RNA sequencing read length used in these experiments, 39 
base pairs, is biased toward RNA transcripts of approximately that length or 
larger. As eukaryotic microRNAs are 21-22 nucleotides in length, they would not 
be readily detected in this analysis. The microRNAs that were detected are likely 
the result of shorter inserts being sequenced or possibly of pre-microRNA 
precursor transcripts. One of the microRNAs detected, mir-718, was upregulated 
approximately 4-fold during incubation with N. gonorrhoeae. We also determined 
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that the 5s ribosomal RNA transcript was upregulated during incubation with N. 
gonorrhoeae approximately 6-fold. 
In addition to detecting non-coding RNA, global sequencing of all RNA in a 
cell permits the detection of previously unknown transcripts that do not align to 
any known human gene. Our analysis of eukaryotic cells identified 1,461 
instances of transcription outside of known coding or non-coding genes in the 
human genome. It is possible that these are previously unknown gene products, 
non-specific transcription or possibly nascent transcription of a known gene that 
was then halted through some regulatory cellular mechanism. A total of 56 of 
these unannotated transcripts showed at least a 1.5-fold increase in expression 
after incubation with N. gonorrhoeae with an FOR of <0.1. Only 3 transcripts 
showed a corresponding decrease in expression. The 18 unannotated host 
transcripts showing the greatest degree of regulation based on incubation with N. 
gonorrhoeae compared to media alone are shown in Table 9. 
Analysis of N. gonorrhoeae and Human Host in vivo 
The ultimate goal of these studies was to obtain a global view of mucosal 
gonorrhea in female and male patients. With the increase in antibiotic strains of 
N. gonorrhoeae emerging worldwide, there is a continuing need for novel 
antibacterials or vaccine targets for N. gonorrhoeae, both of which these studies 
will contribute to. The experiments described above (analysis of N. gonorrhoeae 
alone in vitro and analysis of both N. gonorrhoeae and the host cells after in vitro 
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Table 9. Unannotated transcripts of End E6/E7 cells regulated during 
incubation with N. gonorrhoeae. 
Chromosome Genomic Coordinates Length of Transcript Fold Change (Infection/Media Alone) 
chr3 145778382-145778560 178 459.229 
ch r11 128324498-128324616 118 1498.730 
chrX 45655600-45655781 181 38.121 
chr12 107168176-107168307 131 27.406 
chr6 3173307-3173349 42 18.960 
chr8 128193926-128194009 83 16.258 
chr16 82704421-82704479 58 13.895 
chr19 23294635-23294898 263 12.960 
chr1 12039617-12039791 174 12.290 
chr8 135805558-135805872 314 11 .113 
chr6 31148293-31148754 461 10.353 
chr17 2490437-2490585 148 10.207 
chrX 45671920-45672088 168 8.519 
chr1 168807107-168807153 46 7.592 
chr16 81490085-81490156 71 7.123 
chr5 150962520-150962689 169 0.094 
chr22 26908651-26908869 218 0.014 
chr6 83073148-83073261 113 0.001 
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incubation) offer a wealth of information concerning specific analyses of two 
aspects of gonococcal infection: the pathogen (N. gonorrhoeae) and one cell 
type of the host encountered during infection (epithelial cells). As N. 
gonorrhoeae is a mucosal pathogen whose natural site of infection is the human 
genital tract, the most clinically relevant analyses of the bacteria and the host are 
those that take place during natural in vivo infection. Under these conditions N. 
gonorrhoeae is exposed to the full complement of human cells as well as the 
complete innate and adaptive immune response. N. gonorrhoeae and the host 
are also exposed to contributing factors from the natural microbiota of the genital 
tract. In addition, questions regarding the differential symptomatic response of 
males and females can be answered by analyzing male and female patients with 
confirmed gonococcal infections and comparing the transcriptomes of both host 
and pathogen. We therefore carried out the first analysis of the complete 
transcriptome of N. gonorrhoeae, as well as its human host, during natural 
mucosal infection of the female genital tract. These experiments represent a 
pilot study of a larger set of studies designed to analyze both females and males 
to identify gender specific aspects of infection. These larger studies will expand 
the number of patients under study and include uninfected controls. In addition, 
the role of gender in gonococcal infection will be examined through the inclusion 
of male patients. In total, we plan to analyze 54 male patients and a 
corresponding number of matched female partners. This number of patients will 
provide a higher statistical threshold and increase the confidence in our data. 
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For the pilot experiments described here, we collaborated with researchers at the 
National Center for Sexually Transmitted Diseases (NCSTD) in Nanjing, China to 
obtain specimens as well as clinical information of patients providing specimens. 
Patient Population 
Recruitment Methods and Defining Characteristics: We have developed a highly 
specific protocol for identifying and collecting appropriate samples for our study. 
At the NCSTD, male patients report to the clinic voluntarily due to symptoms that 
may be indicative of gonorrhea. Urethral swabs are then taken and the presence 
of N. gonorrhoeae is examined via growth of the specimens on selective media 
plates. Once gonococcal infection is confirmed, these male patients are treated 
and their matched female partners are asked to come into the clinic. To 
participate in this study, female patients must be at least 18 years of age and live 
in the Nanjing area. They must be HIV negative and have not taken azithromycin 
at any time in the 14 days prior to exposure or have used any other antibiotic in 
the four days prior to exposure. The identification and recruitment of these 
female patients is one aspect that shows distinct advantages in working with a 
Chinese cohort of patients compared to an American cohort. In China, many of 
the male patients who report to clinic are involved in relationships with female 
partners who are monogamous with the male partner. That is, the male patient 
contracts gonorrhea from a female (who may be a professional sex worker or 
mistress) and then infects his monogamous female partner. His monogamous 
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female partner reports that her only sexual contact within at least the two weeks 
before sample collection is the infected male. This unique set of patients 
ensures that both the male and monogamous female partner are infected with 
identical strains of N. gonorrhoeae or other STis, greatly simplifying downstream 
analysis aimed at identifying gender specific transcriptional responses of both the 
host and pathogen. 
Clinical Background and Presentation of Female Patients: Once at the clinic, 
vaginal lavages are collected from female patients and the presence of N. 
gonorrhoeae is tested for based on plating of the organism. In addition, our 
group here in the United States carries out PCR to test for the presence of 
gonococcal DNA. Regardless of the results of these tests, vaginal lavages were 
shipped to the United States and RNA was extracted and sequenced . When 
visiting the clinic, female patients are questioned by a clinician and a complete 
medical history and physical examination takes place, the results are shown in 
Table 10. 
At this point, a total of 4 female patients have provided samples that have 
been fully analyzed by RNA-sequencing . As Table 10 shows, there is a large 
variation in the make up of these patients. The ages range from 23 to 35 and but 
all women are pre-menopausal. There is also a large variation in the days since 
the last menstrual cycle. This observation is critical due to the known effect that 
the menstrual cycle and the presence or absence of sex hormones has on the 
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Table 10. Clinical history of female patients 
Days 
Days Since Last 
Patient Contact Since Last Contact C.F.U./mL Other 
Number Infected Age Menstrual with Contraception ofGC Organsims 
Cycle Infected 
Male (Method) 
1 Yes 29 27 10 Condom Yes No 
C. 
Trachomatis 
(PCR) 
2 Yes 35 26 4 IUD Yes u. 
Urea/yticum 
(Culture) 
3 Yes 31 16 11 None Yes No 
T vagina/is 
Condom/spermacide (PCR) 
4 Yes 23 8 1 /foam No u. 
Urea/yticum 
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ability of N. gonorrhoeae to invade and colonize [254-256]. Two of the women 
had fairly recent contact with the infected male (one within 24 hours) , which may 
suggest that gonococcal infection in these women is less advanced . While it 
cannot be concluded that these women were infected with N. gonorrhoeae during 
their most recent contact with the infected males, it can be concluded that they 
have had a gonococcal infection for at least as long as the last contact with their 
infected males. Patient 3 then has had a N. gonorrhoeae infection for at least 11 
days while it is possible Patient 4 has only been 'infected' for 24 hours or less. 
Most of these women were using some form of contraception and most 
tested positive for N. gonorrhoeae by plating of the organism. Two of the 
patients also had a co-infection of either C. trachomatis, the causative agent of 
chlamydia or T. vagina/is , another common STI. It is of interest to note that 
Patient 4 did not test positive for N. gonorrhoeae by plating but we were able to 
detect gonococcal RNA in the vaginal lavage of this patient. It is possible that 
this patient was exposed toN. gonorrhoeae only in the last 24 hours and that 
there was not yet sufficient viable gonococcal bacteria to yield a positive culture 
test, a phenomenon that could also be affected by the fact that this patient was 
also the youngest of the four and had the least amount of time since her last 
menstrual cycle. Detection of gonococcal RNA is this patient may also be a 
result of her very recent exposure with the infected male with confirmed 
gonococcal infection . 
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Symptomatic Response of Female Patients: The fact that these female patients 
are asked to report to the clinic (rather than reporting on their own) is an 
important factor to consider when determining symptomatic response. None of 
the female patients reporting to the NCSTD were reporting because they 
consider their symptoms (if they have any) to be serious enough to warrant a 
doctor's examination and treatment. These patients considered themselves to 
be 'asymptomatic' when reporting to the clinic and were only visiting the NCSTD 
because they were informed of the possibility of gonococcal infection based on 
the diagnosis of their male partners. However, when questioned or examined by 
a clinician, a subset of symptoms did emerge. The symptomatic responses of 
these female patients were varied (Table 11 ). Several had pain in various 
anatomical regions and all had either cervical or vaginal discharge. In most 
cases, this discharge was grey however; purulent discharge was detected in 
Patient 2, a symptom that is indicative of a high number of PMNs at the site of 
infection [137] . Most of the patients had cervical inflammation and a microscopic 
analysis revealed PMNs at the site of infection for most patients, including 
Patient 2. Again , Patient 4, who did not test positive for N. gonorrhoeae infection 
by plating, did not show cervical inflammation or PMNs at the site of infection. 
This may be related to the recent exposure of this patient to the infected male. It 
is possible· that gonococcal disease in this case is less advanced and a robust 
symptomatic response has not yet been mounted. 
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Table 11. Symptomatic Response of Clinical Patients 
Symptoms of Patient 
Patient Pain Discharge/PMNs 
Number 
Lymph Vaginal Cervix Urination Uterine Abdominal Cervix and Cervical Node Cervical Inflammation PMNs 
1 No No No Yes No Yes, grey Yes + 
2 Yes No No No Yes Yes, Yes +++ purulent 
3 No Yes Yes No Yes Yes, grey Yes +++ 
4 No No No No No Yes, grey No No 
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Gonococcal Transcriptional Response During Mucosal Infection of the 
Female Genital Tract 
Once RNA was isolated from these vaginal lavages and sequenced , it was 
aligned to the three fully sequenced strains of N. gonorrhoeae present in the 
NCBI database: N. gonorrhoeae FA1090, N. gonorrhoeae NCCP11945 and N. 
gonorrhoeae TCDC-NG081 07 using the Rockhopper program. RNA isolated 
from all four patients aligned best to the TCDC-NG081 07 strain that was first 
isolated in Taiwan from a male patient in 2008. The alignment of RNA 
sequencing reads from each sample is shown in Table 12. On average, 2.67% 
of the total RNA from each read aligned to theN. gonorrhoeae TCDC-NG08107 
genome. Interestingly, Patient 4, the patient with a negative culture test and the 
fewest symptoms actually had the highest percentage of RNA that aligned to the 
TCDC-NG081 07 genome. After alignment to the gonococcal genome, gene 
expression levels, transcriptional start and stop sites, operons and non-annotated 
RNA transcripts were identified using Rockhopper as described above. When all 
clinical samples were analyzed , we detected 1577 gonococcal genes as being 
expressed during infection. Expression was defined as an RPKM level of at least 
10% of the average expression of all ORFs. Table 13 shows the top 25 genes 
with the highest expression when all clinical samples are averaged. Those 
genes in bold were found to be in the top 25 expressed genes in all 4 clinical 
samples when each sample was analyzed individually. This suggests that there 
is a core set of gonococcal genes that are highly expressed during infection. 
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Table 12. Preliminary analysis of patient RNA-sequencing 
Patient Total reads Reads aligned to GCA Percent aligned 
1 11691682 331396 2.83 
2 24323815 265148 1.09 
3 49619138 243128 0.49 
4 31629570 2044052 6.26 
APercentage of total reads aligning to the TCDC-NG081 07 N. 
gonorrhoeae genome. 
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Table 13. Top 25 Gonococcal genes with the highest expression during 
clinical infection of the female genital tract 
Gene NameA Product8 Expressionc 
NGTW08 0696 glutaredoxin 3105 
NGTW08 1946 elongation factor Tu 2123 
NGTW08 2040 acyl carrier protein 2045 
NGTW08 1960 elongation factor Tu 2015 
NGTW08 2077 co-chaperonin GroES 1886 
NGTW08 1480 Omp3 1846 
NGTW08 1985 outer membrane protein I 1582 
NGTW08 0879 Phage associated protein 1308 
NGTW08 0356 hypothetical protein 1283 
NGTW08 0687 elongation factor P 1131 
NGTW08 1979 RNA Polymerase Alpha 1108 
NGTW08 2078 chaperonin GroEL 1107 
NGTW08 2130 FOF1 ATP synthase subunit C 864 
NGTW08 2162 hypothetical protein 708 
NGTW08 0762 hypothetical protein 683 
NGTW08 0763 hypothetical protein 633 
NGTW08 0149 RimM 621 
NGTW08 0361 hypothetical protein 618 
NGTW08 1959 elongation factor G 595 
NGTW08 0097 SecB 590 
NGTW08 1619 Ycil-like protein 579 
NGTW08 0163 alcohol dehydrogenase 535 
NGTW08 0001 SecG 522 
NGTW08 0079 protein PiiO 499 
AGene designations are shown according to alignment to the TCDC-NG08107 N. 
gonorrhoeae genome. Genes in bold are in the top 25 expressed genes in all 4 
clinical samples. 
8The gene or protein name or a short description of the gene is shown. 
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cExpression levels are shown as RPKM values, the average expression of all 
protein coding genes is 77. 
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Whether these proteins are highly expressed as a result of infection or are 
merely highly expressed under any condition cannot be determined from these 
experiments. To answer this question the infecting strain of N. gonorrhoeae will 
be grown under in vitro conditions and the transcriptome compared to the 
gonococcal transcriptome during infection to identify genes specifically 
expressed during infection. These experiments are ongoing in our laboratory. 
While earlier experiments described here have obtained the transcriptome of N. 
gonorrhoeae during in vitro growth, those experiments were carried out using 
strain FA 1090. The strains isolated from female patients match most closely with 
strain TCDC_NG08107. Therefore, it will be very difficult to determine if 
differences observed when the two experiments are compared arise from 
gonococcal genetic regulatory mechanisms or from strain differences. A more 
robust and accurate analysis of the gonococcal transcriptome is currently taking 
place comparing identical strains isolated from in vivo mucosal infection to in vitro 
growth conditions. The analysis of all protein coding genes expressed by N. 
gonorrhoeae during mucosal infection offers the possibility of identifying novel 
vaccine targets, a process termed "reverse vaccinology". As described in the 
Introduction, there is currently no viable vaccine for N. gonorrhoeae, an absence 
that will be felt more keenly as antibiotic resistant strains of this pathogen 
continue to emerge worldwide. These studies show that several gonococcal 
genes are highly expressed during mucosal infection and, more importantly, such 
genes are consistently highly expressed under a variety of clinical conditions 
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including variation in symptomatic response, age of the patient, menstrual cycle 
and disease progression. Genes that are highly expressed under many different 
conditions may serve as potential vaccine targets for future study. 
The best vaccine candidates will be those proteins that are present on the 
surface of gonococcal cells, facilitating their exposure to host adaptive immune 
responses. There are two proteins that are highly expressed in all clinical 
samples that may fit this characteristic: NGTW08 _1480 and NGTW08 _1985. 
NGTW08 1480 is a homologue of the Rmp protein of N. gonorrhoeae strain 
FA1090. This protein has already been shown to elicit a strong immune 
response in patients though antibodies to this protein are in fact, not bactericidal 
but rather protective of N. gonorrhoeae [118]. However, it is possible that, as an 
outer membrane protein similar to Rmp, NGTW08_1985 may also elicit a strong 
immune response, making its use a vaccine antigen highly desirable. In addition, 
a hypothetical protein NGTW08_0356 and a phage-associated protein 
NGTW08_0879 are also highly expressed across patient samples. While little is 
known about these genes or the proteins they code for, their consistently high 
expression suggests that they should be further analyzed as potential vaccine 
targets in downstream experiments. 
Development of vaccines relies partly on finding the identification of 
vaccine targets that are properly expressed across disparate conditions, so that 
the resulting vaccine will offer the greatest breadth of immunogenic protection. 
However, equally important information regarding disease progression and 
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outcome can be obtained by identifying differences between patients and 
analyzing how N. gonorrhoeae responds to these differences. In this way, a 
more patient-specific treatment regime can be generated based on specific 
characteristics of each case of gonorrhea reporting to a clinic. While the number 
of patients analyzed so far is small, it is still possible to determine preliminary 
results that can be expanded and confirmed as the number of patients analyzed 
increases. When analyzing the female patients in these studies, the largest 
difference was the lack of a positive culture test for Patient 4 compared to 
Patients 1, 2 and 3. Patient 4 reported the least amount of time between her last 
contact with the infected male and sample collection, one day. It is possible that 
the gonococcal transcriptome derived from the vaginal lavage of this patient 
represents a very early time point in infection. In that case, genes that show 
increased expression in Patients 1-3, compared to Patient 4, would be those that 
are associated with later time points in gonococcal infection. Such genes may be 
involved inN. gonorrhoeae responding the arrival of PMNs at the site of infection, 
invasion and survival within host cells and avoiding an adaptive immune 
response. In contrast, those genes that show increased expression in Patient 4 
might be those that are needed to establish successful infection. Tables 14 and 
15 show the gonococcal genes with the largest increase or decrease in 
expression when comparing RNA isolated from vaginal lavages of Patient 4 to an 
average of the Patients 1 ,2, and 3. Genes showing decreased expression in 
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Table 14. Goncoccoal Genes Showing the Largest Decrease in Expression 
when Comparing Patient 4 to Average of Patients 1, 2 and 3. 
Fold Change: 
Gene NameA Product8 Average of Patient 1, 2 and 
3/Patient 4 c 
NGTW08 1290 hypothetical protein 91.3 
NGTW08 1728 pilin monomer 77.2 
NGTW08 1749 pi lin 76.0 
NGTW08 1355 hypothetical protein 66.7 
NGTW08 0725 hypothetical protein 63.0 
NGTW08 1726 pi lin 59.0 
NGTW08 0456 hypothetical protein 58.3 
NGTW08 1764 putative hydrolase 46.7 
NGTW08 0266 hypothetical protein 33.7 
NGTW08 1755 hypothetical protein 32.7 
NGTW08 1732 trifunctional thioredoxin 26.7 
thiamin-phosphate 
NGTW08 1791 pyrophosphorylase 26.0 
NGTW08 2021 hypothetical protein 25.7 
NGTW08 2157 hypothetical protein 25.0 
phosphoribosyi-AMP 
NGTW08 0249 cyclohyd rolase 23.7 
NGTW08 1864 hypothetical protein 22.7 
NGTW08 2145 hypothetical protein 22.7 
NGTW08 1605 hypothetical protein 22.3 
MarR family transcriptional 
NGTW08 0182 regulator 21.3 
putative sulfate-binding 
NGTW08 0744 protein 21.0 
NGTW08 1474 putative sugar transporter 20.7 
NGTW08 2117 hypothetical protein 20.7 
NGTW08 1570 Hsp33-like chaperonin 18.7 
NGTW08 1133 hypothetical protein 17.7 
NGTW08 1752 L-pilin 16.3 
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AGene designations are shown according to alignment to the TCDC-NG08107 N. 
gonorrhoeae genome. 
8The gene name or a short description of the gene is shown. 
cFold change is shown comparing the average RPKM expression of each gene 
in Patient 1, 2, and 3 to the expression in Patient 4. 
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Table 15. Goncoccoal Genes Showing the Greatest Increase in Expression 
when Comparing Patient 4 to Average of Patients 1, 2 and 3. 
Fold Change: 
Gene NameA Product8 Average of Patient 1, 2 and 3/Patient 
4c 
NGTW08 0562 hypothetical _p_rotei n 0.002 
NGTW08 0801 hypothetical protein 0.005 
NGTW08 1833 hypothetical protein 0.006 
NGTW08 0997 hyR_othetical protein 0.007 
NGTW08 1023 alcohol dehydrogenase 0.007 
NGTW08 1502 hypothetical protein 0.010 
NGTW08 2174 hypothetical protein 0.010 
NGTW08 0358 hypothetical protein 0.011 
NGTW08 1256 hypothetical protein 0.011 
NGTW08 1012 hypothetical protein 0.012 
NGTW08 1832 hypothetical protein 0.012 
NGTW08 1500 hypothetical protein 0.013 
NGTW08 0833 hypothetical protein 0.014 
NGTW08 1287 hypothetical protein 0.015 
NGTW08 1572 hypothetical protein 0.015 
NGTW08 0555 hypothetical protein 0.016 
NGTW08 0727 hypothetical protein 0.016 
NGTW08 1838 membrane protein 0.016 
NGTW08 1794 hypothetical protein 0.017 
putative phage 
NGTW08 0512 associated protein 0.018 
molecular chaperone 
NGTW08 1076 DnaJ 0.019 
NGTW08 0554 hypothetical protein 0.019 
NGTW08 0133 hypothetical protein 0.020 
NGTW08 0474 hypothetical protein 0.021 
NGTW08 0164 181106 transposase 0.022 
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AGene designations are shown according to alignment to the TCDC-NG08107 N. 
gonorrhoeae genome. 
8The gene name or a short description of the gene is shown. 
cFold change is shown comparing the average RPKM expression of each gene 
in Patient 1, 2 and 3 to the expression in Patient 4. 
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Patient 4 include several pilin related proteins, metabolism proteins and one 
global regulator. This gene profile is similar to that seen when cells were 
incubated with End E6/E7 cells and may reflect changes in nutrient levels and 
intracellular trafficking when comparing established infection to early infection. 
Genes showing increased expression were less well characterized with several 
classified as hypothetical proteins. It should be noted that the small number of 
patients analyzed to date preclude our making strong conclusions regarding 
gonococcal responses to time points of infection. Other factors such as use of 
contraception or co-infections may also affect the gonococcal transcriptome. 
Experiments and collaborations with the NCSTD are ongoing in our laboratory to 
obtain additional female patient samples to increase statistical significance and 
confidence in our results. 
Next, the top 1 00 expressed gonococcal genes identified when analyzing 
the average of all four patient samples were categorized based on functional 
pathways (Figure 24). These pathways include stress response, host 
interactions, phage associated proteins and general housekeeping genes. The 
top category of highly expressed genes was represented by stress response 
genes including chaperone proteins and antioxidants. Both pilin and outer 
membrane proteins are involved with initial attachment and invasion of host cells 
and are also shown to be highly expressed. Respiration genes are also highly 
expressed possibly representing the microaerobic or anaerobic nature of the 
female genital tract. 
165 
Stress Response 
Pilin 
Metabolism 
C" Translation 
0 
DNA Metabolism C) (]) 
-ctl Translocase () 
(]) 
c:::: Respiration (]) 
(9 
Porin/OMP 
Phage 
Gene Regulator 
Iron 
0 1 2 3 4 5 6 7 8 
Number of Genes 
Figure 24. Top 100 Gonococcal genes expressed during mucosal infection 
of the female genital tract. Genes were categorized based on their functional 
pathways. The number of genes in each pathway is shown on the x-axis and the 
name of the category on the y-axis. Hypothetical proteins have been removed 
for ease of viewing . 
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Aside from known open reading frames, we were able to determine the 5' 
UTR length for 542 individual genes and 3' UTR lengths for 422 genes. Operon 
analysis predicted that 598 gonococcal genes were expressed as part of 412 
distinct operons during mucosal infection. Our analysis also identified 48 RNA 
transcripts that were expressed either within IG regions or antisense to known 
protein coding genes (Table 16). A total of 43 of these transcripts were 
less than 250 nucleotides in length, suggesting that they may be small regulatory 
RNAs. In addition, alignment of the sequence of these sRNAs to the FA 1090 
genome showed that several were identical to the sRNAs identified through 
RNA-seq of N. gonorrhoeae grown in vitro as described in Chapter 1. Of these 
smRNAs 3, 6, 8, 11, 14, 19, 22 and 30 were also found to be expressed by N. 
gonorrhoeae during mucosal infection. In addition, smRNAs 6, 8, 11, 19 and 30 
were also confirmed by Northern blot analysis Figure 7. The smRNA 11 
represents the previously known 4.5s RNA and smRNA 30 represents the 
previously known RNA subunit of RNaseP [243, 257]. 
Host Transcriptional Response to Gonococcal Infection of the Female 
Genital Tract. 
As with in vitro experiments incubating N. gonorrhoeae with End E6/E7 
cells, RNA sequencing allows us to determine both the pathogen and host 
transcriptome simultaneously during mucosal infection. Because analysis of the 
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Table 16. Non-annotated gonococcal transcripts expressed during 
mucosal infection of the female genital tract 
Translation Transcription Length of 
Stop Stop Transcript Strand Expression 
49423 49641 218 + 574 
49820 50018 198 + 892 
59444 59392 52 - 549 
149810 149847 37 + 1040 
189249 189414 165 + 654 
196300 196275 25 - 366 
282840 282887 47 + 376 
283857 283909 52 + 691 
380123 380027 96 - 1337 
459187 459464 277 + 822 
466665 466696 31 + 478 
588318 588367 49 + 1165 
595459 595446 13 - 698 
718388 718488 100 + 12123 
726894 726515 379 - 23613 
804189 804149 40 - 1125 
817909 817615 294 - 1872 
850202 850181 21 - 542 
951128 951048 80 - 1069 
1116813 1116773 40 - 727 
1165084 1165153 69 + 1758 
1165273 1165356 83 + 6092 
1356132 1356065 67 - 715 
1444761 1444806 45 + 1230 
1464942 1464854 88 - 531 
1530030 1530097 67 + 319 
1585409 1585316 93 - 28485 
1585662 1585727 65 + 1685 
1589862 1589915 53 + 536 
1614098 1614056 42 - 1018 
1697712 1697786 74 + 562 
1697888 1697920 32 + 553 
1701313 1701323 10 + 256 
1723175 1723208 33 + 320 
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1763670 1763782 112 + 5842 
1812050 1811666 384 - 14475 
1921761 1921959 198 + 1551 
1944572 1944800 228 + 1669 
1944851 1944958 107 + 816 
1951902 1951986 84 + 468 
1952061 1952216 155 + 1565 
1952844 1952857 13 + 783 
1953967 1954017 50 + 1692 
2016580 2016515 65 - 776 
2022601 2022568 33 - 1768 
2058667 2058709 42 + 769 
2059019 2059036 17 + 859 
2100526 2100494 32 - 690 
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eukaryotic transcriptome requires different computer programs compared to 
analyzing the gonococcal transcriptome, we have only one female patient whose 
host transcriptome has been fully analyzed , Patient 1. RNA was isolated and 
sequenced as above and aligned to the Hg 19 genome. For Patient 1, 
approximately 45% of the total RNA from the sample aligned to the human 
genome. In total, we identified 12893 human genes that were expressed during 
mucosal infection. This transcriptome was composed of 12493 protein coding 
genes as well as 151 microRNAs and 249 other non-coding genes such as 
snoRNAs or rRNAs. Again, it should be pointed out that the sequencing 
methodology for these experiments was biased for RNA transcripts that are 
longer than 50 nucleotides and thus would not efficiently detect microRNAs. 
Table 17 shows the top 25 expressed human protein coding genes for Patient 1 
during clinical infection with N. gonorrhoeae. Not surprisingly, several of these 
genes were involved in innate and adaptive immunity pathways. These include 
the most highly expressed protein coding gene, IL-8 as well as IL-1 ~and the IL-1 
receptor. All of these genes were found to show increased expression in End 
E6/E7 cells following incubation with N. gonorrhoeae. In addition, IL-8 was also 
found to be one of two host genes showing the greatest increase in expression 
following incubation with N. gonorrhoeae. These results may suggest that the 
lack of pro-inflammatory cytokine response seen in females infected with N. 
gonorrhoeae may result from post-translational mechanisms of control as both 
human cells incubated with N. gonorrhoeae as well as female patients show very 
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Table 17. Top 25 human genes expressed during clinical gonococcal 
infection 
Gene Name Note Expression A 
IL8 Pro-Inflammatory Cytokine 6.21E+08 
S100A9 Cell Progression/Differentation 3.29E+08 
MTRNR2L2 Cell Survival 2.88E+08 
ILlB Pro-Inflammatory Cytokine 2.55E+08 
SPRR2D Cell Progression/Differentation 2.44E+08 
S100A8 Cell Progression/Differentation 2.40E+08 
SATl DNA Regulation 2.07E+08 
SPRR2A Cell Progressibn/Differentation 2.07E+08 
ILlRN Pro-Inflammatory Cytokine 1:84E+08 
B2M MHC Associated Protein 1.60E+08 
SPRR3 Cell Progression/Differentation 1.45E+08 
FTHl Ferritin/Iron Storage 1.28E+08 
BPHL Host Response to viral treatment 1.22E+08 
PLEK Actin cytoskeleton rearrangement 1.18E+08 
SRGN Complement/Monocyte regulation 1.16E+08 
MTRNR2L8 Cell Survival 1.09E+08 
ANXAl Anti-Inflammatory Protein 9.14E+07 
BCL2Al Pro-Inflammatory/Cell Survival 9.04E+07 
VPS41 Cell compartmentalization 7.88E+07 
SPRR2E Cell Progression/Differentation 7.75E+07 
AQP9 Leukocyte Bacteriacidal Activity 7.14E+07 
CRISP3 Upregulated in Cancer 6.45E+07 
FCGR3B lgG Receptor 5.93E+07 
TMEM107 Membrane Related 5.73E+07 
TAGAP GTPase Related Protein 5.47E+07 
AExpression values were determined using RPKM as described in the Methods 
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high RNA levels of IL-8 and other pro-inflammatory cytokines. Other innate 
immunity molecules include SRGN (involved in complement) AQP9 and BCL2. 
Several highly expressed genes were those involved in cell progression and 
differentiation and well as possible cancer related genes such as CRISP3. To 
gain a more accurate overall picture of the human transcriptome during infection, 
the top 3000 expressed human genes were uploaded into the DAVID program 
and 1033 (36%) were categorized based on their KEGG pathway (Figure 25). 
Several of the most highly expressed categories were similar to those seen 
during incubation of N. gonorrhoeae with End E6/E7 cells. In both instances 
genes involved in Pathways in Cancer were among the most highly represented 
gene categories. It should be noted that the p-value for enrichment in a 
particular gene category for all data shown was <0.05. This normalized for the 
number of genes in a particular category and ensured that a particular gene 
category was not highly represented simply because that category contained a 
very large number of genes. Several categories involved in innate and adaptive 
immunity including signaling by chemokines and cytokines as well as sentinel 
proteins such as TLRs were also highly represented during mucosal infection. 
When analyzing the host response during incubation of N. gonorrhoeae with End 
E6/E7 cells in vitro there were few transcripts involved in uptake of bacterium by 
host cells that showed increased expression. In contrast, during mucosal 
infection in vivo, genes associated with the regulation of actin and endocytosis 
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Figure 25. KEGG pathway catergorization (DAVID) of host genes 
expressed during in vivo gonococcal infection. The top 3000 protein coding 
genes expressed during clinical gonococcal infection were subjected to functional 
classification based on their KEGG pathway using DAVID. A total of 1033 genes 
were successfully categorized. The gene category is on the y-axis and the 
number of genes in that category is on the x-axis. All genes have category 
enrichment p-value of <0.05. 
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are highly expressed. This is likely a result of N. gonorrhoeae subverting host 
cell mechanisms during invasion of epithelial cells. Such changes impressed on 
host cells by N. gonorrhoeae may be more relevant when considering N. 
gonorrhoeae and PMNs rather then N. gonorrhoeae and epithelial cells. This 
would explain why actin and endocytosis genes are highly expressed in a 
mucosal setting (which includes PMNs) compared to incubation with epithelial 
cells in vitro (which lack PMNs). Categories of genes associated with active 
phagocytosis were also represented including those involved in lysosome 
maturation and F c gamma phagocytosis. These genes may result from the 
uptake of N. gonorrhoeae by professional immune cells such as PMNs or 
macrophages. Finally, in conjunction with cancer, genes involved in mechanisms 
of host cell apoptosis were also significantly represented during clinical infection. 
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Summary 
These studies are the first to analyze the global transcriptome of both N. 
gonorrhoeae and the human host either during incubation with endocervical cells 
or during mucosal infection in vivo. The use of RNA-seq analysis offers a wealth 
of information regarding how both the host and pathogen respond to each other 
and how disease progression may be a result of these responses. We found that 
during incubation with End E6/E7 cells, N. gonorrhoeae demonstrated increased 
expression of genes involved in metabolism and stress response compared to 
incubation in media alone. This is likely a result of the changes in nutrients and 
metabolites present within End E6/E7 cells compared to media alone and the fact 
that within such cells N. gonorrhoeae were exposed to potentially bactericidal 
epithelial cell responses. In contrast, several respiration-related genes showed 
decreased expression under such conditions. There were also a large number of 
hypothetical proteins regulated during incubation with End E6/E7 cells 
suggesting as yet unknown mechanisms of pathogenesis employed by N. 
gonorrhoeae. End E6/E7 cells also responded to incubation with N. gonorrhoeae 
and exhibited a strong increase in genes associated with cancer, pro-
inflammatory cytokines and anti-apoptotic mechanisms. Both End E6/E7 cells 
and N. gonorrhoeae also expressed a large number of non-coding and non-
annotated transcripts during incubation. 
These experiments also examined the transcriptome of N. gonorrhoeae 
during natural mucosal infection of the female genital tract. Similar to incubation 
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with End E6/E7 cells, RNA isolated from N. gonorrhoeae during mucosal 
infection showed high expression of several genes involved in stress response 
and metabolism. The consistently high expression of outer membrane proteins 
suggests that these proteins may serve as viable vaccine candidates. During 
mucosal infection, the female host responded with a significant increase in pro-
inflammatory cytokines as well as several genes related to apoptosis and cancer, 
similar to that seen with End E6/E7 cells incubated with N. gonorrhoeae. These 
experiments are the first to analyze mucosal specimens with such depth and 
offer a wealth of information regarding how the host and pathogen respond to 
infection. Such information will be of great use when developing novel vaccines 
and antimicrobial therapies to gonococcal disease. 
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Chapter 4. Discussion and Conclusions 
The epidemiological burden of N. gonorrhoeae is increasing as more and 
more strains are being isolated with increased resistance to approved antibiotics. 
The loss of effectiveness of the last FDA-approved antibiotic, cefixime, combined 
with the complete lack of a gonococcal vaccine shows that continued study of the 
pathogen is vital both for the development of effective antibiotics as well as a 
pan-gonococcal vaccine. To answer questions relevant to such developments, 
we set out to determine how both N. gonorrhoeae and the human host respond 
to infection on a global transcriptional level. The experiments carried out in these 
studies are the first to analyze the response of N. gonorrhoeae under in vitro 
conditions relevant to infection as well as during natural mucosal infection of the 
female genital tract with such depth. We began with an analysis of N. 
gonorrhoeae grown in vitro in culture broth with a focus on sRNAs, important 
bacterial regulators with roles in infection, before moving to the complete 
transcriptome of both N. gonorrhoeae and host epithelial cells during incubation 
in KSFM. These studies were facilitated by using the first RNA-seq analysis 
program designed specifically for prokaryotic transcriptomes, Rockhopper. 
Finally, we show the results of the first global transcriptome analysis of a 
mucosal pathogen during in vivo infection through analysis of vaginal lavage 
samples of female patients exposed to N. gonorrhoeae from their male partners. 
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Small RNAs of N. gonorrhoeae 
Bacterial gene regulation via sRNAs is a field of rapidly advancing 
discovery. New technologies such as global RNA sequencing are facilitating the 
discovery of sRNAs, as well as providing the first glimpse of the global sRNAome 
of bacteria where little is known about sRNA regulation, such as N. gonorrhoeae 
[214, 220]. It is possible that sRNAs may play a more prominent role in gene 
regulation in N. gonorrhoeae as compared to other bacteria due to the relatively 
low number of global proteomic transcription factors in the gonococcus. Despite 
this possibility as well as the analysis, to date, of more than 100 sRNAs in other 
organisms such as E. coli, there have been only two sRNAs that have been well 
characterized inN. gonorrhoeae. The analysis presented here sought to identify 
and characterize sRNAs more broadly in N. gonorrhoeae. RNA-seq analysis in 
N. gonorrhoeae identified several hundred instances of transcription that were 
outside or antisense to known genes. Due to the preliminary status of gene 
annotation in N. gonorrhoeae, it is likely that a significant fraction of these 
transcripts are 5' or 3' UTRs or represent background sequencing or non-specific 
transcription . 
In an effort to focus only on transcripts that are more likely to correspond 
to sRNAs, we identified small transcripts that appeared to be distinct from those 
of protein coding genes and that were highly expressed under two separate 
growth conditions. Several were found and confirmed and interestingly, we also 
found 197 putative sRNA transcripts that were expressed only under Condition A 
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and 48 putative sRNA transcripts that were expressed only under Condition B. 
These observations highlight the advantage of choosing different growth 
conditions in an attempt to maximize identification of novel sRNAs, especially in 
organisms for which the sRNAome is only beginning to be explored. 
While the difference in growth conditions was the largest separation 
between the two conditions, it cannot be discounted that the differences in RNA 
preparation described in the methods may have also influenced the results. RNA 
isolated from Condition A was enriched for RNA transcripts between 50-250 
nucleotides in length. This would likely increase the detection of sRNAs by RNA-
seq, an observation that is in agreement with the large number of sRNAs 
detected by this method . This may be of interest to other researchers who are 
interested in focusing RNA sequencing experiments on sRNAs or other classes 
of RNAs that are of relatively homogenous size. A gel electrophoresis step may 
increase the number of RNA transcripts detected and possibly allow the 
detection of transcripts expressed at very low levels. We can conclude from 
these experiments that future experiments designed to identify novel sRNAs in 
bacteria would benefit from a simultaneous analysis of multiple conditions 
combined with an RNA enrichment step focusing on small transcripts . 
Because our sRNA analysis employed several different conditions, we had 
a preliminary view as to how these novel sRNAs might change expression under 
various stimuli. For example, smRNAs 8 and 19 showed differential expression 
when examined under variable iron conditions. Several sRNAs in other 
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organisms, as well as Neisseria, have been shown to be regulated by iron via the 
Fur protein and to be involved in maintaining iron homeostasis [177, 186, 188]. It 
is possible that these sRNAs are involved in similar mechanisms. As regulators, 
sRNAs and their targets are likely controlled by similar stimuli. When searching 
for mRNA targets of smRNA 8, we noted that there were a number of genes that 
were regulated identically to smRNA 8, that are expressed more highly during 
growth under iron-replete conditions. This may reflect the fact that more and 
more sRNAs are found to be positive regulators of mRNAs rather than negative. 
The observation that certain smRNAs were found only under one condition again 
highlights the advantage of using multiple conditions to identify and confirm the 
greatest number of sRNAs. While differences in methodologies may represent a 
general increase in sRNA transcript levels, the observed increased expression of 
smRNAs 6, 15, and 17 was confirmed by both RNA-seq and Northern blot 
methodologies and thus is unlikely to be an unintended artifact of either. Several 
of the sRNAs tested had a predicted RIT, yet the presence of an RIT was absent 
in the majority of sRNAs. This is consistent with sRNAs in E. coli, where many, 
but not all, sRNAs appear to use RITs. We would therefore suggest the 
presence or absence of a predicted RIT should not be considered a disqualifying 
characteristic in future analyses which focus on sRNAs in Neisseria and perhaps 
in other bacteria as well. 
When determining the genomic location of sRNAs, some, for example 
smRNA 15, 20, as well as a portion of smRNA 19, were found to be opposite a 
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previously annotated gene. The increasing amount of anti-sense transcription 
being found in prokaryotic organisms forces us to rethink our ideas regarding 
genetic structure in these organisms. A recent study of H. pylori found that 50% 
of genes contained an anti-sense transcript on the opposite strand [220]. When 
analyzing sRNAs, such anti-sense transcripts are especially interesting given 
their strong potential of being post-transcriptional regulators. As sRNAs function 
through base-pairing with mRNA targets, such anti-sense transcripts may 
suggest a cis-regulatory role for the sRNA. 
Genomic location may also provide preliminary information regarding the 
role of individual sRNAs. In other bacteria, as well as N. gonorrhoeae, some 
sRNAs have been found to be in the vicinity of their target genes [213]. Several 
of the sRNAs found in this study were within bacteriophage genomic regions 
previously identified in N. gonorrhoeae [258]. Our laboratory and others have 
determined that phage DNA can have a role in regulatory pathways of N. 
gonorrhoeae. A mutant strain of N. gonorrhoeae lacking a phage associated 
repressor was found to exhibit increased expression and survival within epithelial 
cells as well as being more fit within a mouse model of infection compared to the 
wild-type strain [248]. The sRNAs, smRNA 7, 15, and 25 were found to be within 
the phage genomes of Ng¢1, <1>2, and <1>3, respectively. It is possible that these 
RNA transcripts may have originally been part of the phage transcriptome but 
have now acquired new roles in regulatory pathways of N. gonorrhoeae. In 
addition, other sRNAs that were found in one condition tested, but not both, were 
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also associated with specific DNA regions of the N. gonorrhoeae genome. The 
lgt-1 locus, a collection of genes involved in LOS biosynthesis, was found to 
contain a putative sRNA that was highly expressed under Condition A. Another 
sRNA was also found in the mtrCDE locus, which encodes for an efflux pump in 
N. gonorrhoeae. We propose that searches for putative targets of these sRNAs 
should begin in these regions and that stimuli that regulate genes in these loci 
may also regulate these putative sRNAs. 
For each sRNA that we characterized, we predicted the lowest free energy 
secondary structure. Several of the sRNAs exhibited large portions of single 
stranded RNA rich in adenosine and uridine. Studies with the bacterial sRNA 
cofactor Hfq have shown that this protein preferentially binds to such regions 
when participating in sRNA regulation [175]. The unstructured AU rich regions in 
these sRNAs may represent putative Hfq binding sites. If these sRNAs are 
indeed Hfq-dependent, such an observation would be of interest as, of the two 
sRNAs examined in Neisseria, one is dependent on Hfq and one is not [163, 
259]. In addition to acting as possible Hfq binding sites, single stranded regions 
may represent possible sites for target interaction [260, 261]. However, analysis 
of target binding regions should not be limited to these unstructured regions as 
Hfq has also been shown to alter the secondary structure of both sRNAs and 
target mRNAs, unfolding them to expose previously occluded sites that can then 
participate in RNA: RNA binding. 
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More broadly, the role of Hfq in sRNA regulation in Neisseria is only 
beginning to be understood. Our experiments showing that NrrF is able to 
function independently of Hfq may suggest that Neisseria! sRNAs generally do 
not require a protein cofactor or that other protein cofactors are present in the 
Neisseria that fulfill the role of Hfq. Other studies have shown that N. 
gonorrhoeae contains a homologue of the FinO sRNA cofactor of E. coli [174]. It 
is important to note that the independence of NrrF from Hfq should not be taken 
as a general rule describing all sRNAs in Neisseria. Other studies have found 
that individual sRNAs within the same bacterial species can have varying 
dependencies on Hfq for their function [171]. The very small number of known 
sRNAs in Neisseria prohibits broad conclusions regarding the role of Hfq in these 
pathogens. As more sRNAs are analyzed inN. meningitidis and N. gonorrhoeae 
and the role of Hfq described for each it will be possible to make more accurate 
statements regarding how Hfq functions in genetic regulatory pathways of 
Neisseria. 
Global Transcriptome of N. gonorrhoeae 
In the experiments described above, the Rockhopper program was used 
to identify novel sRNAs in N. gonorrhoeae. However, as sRNAs are only a small 
portion of the total RNA expressed by an organism, we set out to analyze the 
complete transcriptome of N. gonorrhoeae after a two-hour incubation in KSFM. 
While the experiments described here were focused on the gonococcal 
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transcriptome, we also used Rockhopper to analyze RNA-seq data from other 
bacterial species, mainly E. coli. In addition to species differences, the 
experimental design for E. coli experiments differed from N. gonorrhoeae 
experiments in read length: RNA-seq experiments examining E. coli used a 101 
basepair read length and experiments examining N. gonorrhoeae used 36-40 
basepair read lengths. Generally speaking, RNA-seq experiments from E. coli 
(those that used a longer read length) aligned better with predictions made by 
Rockhopper. This suggests that when analyzing the global transcriptome of 
bacteria, a read length closer to 100 basepairs may yield more accurate data 
then a shorter read length of 35-40 basepairs. 
One of the main advantages of a longer read length is more accurate 
localization of the read to the genome. With a shorter read length it is possible 
that a single read could align to more than one location in the genome. 
Misalignment is also a function of genome size (the larger the genome the more 
likely a read will align to multiple genomic locations by chance) as well as the 
number of mismatches allowed when aligning reads. As described above, 
Rockhopper allows up to 15% mismatches by default. This allows for the 
alignment of the greatest number of reads while taking into account inherent 
errors in sequencing methodology. However, this 15% misalignment threshold is 
only a factor after initial alignment of a seed region of the RNA-seq read of no 
less than 33% of the total read length. In short, a read length of 36 basepairs 
must have at least 12 nucleotides that align exactly to the genome before 
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subsequent alignment attempts are made. It is possible that a single 12 
nucleotide sequence can appear multiple times in a genome, especially when 
taking into consideration the presence of repeat regions in the genomes of many 
bacteria including N. gonorrhoeae [262, 263]: In contrast, a read of length 100 
nucleotides must have a seed region of at least 33 nucleotides matching exactly 
to the genome before subsequent alignment attempts are made. It is much less 
likely that longer eDNA sequences will align at random within the bacterial 
genome and thus a longer read length is likely to align at only one spot in the 
genome leading to a more accurate determination as to transcription from that 
region. 
Increasing the read length can have a positive effect on alignment. 
However, the longer the read length the less of the global bacterial transcriptome 
can be analyzed in a single experiment. Selecting for a read length of 100 
basepair can lead to a bias towards those RNA transcripts that are significantly 
longer than 100 basepair. As a first step in eDNA library construction, RNA is 
fragmented with either enzymatic methods or metal ion scission . It is likely that 
shorter RNA transcripts will be cleaved into fragments that are less than 1 00 
basepair and thus, such transcripts will not be analyzed as efficiently as longer 
transcripts. In addition, many sRNAs are shorter than 100 nucleotides making 
their detection using a longer read length more difficult. Overall , our experiments 
demonstrate that a longer read length generally leads to more accurate results 
when analyzing transcriptional start sites, gene expression levels and operons. 
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Therefore, when initially determining the global transcriptome of a given bacteria, 
a longer read length would be advisable. However, for more in-depth and 
specific analyses (such as experiments targeting short transcripts or sRNAs as 
described in Chapter 1) a shorter read length may be more likely to detect 
smaller transcripts. 
It is also possible to increase the accuracy of data by increasing or 
decreasing the stringency of the read alignment. The current settings of 
Rockhopper (33% alignment for seed regions and 15% total misalignment) are 
fairly relaxed and further loosening of the parameters could lead to an increase in 
misaligned reads. A more stringent cutoff for read alignment would have a 
positive effect on the data quality but with a corresponding lower number of total 
reads aligning the genome. However, as these studies show, lowering the 
number of total read under analysis by more that 85% did not lead to a decrease 
in correspondence of RNA-seq data with qRT-PCR data. Hence, in future 
experiments it may be advisable to sacrifice total read alignment in an effort to 
generate greater accuracy of genomic localization of reads by increasing the 
stringency of alignment parameters. The decrease in correspondence with qRT-
PCR analysis is minimal to non-existent and a more accurate localization of 
reads will lead to higher quality data overall. 
Analyses of N. gonorrhoeae transcriptional start and stop sites are in 
conjunction with previous global analysis of bacterial transcriptomes where many 
promoters were found to be short and many were found to start downstream from 
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predicted translational start site [264, 265]. The observation that many of theN. 
gonorrhoeae 5' UTRs have a length of zero is likely the result of one of two 
contributions. First, Rockhopper, by default, begins to analyze 5' UTR length at 
the start of the predicted translational start site as a time saving method. If this 
predicted location is incorrect and the true translational start site is actually 
downstream of the predicted site then it is possible that there will be no 
transcription at the predicted translational start site. This would result in 
Rockhopper reporting a transcriptional start site of zero nucleotides upstream of 
the predicted translational start site. Therefore, it is possible that several of the 
genes that show a 5' UTR of zero actually have misannotated translational start 
sites and possess a longer 5' UTR. This could be corrected in future versions of 
Rockhopper by having 5' UTR calculation begin at a site well within the coding 
region (approximately +50 basepair) and working upstream from that point. Such 
a method would detect all transcriptional start sites, even those associated with 
whose start codon is misannotated. 
The other reason for a large number of 5' UTRs with length zero is that 
another transcriptional start site may be in use that is downstream of the correctly 
annotated translational ATG start codon. Bacterial genes with multiple 
transcriptional start sites have been seen in a variety of organisms including N. 
gonorrhoeae [220, 264, 266-268]. These genes may have more than one 
transcriptional start site as well as more than one true ATG start codon. 
However, Rockhopper only begins analysis with the ATG start codon listed in the 
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NCB I database for the genome under analysis. Therefore, it is possible that 
such alternative transcriptional start sites would not be detected. The detection 
of alternative transcriptional start sites can be carried out using alternative 
methods of eDNA library preparation prior to RNA sequencing being carried out. 
Use of a terminator exonuclease to enrich for primary RNA transcripts allows for 
the sequencing only of the 5' end of genes. Using this method multiple 
transcriptional sites can be detected as internal start sites are not masked by 
transcription of the entire ORF from an upstream site. Using this method to 
analyze N. gonorrhoeae may reveal that many of the genes with 5' UTR lengths 
of zero are actually being expressed from alternative start sites that are 
downstream of the ATG start codon. Consistent with this hypothesis is the 
observation that several transcripts show multiple extension products when 
carrying out primer extension, indicating that the mRNA under analysis has a 
promoter region of varying length. Under current conditions Rockhopper can 
only determine the most upstream transcriptional start site. However, methods 
using terminator exonuclease enzymes will allow determination of all 
transcriptional sites being used by a given ORF at once. Again, it should be 
noted that Rockhopper was slightly better at predicting 5' UTR length when using 
the E. coli 101 basepair read length data compared toN. gonorrhoeae 36-40 
basepair read length data. This is likely a result of more accurate data using a 
longer read count as well as more accurate annotation of true start codons in E. 
coli due to the detailed analysis of this common model organism. 
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When determining gene expression levels, Rockhopper was able to make 
more accurate predictions when using E. coli 1 01 basepair read length data 
compared toN. gonorrhoeae 36-40 basepair read length data again likely 
reflecting the higher accuracy of longer read lengths. Subsequent experiments 
by our group have used 76 basepair read lengths with Rockhopper and we have 
found a high correlation between RNA-seq and qRT-PCR [248]. One of the 
reasons for the modest correlation in gene expression levels between 
Rockhopper and qRT-PCR when analyzing N. gonorrhoeae RNA-seq data is 
differing methods of normalization. Rockhopper uses the method of upper 
quartile normalization where the top 25% of genes are used to determine a total 
read count. This total read count is then used in conjunction with RPKM to 
determine gene expression levels. In contrast, qRT-PCR experiments normalize 
not to total expression of all RNA or the upper quartile but rather to one (or at 
most two) housekeeping genes which are assumed to have identical expression 
levels across biological conditions. Normalization methods can have a large 
effect on apparent gene expression levels and this may be one reason why RNA-
seq gene expression levels do not correspond exactly with those determined by 
qRT-PCR. While Bullard et al have shown that upper quartile normalization does 
have the best concordance with qRT-PCR these experiments were done using 
eukaryotic RNA-seq data rather than the prokaryotic data used here [231]. 
Indeed, even when analyzing differentially expressed genes in E. coli with 
0 
Rockhopper, 3 out of 10 show regulatory patterns opposite those determined by 
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qRT-PCR. This was consistent even when using other RNA-seq alignment 
algorithms and suggests that this discrepancy is likely a result of data 
normalization between methods rather than an issue concerning Rockhopper 
analysis. 
Finally, we used Rockhopper to predict operon structures in N. 
gonorrhoeae. Rockhopper predicted the existence of several of the known 
operon structures inN. gonorrhoeae including the min operon [269], the mtr 
operon [55], and the fbpABC operon [270]. Generally, operon prediction showed 
high sensitivity and modest specificity when analyzing N. gonorrhoeae RNA-seq 
data. This observation was also apparent when analyzing RNA-seq data from E. 
coli. It is also of interest to note that Rockhopper (which uses genomic structure 
and expression) aligned very well with the DOOR database (which uses only 
genomic structure). This may suggest that analysis of genomic structure alone 
yields highly accurate operon maps of bacterial species. 
The modest specificity of Rockhopper's analysis when analyzing N. 
gonorrhoeae could be explained by the observation that some genes within 
operons of certain bacterial species do not show similar expression levels in 
contrast to what would be expected. Studies on E. coli and B. subtilis have 
indeed shown that genes within a single operon show correlation in expression 
levels [271, 272]. However, studies of other organisms have shown that 
expression of individual genes within an operon is reduced as function of gene 
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distance from the operon promoter [273, 274]. We have also seen a similar 
phenomenon in N. gonorrhoeae [275] [248]. 
Host and Pathogen Transcriptome Response to in vitro incubation. 
We next applied Rockhopper to analysis of N. gonorrhoeae during 
incubation with End E6/E7 endocervical epithelial cells. This cell line has been 
used by our laboratory in the past to examine the role of N. gonorrhoeae in 
inducing an anti-apoptotic effect during infection as well as how individual 
gonococcal proteins are involved in adherence and invasion of host cells [46]. 
These cells have also been used to examine how individual iron-regulated 
proteins of N. gonorrhoeae are expressed and regulated during in vitro 
incubation [148]. Because of our experience with this cell line and because it 
maintains characteristics of its tissue of origin we chose to use it to examine the 
complete gonococcal and host transcriptome during in vitro incubation of N. 
gonorrhoeae with these cells. These experiments revealed how N. gonorrhoeae 
responds to incubation specifically with epithelial cells as well as the contribution 
of these host cells to the total host response to infection. 
The increased expression of genes related to host resistance likely 
reflects the bactericidal fatty acids and hydrophobic agents that are produced by 
epithelial cells. Previous studies have shown that these transcripts are 
upregulated in conjunction with cells or with hydrophobic agents and fatty acids 
[55, 57]. Also of interest is the observation that glutaredoxins (proteins that 
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detoxify free radicals) were also upregulated during incubation with End E6/E7. 
Changes in expression of housekeeping genes may reflect the fact that N. 
gonorrhoeae is subjected to a different milieu of nutrients when growing 
intracellularly compared to growing in KSFM alone. Alternatively, the presence 
of human cells in the growth media could dramatically alter the amount and form 
of nutrients present necessitating corresponding changes by N. gonorrhoeae. It 
is also possible that genes considered to be housekeeping such as translation 
related riboproteins could have more direct roles in infection . Studies have 
shown that the riboprotein L 12 of N. gonorrhoeae is involved in adherence to 
host cells [43, 44]. While we did not detect expression changes in L 12 in this 
study, it is possible that one or more of the other 9 riboproteins that did show 
regulation may be involved in similar mechanisms. 
It is of interest to note that phage-associated proteins were also highly 
expressed during infection (with no phage-related genes showing decreased 
expression). N. gonorrhoeae encodes 9 prophages within its genome and 
several of them are thought to encode sufficient DNA to produce functional 
phage particles, a phenomenon which has been seen in N. gonorrhoeae [258, 
276]. These experiments show that N. gonorrhoeae increased expression of 4 
phage-associated genes upon incubation with End E6/E7 cells compared to 
media alone. Two of these genes are within phage sequences that may encode 
functional phage particles (NG01141 and NG01647). Even phage-associated 
genes that are within incomplete phage genomes can have an effect on 
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successful infection mechanisms. Other studies in our group have identified a 
phage repressor protein NG01 013 that is encoded in a non-functional phage 
genome that had profound effects on adhesion and invasion of End E6/E7 cells 
as well as infection in a mouse model. Strains of N. gonorrhoeae lacking 
NG01013 showed greater ability to adhere to and invade epithelial cells as well 
as greater persistence in a mouse model of infection [248]. While the phage 
proteins here are from a different phage genome they may have similar roles in 
interactions with host cells. 
The increased expression of regulators such as RpoH is of interest as 
other studies have shown that the RpoH alternative sigma factor has an effect on 
expression of genes involved in pathogenic mechanisms of Neisseria [151, 152]. 
By far the most highly represented class of genes were hypothetical proteins. It 
is likely that this reflects the modest characterization of the gonococcal genome 
and suggests that N. gonorrhoeae may use previously unknown mechanisms of 
pathogenesis during infection. 
Besides the analysis and confirmation of genes already suspected to be 
regulated via incubation with host cells the real power of RNA-seq is identification 
of novel transcripts that were previously not known. We detected several small 
RNA transcripts including smRNA 17 and a pilin associated sRNA [213]. In other 
bacterial species, several sRNAs have been shown to have a role in pathogenic 
mechanisms and the comparative lack of protein-based regulatory mechanisms 
in N. gonorrhoeae suggests that sRNAs may be a very important means of 
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expression control in this organism. One of the challenges with sRNA studies is 
identification of mRNA targets of sRNAs. As regulatory entities, it is likely that 
sRNAs and their mRNA targets are regulated by similar stimuli. Use of global 
RNA sequencing experiments allows for an analysis of sRNAs as well as 
providing a base of coding mRNAs that are regulated by similar means, possibly 
representing targets for sRNAs. Experiments are currently underway in our 
laboratory to identify targets of sRNAs expressed during incubation with End 
E6/E7 cells. Gonococcal mRNAs that are also regulated during such incubation 
will be preferentially considered as targets for analysis. 
The End E6/E7 cells used in these experiments are female endocervical 
cells and reports regarding the inflammatory response of female cells and female 
patients vary. Some studies have reported an upregulation of such cytokines 
during incubation of host cells with N. gonorrhoeae [11 0]. However, other 
studies have reported no increase in either protein levels of pro-inflammatory 
cytokines during mucosal infection [16] or RNA levels of such transcripts during 
in vitro incubation of N. gonorrhoeae with primary cervical cells [137]. These 
studies, through their identification of pro-inflammatory cytokines expressed 
during incubation, support the idea that several such cytokines as well as other 
pathways of immune systems are upregulated upon exposure to N. gonorrhoeae. 
However, it should be noted that these experiments measure RNA levels of 
cytokine coding transcripts and it is possible that post-transcriptional 
mechanisms are at play during natural mucosal infection that reduce translation 
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of these transcripts. Post-translational mechanisms that reduce effectiveness of 
pro-inflammatory proteins could also be involved. N. gonorrhoeae is already 
known to express a host specific protease that cleaves both lgA and Lamp 1 of 
endosomes and several other studies have reported on this mechanism in other 
bacteria [277, 278]. 
In addition to cytokines of the innate immune system we also observed 
increased expression of genes associated with T-cell signaling. Interestingly, 
individual antigens of N. gonorrhoeae such as pilin, lgA protease, and porin can 
act to stimulate expression ofT and B-cell signaling and proliferation [279]. 
However, whole viable N. gonorrhoeae have a negative effect on the 
downstream signaling of these T- cell signaling and proliferation [112, 263]. It is 
possible that N. gonorrhoeae can induce the early stages ofT-cell proliferation 
(such as an increase in expression of related genes) but downstream signaling is 
circumvented by other virulence mechanisms of the gonococcus, similar to 
interactions between N. gonorrhoeae and PMNs [71]. There are fewer studies 
examining the relationship between N. gonorrhoeae and B-cells but work by So 
et al demonstrated that N. gonorrhoeae could have a positive effect on the 
proliferation of B cells [280]. 
The relationship between apoptosis and N. gonorrhoeae is well 
established and it has been shown that this pathogen can inhibit apoptosis in 
both epithelial cells and PMNs [46, 127, 128]. Similar mechanisms may be at 
play here as specific anti-apoptotic factors that were previously examined by our 
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group at the protein level in these cells were also upregulated at the RNA level 
as determined by RNA-seq [46]. When considering the upregulation of cancer 
related genes it is important to keep in mind the transformed nature of these 
cells. However, several studies have established a link between inflammation 
and cancer and PID, a common result of untreated gonorrhea, has also been 
shown to be associated with cancer [281-284]. In addition, incubation of vaginal 
cells with N. gonorrhoeae has been shown to promote DNA damage and 
dysregulation of p53, p21 and p27. It is possible that the upregulation of pro-
apoptotic and cancer related genes upon incubation with N. gonorrhoeae reflects 
this relationship. 
The identification of over 1 ,400 instances of transcription outside of 
annotated genes of the human genome may represent various kinds of non-
coding RNA such as PIWI-RNAs, microRNAs and siRNAs these studi~s are not 
designed to detected transcripts so small. It is possible that these represent 
previously known gene products that code for proteins but another possibility is 
the emerging function of long non-coding RNAs (lncRNAs) in eukaryotes. The 
lncRNAs are expressed by eukaryotes either opposite known open reading 
frames or within IG regions [285, 286]. These RNAs are approximately the same 
length as mRNAs and are capped, poly-adenylated and spliced but are not · 
translated [287]. Amazingly, some studies estimate the existence of -20,000 
lncRNAs making their study just as important as the study of traditional protein 
coding genes [288]. The roles of lncRNAs are quite varied and include regulating 
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gene expression, impacting nuclear organization and controlling alternative 
splicing, among others [288]. The lncRNAs function in a variety of human 
diseases including psoriasis , fragile X syndrome and Alzheimer's disease as well 
as several kinds of cancer [289-293]. While the role of lncRNAs in infectious 
diseases is still being analyzed , it is likely that severallncRNAs are expressed 
during infection and that some may be regulated and have downstream effects 
affecting disease progression. 
Analysis of in vivo mucosal infection. 
N. gonorrhoeae is mucosal disease that primarily infects the male and 
female genital tracts. It is a strict human pathogen and gonococcal disease is 
best studied in the context of natural in vivo infection. As described above, the 
ultimate goal of these studies is to obtain a global transcriptomic view of both the 
host and pathogen during mucosal infection. To that end, we next used 
Rockhopper and other programs to analyze the transcriptome of N. gonorrhoeae 
and the female human host during such infection. It is important to note that 
female patients we analyzed were asymptomatic in that they did not seek a 
doctor's counsel themselves but only because they were specifically recruited . 
We isolated cervical swabs from 4 female patients, isolated RNA and carried out 
RNA-seq and analysis as described above. 
When analyzing the global transcriptome of a pathogen during clinical 
infection it is possible to use the data to generate hypotheses regarding new 
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vaccine targets. As described above, there is currently no vaccine for N. 
gonorrhoeae, an absence that will become more worrisome as the number of 
antibiotic resistant strains of N. gonorrhoeae increase. Analysis of RNA-seq data 
during infection can identify possible new targets that have not yet been 
analyzed. Outer membrane proteins often serve as good vaccine targets due to 
their location of the exterior of the bacterial cells. This location exposes them to 
host defense mechanisms including adaptive pathways thereby leading to the 
development of specific antibodies against these proteins. While N. gonorrhoeae 
is able to avoid the adaptive host response to some degree, it is possible that 
previously uncharacterized proteins identified in these studies will lack such 
avoidance mechanisms. We find two outer membrane proteins (NGTW08_1480 
and NGTW08_1985) to be very highly expressed during infection. Hypothetical 
proteins may also serve as novel vaccine targets once they are characterized in 
more detail. The process of using global sequencing techniques to identify novel 
vaccine targets is not new and has been used for other infectious diseases, a 
process termed "reverse vaccinology" [294, 295]. 
Analysis of total RNA from patient samples also allowed for the 
identification and analysis of the transcriptome of other bacterial species of the 
female genital tract. As described in the Introduction, there are significant 
differences in the composition of the microbiome of the male and female genital 
tracts and such differences may lead to symptomatic differences in infection. We 
specifically analyzed transcripts from Gardnerella and Lactobacilli species. Both 
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were detected but there were too few reads aligning to the species to carry out a 
robust analysis. Future studies using more powerful methods that generate a 
higher number of sequencing reads may allow for the analysis of contributions 
from the natural microbiome during infection. It is thought that Lactobacilli offer 
some degree of protection toward gonococcal infection in the female genital tract 
through the production of acidic compounds [144, 145]. It will be of great interest 
to determine if such genes are highly expressed during gonococcal infection of 
the female genital tract, particularly when comparisons are made to uninfected 
females. 
These analyses were also performed on four different female patients and 
allow for a preliminary analysis of how N. gonorrhoeae alters its transcriptome at 
different stages of infection or in the face of differing host backgrounds. The 
transcriptome of N. gonorrhoeae during infection of Patient 4 was compared to 
an average of the other three patients to identify the possible response of this 
pathogen in the early stages of infection. Our proposed studies include the 
recruitment of approximately 70 female patients. It is likely that these patients 
will have been infected for various amounts of time, similar to the spread of 
infection times seen in our four analyzed patients. By increasing our patient 
number in future experiments we will not only be able to discern the gonococcal 
transcriptome at different points of infection, so called "snapshots" of infection, 
but also analyze how the transcriptome is altered at different points of infection of 
the female genital tract. This more detailed analysis of the gonococcal 
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transcriptome at stages of infection will likely aid in our analysis of the 
asymptomatic nature of infection. 
Finally, we have begun to analyze the human transcriptome during 
infection using RNA sequencing. Analysis of eukaryotic transcriptomes requires 
programs other than Rockhopper. To date, we have fully analyzed only a single 
patient, Patient 1. It was of interest to note that the most highly expressed 
protein coding gene was IL-8, a pro-inflammatory cytokine, and also the most 
highly expressed gene when examining End E6/E7 cells. This again suggests 
that female patients infected with N. gonorrhoeae show a robust inflammatory 
response during in vivo infection at least at the RNA level. Differences between 
these experiments and others may lie in the strain of infecting N. gonorrhoeae or 
patient differences. Also, our analysis is focused on RNA while others have 
looked at inflammatory proteins directly. It is possible that post-transcriptional 
mechanisms of the host or gonococcus are involved that prevent successful 
translation and excretion of pro-inflammatory cytokines, similar to what has been 
seen for the gonococcallgA protease as well as other infectious disease [296, 
297]. The experimental design described here also allowed for the simultaneous 
isolation of the gonococcal and human proteome from these samples. Analysis 
of such samples at the protein level may reveal a high concentration of specific 
pro-inflammatory cytokines to corroborate our RNA data. In addition, antibody 
levels to specific gonococcal antigens, particularly those that have not yet been 
examined and were identified in these RNA-seq studies, can be analyzed. Such 
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experiments are part of our on going studies with our collaborators at the NCSTD 
and the University of Massachusetts. A more general view of the human 
transcriptome using DAVID again showed several pathways involved in immunity 
and, as before, high expression and enrichment of genes involved in cancer 
pathways. Here, it is important to keep in mind that we have not yet analyzed a 
control, a cervical swab from an uninfected female. Such experiments are 
ongoing in our laboratory. It is possible that this transcriptome is not related to 
infection but is rather the expression levels of genes during normal transcription. 
These highly expressed cancer genes may have little to do with gonococcal 
infection. However, the link between PID and inflammation and cancer suggests 
that further experiments are necessary [298, 299]. 
Finally, it is interesting to consider these female patients in the context in 
"symptomatic" or "asymptomatic" infection. It is generally accepted that women 
are asymptomatic more often than men during gonococcal infection. All of the 
women in this study reported to the NCSTD because they were asked to come, 
none of them considered themselves to be "symptomatic". However, upon 
examination by a clinician, many of them did in fact report symptoms such as 
painful urination and cervical pain. Others showed a PMN influx at the site of 
infection. This complicates future studies of infectious disease as the terms 
"symptomatic" and "asymptomatic" are in fact very subjective and can change 
with variables such as ethnicity, age, personality and culture. We would propose 
that each gonococcal study determine its own definition of symptomatic that is 
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most appropriate to the study cohort. For our purposes, we are considering 
these women to be asymptomatic as they did not report to the clinic or another 
physician on their own. 
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CONCLUSIONS AND FUTURE DIRECTIONS 
These experiments are the first to analyze the global transcriptional 
response of the human pathogen N. gonorrhoeae in such depth and under both 
in vitro as well as in vivo infection conditions. The relatively new method of 
global RNA sequencing was combined with novel computer algorithms to 
determine the entire transcriptome of N. gonorrhoeae during in vitro growth. We 
report here several hundred putative sRNAs and confirm the expression of 7 new 
sRNAs in the gonococcus. N. gonorrhoeae contains comparatively few protein 
regulators and as such may be more likely to use sRNA-mediated mechanisms 
of control to regulate genes. This observation combined with the fact that many 
sRNAs known in other organisms are involved in pathogenesis as well as the 
alarming rise in antibiotic resistant strains of N. gonorrhoeae emphasize the 
importance of the continued study of sRNAs in this organism. Future studies 
regarding sRNAs will be focused on determining to which stimuli these sRNAs 
respond and equally importantly, their mRNA or proteins targets. 
The open-source computer program Rockhopper was developed and 
used to identify new sRNAs inN. gonorrhoeae and was then expanded to 
analyze other aspects of the gonococcal transcriptome including transcriptional 
start sites, gene expression levels, and operon structure. In general, we find 
strong correlation between the predictions of Rockhopper and secondary 
methods including primer extension and RT-PCR. There was good correlation 
between Rockhopper and primer extension when analyzing transcriptional start 
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sites, modest correlation when analyzing gene expression levels and high 
sensitivity and modest specificity when predicting operon structure. We found 
that several N. gonorrhoeae genes had a predicted 5' and 3' UTR length of zero. 
This was likely a result of transcriptional start sites internal to the start codon or 
mis-annotation of the start codon for certain genes. Information regarding 
I 
regulation of UTR length as a result of stimuli is lacking in bacteria and RNA 
sequencing combined with other methods could be used to fill this gap. 
Rockhopper was also used to analyze other RNA-seq data sets and it was found 
that longer read lengths generally corresponded with more accurate data. Thus, 
in the future, initial experiments of a bacterial transcriptome may benefit from a 
longer read length whereas subsequent experiments analyzing specific aspects 
of the transcriptome (such as sRNAs) may benefit from shorter read length. 
Finally, as N. gonorrhoeae is a human pathogen, we used Rockhopper 
and other programs to analyze both the host and pathogen transcriptome during 
both incubation of N. gonorrhoeae with host epithelial cells as well as during 
mucosal infection. During incubation with host cell as well as during in vivo 
infection the gonococcus showed high expression of several genes related to 
stress response and host resistance as well as several housekeeping genes. In 
contrast, such genes rarely showed contrasting low levels of expression during 
infection and instead, respiration-related genes showed significantly lower 
expression during incubation with host cells. Several novel sRNAs were also 
regulated during such incubation. 
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The host shows a significant increase in genes related to both innate and 
adaptive immunity as well as cancer and apoptosis related genes. While these 
cells are of a transformed nature the expression of such genes may reflect the 
link between N. gonorrhoeae and modulation of host apoptosis. During mucosal 
infection N. gonorrhoeae highly expresses a core set of genes including those 
involved in stress response as well as several hypothetical and outer membrane 
proteins. RNA-seq also detected several confirmed sRNAs to be expressed 
during mucosal infection. High expression of outer membrane proteins or 
hypothetical proteins may represent novel vaccine targets ideal for future study. 
When examining the host transcriptome there is again a high expression and 
enrichment for genes involved in cancer and apoptosis as well as immunity. 
RNA isolated from these experiments is not from transformed cells but rather 
from a vaginal lavage of natural mucosal infection. While there has currently 
been no definitive link found between gonorrhea and cancer there are 
publications showing a connection between chronic inflammation and cancer 
suggesting the need for further studies . 
Current studies are focused on increasing our cohort of female patients as 
well as isolating infecting strains of N. gonorrhoeae for downstream experiments. 
These studies used 4 female patients for analysis but a robust study of statistical 
significance would likely require 40-50 female patients based on the size of the 
human and gonococcal genomes and the depth of detection. To identify host 
genes which are specifically regulated during infection we plan to also isolate 
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samples from uninfected females to serve as controls. We also plan to expand 
our studies to include clinical samples from male patients. It is possible that the 
symptomatic differences between males and females are a result of 
transcriptomic differences between the host and pathogen that are related to 
gender. RNA sequencing analysis of uninfected males and females compared to 
infected males and females may generate hypotheses as to this disparate 
symptomatic response. 
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